Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,A1BG,Alpha-1B-glycoprotein,3917,422,1.34 [0.77-2.32],0.3010347537278031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AAMDC,Mth938 domain-containing protein,3805,414,1.07 [0.89-1.28],0.4827098949456325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,4485,502,1.00 [0.87-1.15],0.9651580334542438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABCA2,ATP-binding cassette sub-family A member 2,3783,414,1.41 [1.08-1.82],0.0101819581266579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABHD14B,Protein ABHD14B,4458,504,1.00 [0.87-1.15],0.9920077231573428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABL1,Tyrosine-protein kinase ABL1,4485,502,1.07 [0.96-1.20],0.220111259493621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABO,Histo-blood group ABO system transferase,3921,425,1.03 [0.97-1.10],0.3662070720983702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABRAXAS2,BRISC complex subunit Abraxas 2,3783,414,1.05 [0.91-1.21],0.5385735809727806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",4377,493,1.02 [0.94-1.12],0.6100817767323763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",3845,412,1.07 [0.93-1.22],0.3566054923900863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",3900,420,0.93 [0.83-1.03],0.1595881827942487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACAN,Aggrecan core protein,4460,502,1.02 [0.78-1.33],0.9113389710579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACE,Angiotensin-converting enzyme,3921,425,1.37 [0.99-1.91],0.0612011354140685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACE2,Angiotensin-converting enzyme 2,4430,500,0.96 [0.85-1.09],0.551063131091765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACHE,Acetylcholinesterase,3838,411,1.01 [0.78-1.30],0.9614523486280584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACOT13,Acyl-coenzyme A thioesterase 13,3888,421,0.98 [0.90-1.06],0.6283242920440937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,4508,505,0.97 [0.83-1.13],0.6803824035829913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,3792,418,0.89 [0.72-1.10],0.2866208700425443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP5,Tartrate-resistant acid phosphatase type 5,4535,510,1.58 [1.26-1.99],8.625699243618164e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP6,Lysophosphatidic acid phosphatase type 6,4535,508,1.01 [0.89-1.14],0.920899440384215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACRBP,Acrosin-binding protein,3890,418,1.00 [0.79-1.27],0.9726845635068154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACRV1,Acrosomal protein SP-10,3792,418,1.12 [1.02-1.24],0.0208524382592111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,3783,414,1.10 [0.84-1.43],0.4799658047724868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTA2,"Actin, aortic smooth muscle",4430,500,1.55 [1.35-1.77],1.07763125097586e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTN2,Alpha-actinin-2,3783,414,1.10 [0.95-1.27],0.2219794719758966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTN4,Alpha-actinin-4,4402,494,1.21 [0.97-1.50],0.0838874108863352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACVRL1,Serine/threonine-protein kinase receptor R3,4466,505,2.65 [2.08-3.38],4.175595606382386e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACY1,Aminoacylase-1,4508,505,0.93 [0.83-1.03],0.1683340746481468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,3783,414,1.16 [1.00-1.35],0.0442890306236639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACYP1,Acylphosphatase-1,3828,409,0.97 [0.84-1.11],0.635334872235386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA,Adenosine deaminase,4556,506,1.19 [0.97-1.48],0.1013959625040714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA2,Adenosine deaminase 2,4484,500,1.87 [1.61-2.18],3.866508244498319e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,3792,418,1.48 [1.17-1.88],0.0012513969086048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,4430,500,1.35 [1.05-1.73],0.018372457520312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,4473,505,1.42 [1.15-1.74],0.00106091457717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,4556,506,1.44 [1.14-1.82],0.0025420411398179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,4535,507,1.35 [1.04-1.75],0.0246011267047722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,3888,421,2.24 [1.75-2.88],1.807490692784244e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,3792,418,1.18 [0.86-1.60],0.3049668113236116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,4564,512,0.95 [0.70-1.30],0.7595513164832997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,4485,502,1.01 [0.85-1.19],0.9338365639314274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,4430,500,1.02 [0.80-1.31],0.871025507620617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,3792,418,1.05 [0.81-1.37],0.7065411409923001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,4513,505,0.89 [0.76-1.05],0.1720462942563881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL2,ADAMTS-like protein 2,3920,425,1.30 [1.04-1.61],0.0197763555892825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL4,ADAMTS-like protein 4,3805,414,0.96 [0.65-1.41],0.8376681043810861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL5,ADAMTS-like protein 5,3900,420,1.10 [0.87-1.39],0.4121330266052357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,4377,493,1.05 [0.84-1.31],0.6576942759932985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADD1,Alpha-adducin,3838,411,0.96 [0.83-1.09],0.508024158226156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRB3,Adhesion G protein-coupled receptor B3,4466,505,2.04 [1.67-2.49],1.9934749581776344e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRD1,Adhesion G-protein coupled receptor D1,3838,411,1.29 [1.04-1.60],0.0203258430795168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE1,Adhesion G protein-coupled receptor E1,3888,421,1.11 [0.94-1.30],0.2152926904919425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE2,Adhesion G protein-coupled receptor E2,4527,505,2.29 [1.80-2.91],1.4967703344007246e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE5,Adhesion G protein-coupled receptor E5,4547,512,2.29 [1.87-2.79],5.811896793246971e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRF5,Adhesion G protein-coupled receptor F5,3900,420,1.17 [0.83-1.65],0.3569097972189655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG1,Adhesion G-protein coupled receptor G1,4485,502,1.22 [1.14-1.31],4.1206163555394965e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG2,Adhesion G-protein coupled receptor G2,4508,505,0.50 [0.38-0.66],7.636626219034065e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRV1,Adhesion G-protein coupled receptor V1,3781,416,0.98 [0.85-1.13],0.785141555747289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH1B,All-trans-retinol dehydrogenase,3838,411,0.84 [0.75-0.94],0.0019057386827927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,4430,500,0.84 [0.77-0.91],8.59458396423247e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADIPOQ,Adiponectin,3917,422,1.08 [0.96-1.23],0.1983881242292918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADM,Pro-adrenomedullin,4543,508,1.92 [1.44-2.55],7.594856763799288e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADRA2A,Alpha-2A adrenergic receptor,3783,414,0.98 [0.85-1.13],0.7531450676529857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFAP1,Actin filament-associated protein 1,3838,411,1.01 [0.90-1.14],0.8663453887866324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFM,Afamin,3917,422,0.36 [0.24-0.54],6.375328105859507e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFP,Alpha-fetoprotein,4457,503,0.69 [0.61-0.78],7.589734572627236e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGBL2,Cytosolic carboxypeptidase 2,3781,416,1.05 [0.95-1.16],0.3659737529678659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGER,Advanced glycosylation end product-specific receptor,4499,502,1.07 [0.89-1.29],0.447345130226267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR2,Anterior gradient protein 2 homolog,4347,490,1.29 [1.20-1.39],1.0554369415067675e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR3,Anterior gradient protein 3,4370,493,1.20 [1.06-1.37],0.005291592816083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRN,Agrin,4527,505,1.74 [1.46-2.08],8.645471242699213e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRP,Agouti-related protein,4556,506,1.20 [1.04-1.39],0.0138858188612459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGT,Angiotensinogen,3921,425,0.97 [0.65-1.45],0.8855778381028511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGXT,Serine--pyruvate aminotransferase,4508,505,1.00 [0.92-1.10],0.923105610669808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHCY,Adenosylhomocysteinase,4508,505,0.91 [0.81-1.02],0.1093138465713969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,3805,414,0.98 [0.73-1.32],0.8833094625725089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHNAK2,Protein AHNAK2,3805,414,1.38 [1.05-1.80],0.0196397393512358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,3890,418,0.92 [0.79-1.08],0.3078247232188007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSG,Alpha-2-HS-glycoprotein,3921,425,0.86 [0.62-1.19],0.3673858078542195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSP,Alpha-hemoglobin-stabilizing protein,4516,508,0.94 [0.86-1.03],0.1869866216667019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIDA,"Axin interactor, dorsalization-associated protein",3819,418,1.03 [0.92-1.15],0.6333241938454522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIF1,Allograft inflammatory factor 1,4377,493,0.99 [0.85-1.15],0.9056306468106852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIF1L,Allograft inflammatory factor 1-like,3805,414,1.06 [0.90-1.25],0.4992228011954428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",4480,502,1.00 [0.93-1.08],0.9874550170594512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AK1,Adenylate kinase isoenzyme 1,4508,505,0.90 [0.79-1.02],0.0858545048344454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AK2,"Adenylate kinase 2, mitochondrial",3892,422,1.03 [0.94-1.12],0.5337041137946839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKAP12,A-kinase anchor protein 12,3838,411,1.23 [0.79-1.92],0.3573961077910601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1B1,Aldo-keto reductase family 1 member B1,4377,493,1.02 [0.91-1.13],0.7825789899221959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1B10,Aldo-keto reductase family 1 member B10,3819,418,1.01 [0.90-1.13],0.8970639276060368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1C4,Aldo-keto reductase family 1 member C4,4430,500,1.09 [0.95-1.26],0.2331069311334505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,3792,418,0.97 [0.86-1.10],0.6385593692461041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT1S1,Proline-rich AKT1 substrate 1,4377,495,1.01 [0.89-1.13],0.9260508978766676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT2,RAC-beta serine/threonine-protein kinase,3905,425,0.99 [0.92-1.07],0.8822736345696843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT3,RAC-gamma serine/threonine-protein kinase,4350,489,1.02 [0.89-1.17],0.7809904047258289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALCAM,CD166 antigen,4564,512,2.04 [1.43-2.90],7.542936563976144e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH1A1,Retinal dehydrogenase 1,4525,508,0.85 [0.75-0.96],0.009902925517187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",3890,418,0.96 [0.79-1.15],0.6401705705974969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",4495,506,1.02 [0.93-1.12],0.6657697088901002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",3905,425,1.08 [0.89-1.31],0.4615330364643101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALMS1,Alstrom syndrome protein 1,3845,412,1.00 [0.80-1.25],0.975903302568584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPI,Intestinal-type alkaline phosphatase,3792,418,1.12 [1.04-1.20],0.0018220713973379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPP,"Alkaline phosphatase, placental type",4485,502,1.11 [1.03-1.19],0.0068543531114599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBN,Ameloblastin,4402,494,1.03 [0.79-1.34],0.8400419717120569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBP,Protein AMBP,4538,507,3.93 [2.79-5.55],6.639972068988979e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,3920,425,0.87 [0.61-1.25],0.4607852447896829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMFR,E3 ubiquitin-protein ligase AMFR,4377,495,1.05 [0.93-1.20],0.4321173835890775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO1,Amphoterin-induced protein 1,3819,418,0.93 [0.77-1.13],0.4671960200565141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO2,Amphoterin-induced protein 2,4485,502,1.78 [1.29-2.45],0.0003948944035083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMN,Protein amnionless,4402,494,0.94 [0.80-1.11],0.4579920121252552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMOT,Angiomotin,3838,411,0.70 [0.55-0.89],0.0034912408561333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMOTL2,Angiomotin-like protein 2,3874,414,1.01 [0.83-1.23],0.928209151321068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMPD3,AMP deaminase 3,3892,422,1.05 [0.92-1.19],0.4547210723127152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,3683,408,0.89 [0.74-1.07],0.2059322128182864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY2A,Pancreatic alpha-amylase,4331,487,0.92 [0.79-1.07],0.2792157214541348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY2B,Alpha-amylase 2B,4201,474,0.88 [0.75-1.02],0.0966778028232901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANG,Angiogenin,4507,503,1.71 [1.39-2.12],6.787046157194084e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPT1,Angiopoietin-1,4489,500,0.99 [0.90-1.08],0.8044641719706135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPT2,Angiopoietin-2,4543,508,1.39 [1.14-1.70],0.0013771919264274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL1,Angiopoietin-related protein 1,4436,497,1.30 [1.00-1.69],0.0478124297971564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL2,Angiopoietin-related protein 2,4512,504,1.06 [0.88-1.28],0.5090704156634012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL3,Angiopoietin-related protein 3,4517,503,0.77 [0.63-0.95],0.0124018488626537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL4,Angiopoietin-related protein 4,4520,504,1.76 [1.49-2.08],3.812928734560372e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL7,Angiopoietin-related protein 7,4543,508,1.34 [1.12-1.61],0.00154501213553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANK2,Ankyrin-2,3783,414,0.90 [0.77-1.04],0.1476813942945513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,3792,418,0.99 [0.88-1.11],0.8717106578303964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKRA2,Ankyrin repeat family A protein 2,3762,409,1.00 [0.85-1.19],0.9652742700337444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKRD54,Ankyrin repeat domain-containing protein 54,4377,493,0.88 [0.76-1.01],0.072643874330021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,3805,414,0.84 [0.64-1.10],0.212951282693461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANPEP,Aminopeptidase N,4516,505,1.28 [0.99-1.66],0.0631412636902495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA1,Annexin A1,3821,409,0.88 [0.71-1.10],0.2610766895521283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA10,Annexin A10,4377,495,1.16 [1.07-1.26],0.0004586517044487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA11,Annexin A11,4498,506,0.91 [0.81-1.03],0.122010200213342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA2,Annexin A2,3756,409,1.04 [0.91-1.19],0.5257037428867272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA3,Annexin A3,4535,507,0.97 [0.87-1.08],0.5662817691679526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA4,Annexin A4,4486,502,0.93 [0.83-1.04],0.1868966090819007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA5,Annexin A5,4363,492,1.74 [1.44-2.12],1.8426354223669657e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],4402,494,0.97 [0.84-1.12],0.707117543234195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC3,Membrane primary amine oxidase,4526,507,3.18 [2.51-4.03],1.476538346849945e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP1G2,AP-1 complex subunit gamma-like 2,3890,418,1.02 [0.91-1.15],0.6903260862068279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP2B1,AP-2 complex subunit beta,3819,418,1.09 [0.90-1.31],0.3661770010177069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP3B1,AP-3 complex subunit beta-1,3888,421,1.06 [0.93-1.19],0.3866186161263659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP3S2,AP-3 complex subunit sigma-2,3892,422,1.06 [0.88-1.28],0.5203317334221652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,4485,502,1.08 [0.92-1.28],0.3566508920271154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APCS,Serum amyloid P-component,3876,421,0.71 [0.54-0.94],0.0144198342997146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,4529,507,0.93 [0.81-1.06],0.2689830039157718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APLP1,Amyloid-like protein 1,4508,505,0.81 [0.70-0.95],0.0071121761745098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA1,Apolipoprotein A-I,3917,422,0.53 [0.36-0.78],0.0013326958473397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA2,Apolipoprotein A-II,3921,425,1.36 [1.15-1.62],0.0003880786920865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA4,Apolipoprotein A-IV,3917,422,2.44 [1.98-3.01],9.436809156002174e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOB,Apolipoprotein B-100,3921,425,0.86 [0.58-1.29],0.4619656263756683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOBR,Apolipoprotein B receptor,3805,414,0.75 [0.61-0.94],0.0114050557079757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOC1,Apolipoprotein C-I,3908,422,0.53 [0.42-0.68],2.579870963599835e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOD,Apolipoprotein D,3754,403,0.71 [0.55-0.94],0.0150665207568547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOE,Apolipoprotein E,3917,422,0.69 [0.57-0.82],5.0650774462712566e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOF,Apolipoprotein F,3921,425,1.08 [0.85-1.38],0.5113976038849114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOH,Beta-2-glycoprotein 1,4525,508,1.25 [1.02-1.51],0.0274812513886233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOL1,Apolipoprotein L1,3921,425,0.87 [0.74-1.02],0.0785843985205241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOM,Apolipoprotein M,4523,505,0.70 [0.54-0.90],0.0060852646093099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APP,Amyloid-beta precursor protein,4521,508,1.02 [0.91-1.15],0.6944974826700288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APPL2,DCC-interacting protein 13-beta,3838,411,0.97 [0.89-1.06],0.510670371255143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APRT,Adenine phosphoribosyltransferase,4470,505,1.07 [0.90-1.27],0.4258837695047209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARAF,Serine/threonine-protein kinase A-Raf,3845,412,1.07 [0.94-1.23],0.2980427999935716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AREG,Amphiregulin,4485,502,1.95 [1.69-2.25],4.006599565752704e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARF6,ADP-ribosylation factor 6,3888,421,1.01 [0.93-1.10],0.7926192346013368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARFIP1,Arfaptin-1,3905,425,1.01 [0.88-1.15],0.9196374482496388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARG1,Arginase-1,4470,503,0.90 [0.78-1.04],0.1441218155978273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARG2,"Arginase-2, mitochondrial",3890,418,1.09 [0.88-1.35],0.4064659731736291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP1,Rho GTPase-activating protein 1,4377,493,0.91 [0.76-1.08],0.2797975711747876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP25,Rho GTPase-activating protein 25,4377,493,1.00 [0.87-1.14],0.990338055468958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP30,Rho GTPase-activating protein 30,3845,412,1.12 [0.89-1.42],0.3394905846338047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP45,Rho GTPase-activating protein 45,3838,411,0.96 [0.86-1.08],0.4995039931585681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP5,Rho GTPase-activating protein 5,3762,409,1.05 [0.93-1.18],0.4661743810763383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,3892,422,1.00 [0.90-1.11],0.9966005546523375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,3905,425,0.97 [0.87-1.07],0.4819567521650786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,4504,507,0.98 [0.91-1.06],0.6348429955389521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,3781,416,1.18 [1.05-1.33],0.0050248199702125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARID3A,AT-rich interactive domain-containing protein 3A,3781,416,0.95 [0.74-1.23],0.6960342632202468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARID4B,AT-rich interactive domain-containing protein 4B,4377,495,0.98 [0.81-1.19],0.8467683946592626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARL13B,ADP-ribosylation factor-like protein 13B,3783,414,1.01 [0.88-1.16],0.8680755200361645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,3783,414,0.91 [0.72-1.16],0.4610214971837882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,3781,416,0.91 [0.76-1.08],0.2795110543839297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,4402,494,1.07 [0.87-1.31],0.5429691377684163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,3783,414,0.89 [0.72-1.08],0.2347577831049903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARSA,Arylsulfatase A,4525,508,0.96 [0.81-1.12],0.5848494360276062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARSB,Arylsulfatase B,4485,502,0.94 [0.82-1.08],0.4023934946897407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART3,Ecto-ADP-ribosyltransferase 3,4526,507,1.66 [1.36-2.01],4.4405689552816843e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART5,Ecto-ADP-ribosyltransferase 5,3781,416,1.02 [0.88-1.18],0.7890569636981823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARTN,Artemin,4402,494,0.96 [0.79-1.16],0.6865638312421414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASAH1,Acid ceramidase,3897,423,1.06 [0.87-1.29],0.5664877560144679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASAH2,Neutral ceramidase,4473,505,0.95 [0.83-1.10],0.5219941111482127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR1,Asialoglycoprotein receptor 1,4473,505,1.69 [1.34-2.12],7.355699854718005e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR2,Asialoglycoprotein receptor 2,3921,425,2.03 [1.49-2.76],6.93771429645111e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASPN,Asporin,3900,420,1.35 [0.99-1.84],0.0545530651593453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASPSCR1,Tether containing UBX domain for GLUT4,3905,425,0.98 [0.85-1.13],0.8126285874729998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,3805,414,0.98 [0.89-1.08],0.7177748534927504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASS1,Argininosuccinate synthase,3783,414,0.96 [0.86-1.07],0.4796571027280272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,4377,495,1.09 [0.98-1.21],0.0961342527989036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,3762,409,0.82 [0.62-1.09],0.1778240476750118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATG16L1,Autophagy-related protein 16-1,3888,421,1.00 [0.90-1.12],0.9762828807949024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATG4A,Cysteine protease ATG4A,4377,493,1.00 [0.88-1.14],0.9837308308695488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATOX1,Copper transport protein ATOX1,4513,505,1.08 [0.96-1.21],0.1794550541415968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,3783,414,1.25 [1.05-1.49],0.0135237824562473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,3783,414,1.12 [0.87-1.43],0.3739765325274917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,3783,414,1.21 [0.97-1.51],0.0898760217455747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B4,Protein ATP1B4,3762,409,1.09 [0.87-1.36],0.4577519552779153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,3783,414,1.01 [0.87-1.18],0.8699745221357131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",3783,414,1.13 [0.94-1.36],0.1998746830775507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5IF1,"ATPase inhibitor, mitochondrial",4527,505,1.01 [0.94-1.09],0.7593240941342677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5PO,"ATP synthase subunit O, mitochondrial",4377,495,1.12 [0.96-1.30],0.1525243496724035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6AP2,Renin receptor,4377,493,1.18 [0.97-1.43],0.1036569868761749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1D,V-type proton ATPase subunit D,4485,502,1.29 [1.00-1.68],0.0534737486082817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1F,V-type proton ATPase subunit F,4368,494,0.94 [0.84-1.07],0.3609774273099754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1G1,V-type proton ATPase subunit G 1,3805,414,1.02 [0.90-1.17],0.713577200284311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1G2,V-type proton ATPase subunit G 2,3783,414,0.95 [0.85-1.05],0.3121501865619114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRAID,All-trans retinoic acid-induced differentiation factor,3888,421,2.05 [1.62-2.61],4.094144017855636e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRN,"Attractin, Isoform 2",3917,422,0.86 [0.51-1.48],0.5943584510717661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN10,Ataxin-10,4377,495,1.03 [0.92-1.14],0.6555520587267997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN2,Ataxin-2,3781,416,0.99 [0.91-1.08],0.788154213084912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN2L,Ataxin-2-like protein,3905,425,0.97 [0.80-1.17],0.7415546152658098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN3,Ataxin-3,3892,422,0.99 [0.85-1.15],0.900734223906986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXIN1,Axin-1,4504,507,0.97 [0.89-1.05],0.4211358520147428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXL,Tyrosine-protein kinase receptor UFO,4526,507,1.68 [1.29-2.19],0.0001169242695576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AZI2,5-azacytidine-induced protein 2,3905,425,0.94 [0.79-1.11],0.4472436810390059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AZU1,Azurocidin,4387,494,0.95 [0.86-1.05],0.3163426149856511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B2M,Beta-2-microglobulin,3917,422,2.16 [1.68-2.79],2.2602738796106147e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,3783,414,0.95 [0.60-1.53],0.8459575058896646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",3805,414,3.01 [2.35-3.86],2.204045757886936e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",4527,505,2.22 [1.73-2.85],3.3486158188392016e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",4525,508,1.32 [0.96-1.82],0.0915808138879937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BABAM1,BRISC and BRCA1-A complex member 1,3792,418,1.01 [0.71-1.43],0.9751457061702128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BACH1,Transcription regulator protein BACH1,4504,507,0.92 [0.82-1.02],0.1212065335582574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG3,BAG family molecular chaperone regulator 3,4466,505,0.89 [0.75-1.07],0.2239995710619058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG4,BAG family molecular chaperone regulator 4,3792,418,0.95 [0.78-1.15],0.5843225769989205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG6,Large proline-rich protein BAG6,4430,500,1.02 [0.83-1.27],0.8314048017850152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,4377,493,1.13 [1.02-1.26],0.0251792033952742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,4377,493,1.70 [1.38-2.09],6.035494098470809e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BANK1,B-cell scaffold protein with ankyrin repeats,4504,507,0.96 [0.89-1.03],0.2568642997609405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAP18,Chromatin complexes subunit BAP18,3892,422,0.90 [0.78-1.03],0.1314981254346035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BATF,Basic leucine zipper transcriptional factor ATF-like,3819,418,0.99 [0.88-1.11],0.848707706936066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAX,Apoptosis regulator BAX,4370,494,1.07 [0.98-1.17],0.155874918932701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAM,Basal cell adhesion molecule,4525,508,1.73 [1.27-2.35],0.0004606210099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAN,Brevican core protein,4473,505,0.52 [0.42-0.64],1.0969129808396524e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",3900,420,0.86 [0.63-1.17],0.3467218093324693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",3781,416,0.87 [0.71-1.07],0.1953728143580149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCHE,Cholinesterase,3855,421,0.99 [0.71-1.37],0.9362664462747462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2,Apoptosis regulator Bcl-2,3888,421,1.17 [1.00-1.37],0.0568806981139238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L1,Bcl-2-like protein 1,3892,422,1.00 [0.91-1.10],0.94590577066488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",4504,507,1.61 [1.31-1.98],6.62337665571866e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L15,Bcl-2-like protein 15,3792,418,1.13 [0.98-1.30],0.0930700702402218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,3762,409,0.98 [0.84-1.14],0.800447299953249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,3890,418,0.95 [0.76-1.19],0.6493303182938986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCR,Breakpoint cluster region protein,4504,507,1.00 [0.92-1.09],0.9806037242292864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BDNF,Brain-derived neurotrophic factor,3920,425,0.99 [0.89-1.11],0.9022871377137636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BECN1,Beclin-1,3805,414,0.99 [0.85-1.17],0.942268095942781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BEX3,Protein BEX3,3762,409,1.11 [0.94-1.32],0.2118465516708118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGLAP,Osteocalcin,3920,425,0.75 [0.69-0.82],4.1685342133466326e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGN,Biglycan,4372,492,1.02 [0.96-1.09],0.5164967335644352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BHLHE40,Class E basic helix-loop-helix protein 40,3781,416,1.07 [0.95-1.22],0.2736591105906591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,3783,414,0.92 [0.63-1.35],0.687244302209207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BID,BH3-interacting domain death agonist,4504,507,0.97 [0.86-1.09],0.592778240086713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BIN2,Bridging integrator 2,4525,508,0.96 [0.88-1.05],0.3868774258855413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BIRC2,Baculoviral IAP repeat-containing protein 2,4377,493,1.05 [0.92-1.19],0.496645403438125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLMH,Bleomycin hydrolase,4564,512,0.87 [0.69-1.10],0.2428818431514976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLNK,B-cell linker protein,3792,418,0.91 [0.71-1.16],0.4307034324340946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,3781,416,1.00 [0.89-1.14],0.9678240935512984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,3892,422,0.94 [0.74-1.18],0.5716224318283486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLVRB,Flavin reductase,4525,508,0.95 [0.85-1.07],0.4204659584762801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP10,Bone morphogenetic protein 10,3838,411,1.79 [1.34-2.41],0.0001017536500837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP4,Bone morphogenetic protein 4,4466,505,1.16 [0.99-1.35],0.0594303962119203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP6,Bone morphogenetic protein 6,4426,500,0.99 [0.81-1.21],0.9208039748903676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMPER,BMP-binding endothelial regulator protein,3838,411,2.44 [1.72-3.46],6.652051903160031e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,3900,420,1.02 [0.76-1.36],0.9006806455203051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,3792,418,1.12 [0.91-1.38],0.2885530129759877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOC,Brother of CDO,4430,500,2.68 [1.94-3.68],1.6202492301727275e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOLA1,BolA-like protein 1,3781,416,1.06 [0.90-1.25],0.4607211916683639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOLA2_BOLA2B,BolA-like protein 2,3805,414,0.92 [0.77-1.09],0.3391086659508833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFA2,BPI fold-containing family A member 2,3689,402,1.07 [0.98-1.16],0.1159439365287353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFB1,BPI fold-containing family B member 1,4493,503,1.05 [0.93-1.18],0.4486222313102866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFB2,BPI fold-containing family B member 2,3894,419,0.87 [0.77-0.99],0.0381423704764272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRAP,BRCA1-associated protein,3847,418,1.02 [0.94-1.12],0.616584346192591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD1,Bromodomain-containing protein 1,3845,412,1.12 [0.83-1.50],0.4527966048549504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD2,Bromodomain-containing protein 2,3781,416,0.96 [0.72-1.28],0.7873912311039394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD3,Bromodomain-containing protein 3,3783,414,0.94 [0.76-1.17],0.586146872347947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRDT,Bromodomain testis-specific protein,3783,414,1.07 [0.83-1.39],0.5908161489764725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRK1,Protein BRICK1,4377,495,1.26 [1.06-1.49],0.0070842801296842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRME1,Break repair meiotic recombinase recruitment factor 1,3781,416,1.04 [0.81-1.33],0.7731847061040785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRSK2,Serine/threonine-protein kinase BRSK2,3905,425,1.02 [0.80-1.31],0.8632196734723268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSG,Basigin,4548,506,2.07 [1.48-2.89],2.3124021782372443e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSND,Barttin,3762,409,1.28 [1.00-1.63],0.0480005352059227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,4541,507,1.15 [0.95-1.39],0.1589147863454025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BST2,Bone marrow stromal antigen 2,4541,507,1.10 [0.96-1.25],0.1715445532963103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTC,Probetacellulin,4377,493,0.98 [0.88-1.10],0.7663437754429689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTD,Biotinidase,3917,422,1.50 [0.96-2.35],0.0729540529940936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTLA,B- and T-lymphocyte attenuator,3762,409,0.99 [0.89-1.10],0.8241235751070746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN1A1,Butyrophilin subfamily 1 member A1,3884,418,1.11 [0.89-1.39],0.3606348033193759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN2A1,Butyrophilin subfamily 2 member A1,4527,505,2.67 [2.15-3.32],6.737248650763448e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN3A2,Butyrophilin subfamily 3 member A2,4504,507,1.42 [1.15-1.74],0.0008633663044344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTNL10,Butyrophilin-like protein 10,3762,409,0.98 [0.77-1.26],0.8961466450598536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C19orf12,Protein C19orf12,4377,495,0.91 [0.82-1.01],0.0669919878722952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1GALT1C1,C1GALT1-specific chaperone 1,3783,414,1.10 [0.83-1.45],0.5127683213322157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QA,Complement C1q subcomponent subunit A,4532,504,1.54 [1.11-2.14],0.0095677608030769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",3905,425,1.02 [0.89-1.16],0.8106399579775777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QL2,Complement C1q-like protein 2,3792,418,0.75 [0.60-0.93],0.0105672681597115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,4526,507,1.39 [1.20-1.61],1.0503327507829786e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,3838,411,0.76 [0.59-0.98],0.0316803361617543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,3905,425,1.10 [0.84-1.46],0.4855841640335356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,3832,410,0.86 [0.71-1.03],0.0958200610928766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1R,Complement C1r subcomponent,3917,422,0.49 [0.27-0.88],0.017355375464515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1RL,Complement C1r subcomponent-like protein,3908,422,1.54 [0.97-2.45],0.0699617302317272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1S,Complement C1s subcomponent,3917,422,0.75 [0.50-1.13],0.1657280215936674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2,Complement C2,4523,505,2.88 [1.94-4.28],1.643092414874641e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2CD2L,Phospholipid transfer protein C2CD2L,4368,494,1.07 [0.88-1.29],0.4942019276031811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2orf69,UPF0565 protein C2orf69,3819,418,1.07 [0.92-1.26],0.3780877334660663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C3,Complement C3,3710,400,0.93 [0.75-1.16],0.5373079372144544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C4BPB,C4b-binding protein beta chain,4513,505,1.07 [0.89-1.30],0.4661577564522815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C5,Complement C5,3917,422,1.23 [0.67-2.26],0.4955741687972731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7,Complement component C7,3818,416,2.55 [1.99-3.27],1.8708724293512889e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7orf50,Uncharacterized protein C7orf50,3892,422,0.96 [0.63-1.47],0.8530900282138237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C8B,Complement component C8 beta chain,3917,422,0.74 [0.55-0.99],0.0460032552755704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C9,Complement component C9,3921,425,1.05 [0.91-1.22],0.4987204936692069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C9orf40,Uncharacterized protein C9orf40,3888,421,0.94 [0.84-1.06],0.3194326481423205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA1,Carbonic anhydrase 1,4434,495,0.94 [0.83-1.07],0.3433697196834566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA11,Carbonic anhydrase-related protein 11,4377,493,1.14 [0.94-1.39],0.1683344084190855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA12,Carbonic anhydrase 12,4485,502,2.36 [2.00-2.78],1.5618746074635575e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA13,Carbonic anhydrase 13,4462,496,0.99 [0.92-1.07],0.7590681531479593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA14,Carbonic anhydrase 14,4543,508,1.50 [1.24-1.83],3.9069315573002125e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA2,Carbonic anhydrase 2,4512,508,0.97 [0.87-1.08],0.5524263450421115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA3,Carbonic anhydrase 3,4559,511,1.12 [1.00-1.27],0.0594235016673941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA4,Carbonic anhydrase 4,4564,512,1.67 [1.25-2.23],0.000537152681215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",4430,500,0.95 [0.87-1.03],0.186590139767041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA6,Carbonic anhydrase 6,4505,501,0.97 [0.86-1.09],0.5984758879211158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA7,Carbonic anhydrase 7,3845,412,0.97 [0.72-1.29],0.8119831600990541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA8,Carbonic anhydrase-related protein,3792,418,1.00 [0.69-1.46],0.9926405920743812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA9,Carbonic anhydrase 9,4543,508,1.54 [1.35-1.75],5.14188754580504e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CABP2,Calcium-binding protein 2,3819,418,1.09 [0.94-1.26],0.2615591309912167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,3781,416,1.00 [0.74-1.36],0.9884462106379592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,3783,414,1.01 [0.86-1.18],0.9220253204161096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,3781,416,1.10 [0.95-1.27],0.2164354502226454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,3905,425,1.00 [0.90-1.12],0.9579970864063088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACYBP,Calcyclin-binding protein,3832,409,0.97 [0.88-1.06],0.4813279045478288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CADPS,Calcium-dependent secretion activator 1,3819,418,1.00 [0.80-1.25],0.990880021924508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB1,Calbindin,4485,502,1.23 [1.03-1.46],0.0202635305465773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB2,Calretinin,4377,495,1.84 [1.47-2.31],1.4429436820125537e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCA,Calcitonin,4464,504,1.31 [1.17-1.45],8.955442632816388e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCB,Calcitonin gene-related peptide 2,3892,422,1.34 [1.12-1.60],0.0011270534497928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,4526,507,0.97 [0.90-1.05],0.430126719553023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,3805,414,1.02 [0.90-1.16],0.7685276286790375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALY,Neuron-specific vesicular protein calcyon,3783,414,0.81 [0.61-1.08],0.1449030435681005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,4377,493,1.17 [0.98-1.40],0.0774964335128278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,3819,418,1.06 [0.89-1.26],0.5045305048867175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,3905,425,0.98 [0.89-1.07],0.5926471878211913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CANT1,Soluble calcium-activated nucleotidase 1,4492,503,1.45 [1.01-2.10],0.046472562813102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPG,Macrophage-capping protein,4474,499,1.12 [0.99-1.28],0.0745134683307493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPN3,Calpain-3,3890,418,1.01 [0.79-1.31],0.9080785270267276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPS,Calcyphosin,3892,422,0.99 [0.90-1.09],0.858495486638977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CARHSP1,Calcium-regulated heat-stable protein 1,4377,495,0.98 [0.84-1.14],0.7781970993588734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASC3,Protein CASC3,3819,418,1.07 [0.86-1.33],0.5346492375846278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP1,Caspase-1,4377,495,0.98 [0.88-1.10],0.740580632136944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP10,Caspase-10,4377,495,0.96 [0.86-1.08],0.492051312004046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP2,Caspase-2,4504,507,0.96 [0.86-1.08],0.5040210200468465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP3,Caspase-3,4564,512,1.00 [0.91-1.09],0.9581731128805032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP4,Caspase-4,3845,412,0.99 [0.94-1.05],0.7920410096812128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP7,Caspase-7,3892,422,0.98 [0.87-1.10],0.736087500205612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP8,Caspase-8,4530,507,0.99 [0.88-1.12],0.8836061619925695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP9,Caspase-9,3792,418,0.95 [0.81-1.11],0.5128446713623209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASQ2,Calsequestrin-2,3783,414,0.96 [0.76-1.20],0.707804488262505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAT,Catalase,3859,418,0.92 [0.78-1.09],0.3429732238808955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLIF,Cobalamin binding intrinsic factor,4506,503,1.18 [1.08-1.29],0.0003849838687405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLN1,Cerebellin-1,3781,416,1.02 [0.92-1.14],0.6602920504484451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLN4,Cerebellin-4,4543,508,0.69 [0.55-0.86],0.0011828964768166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBS,Cystathionine beta-synthase,3805,414,0.82 [0.69-0.98],0.0259419562796496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBX2,Chromobox protein homolog 2,3783,414,1.05 [0.82-1.33],0.712806999652221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,4473,505,0.99 [0.89-1.10],0.8721385959643119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCAR2,Cell cycle and apoptosis regulator protein 2,3892,422,1.13 [0.97-1.31],0.1109887820024826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC134,Coiled-coil domain-containing protein 134,3890,418,1.19 [0.99-1.44],0.0683275196006459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC28A,Coiled-coil domain-containing protein 28A,3819,418,1.20 [0.88-1.64],0.2581587305718671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC50,Coiled-coil domain-containing protein 50,3905,425,1.04 [0.92-1.17],0.5592171224750997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC80,Coiled-coil domain-containing protein 80,4508,505,1.34 [1.09-1.64],0.0058753165370639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,3805,414,0.98 [0.85-1.13],0.7632992655802775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL11,Eotaxin,4556,506,1.92 [1.57-2.35],1.8205303227384843e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL13,C-C motif chemokine 13,4548,505,1.04 [0.93-1.16],0.5293058988603396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL14,C-C motif chemokine 14,4507,503,1.45 [1.21-1.73],6.692341603718205e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL15,C-C motif chemokine 15,4564,512,1.74 [1.50-2.02],3.3870085850830465e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL16,C-C motif chemokine 16,4564,512,1.19 [1.03-1.36],0.0142345069791766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL17,C-C motif chemokine 17,4503,504,1.00 [0.92-1.09],0.9619806530458468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL18,C-C motif chemokine 18,4465,499,0.98 [0.87-1.09],0.6760019169744088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL19,C-C motif chemokine 19,4541,507,0.98 [0.93-1.05],0.6129769661996683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL2,C-C motif chemokine 2,4466,505,1.12 [0.96-1.29],0.147518753435504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL20,C-C motif chemokine 20,4556,506,1.07 [0.99-1.16],0.1035971179261131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL21,C-C motif chemokine 21,4527,505,1.33 [1.16-1.52],3.0025179114843926e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL22,C-C motif chemokine 22,4471,502,0.94 [0.81-1.09],0.3865269860591229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL23,C-C motif chemokine 23,4527,505,0.95 [0.80-1.13],0.5584126621914425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL24,C-C motif chemokine 24,4520,504,1.03 [0.94-1.13],0.5402013648415451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL25,C-C motif chemokine 25,4556,506,1.73 [1.47-2.02],2.1138696505197542e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL26,C-C motif chemokine 26,4504,507,0.95 [0.87-1.03],0.2351151372508274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL27,C-C motif chemokine 27,4508,505,0.99 [0.88-1.13],0.9351558555616828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL28,C-C motif chemokine 28,4489,505,1.17 [1.03-1.32],0.0125577347013657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL3,C-C motif chemokine 3,4504,507,1.09 [1.00-1.19],0.0411608197899849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL4,C-C motif chemokine 4,4517,505,1.02 [0.91-1.15],0.749341655506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL5,C-C motif chemokine 5,4526,507,0.98 [0.91-1.06],0.5821522782141677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL7,C-C motif chemokine 7,4504,507,1.16 [1.01-1.32],0.0309046165327941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL8,C-C motif chemokine 8,4538,507,1.11 [0.98-1.27],0.1053766023440306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN1,CCN family member 1,4480,501,0.95 [0.85-1.05],0.3143981781766427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN2,CCN family member 2,4506,503,1.02 [0.88-1.17],0.8301824586115935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN3,CCN family member 3,4550,512,1.46 [1.20-1.78],0.0001880332031311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN4,CCN family member 4,4543,508,1.67 [1.40-1.99],1.1745828239925576e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN5,CCN family member 5,4525,508,1.54 [1.28-1.86],6.547597048314057e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCND2,G1/S-specific cyclin-D2,3845,412,0.96 [0.75-1.23],0.7525940704185029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCNE1,G1/S-specific cyclin-E1,3792,418,0.94 [0.82-1.07],0.3335676055677623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCS,Copper chaperone for superoxide dismutase,4473,505,0.83 [0.71-0.98],0.0321230879136069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCT5,T-complex protein 1 subunit epsilon,4377,493,0.92 [0.77-1.10],0.3757807031214504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD101,Immunoglobulin superfamily member 2,3888,421,1.31 [1.06-1.62],0.0134406022321547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD109,CD109 antigen,4525,508,1.67 [1.34-2.08],5.871400628612227e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD14,Monocyte differentiation antigen CD14,4439,496,1.81 [1.51-2.16],5.776806521272817e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD160,CD160 antigen,4556,506,1.73 [1.50-2.00],5.3811512163470993e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,4526,507,1.35 [1.14-1.59],0.0005512241829454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164,Sialomucin core protein 24,4525,508,1.54 [1.33-1.77],3.4403500972661404e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164L2,CD164 sialomucin-like 2 protein,3819,418,1.18 [0.93-1.50],0.1641365174577576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD177,CD177 antigen,4514,508,0.99 [0.93-1.05],0.6371870059218356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD1C,T-cell surface glycoprotein CD1c,4513,505,0.69 [0.52-0.91],0.0083177509978905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD2,T-cell surface antigen CD2,3783,414,1.19 [0.97-1.46],0.1007905516988373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200,OX-2 membrane glycoprotein,4504,507,1.79 [1.40-2.29],3.837008228450434e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,4490,506,1.05 [0.84-1.31],0.6939692951565173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD207,C-type lectin domain family 4 member K,4413,497,1.68 [1.39-2.03],7.02071588545721e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD209,CD209 antigen,4523,508,1.12 [0.91-1.38],0.289703700907562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD22,B-cell receptor CD22,4556,506,1.11 [0.93-1.32],0.2355163599379418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD226,CD226 antigen,3792,418,1.06 [0.85-1.33],0.5908005542113781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD244,Natural killer cell receptor 2B4,4556,506,1.35 [1.03-1.76],0.028705567443297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD248,Endosialin,3920,425,0.86 [0.69-1.06],0.1631453573119409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD27,CD27 antigen,4513,505,2.32 [2.00-2.69],6.081150152007033e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD274,Programmed cell death 1 ligand 1,4473,505,1.48 [1.21-1.81],0.000151415064515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD276,CD276 antigen,4504,504,2.54 [2.10-3.07],3.464491832521821e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD28,T-cell-specific surface glycoprotein CD28,4377,493,1.65 [1.36-2.00],4.867074562284329e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD2AP,CD2-associated protein,4508,505,1.00 [0.88-1.13],0.9915840086412976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300A,CMRF35-like molecule 8,3838,411,1.53 [1.14-2.05],0.0046134302703538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300C,CMRF35-like molecule 6,4541,507,1.68 [1.37-2.06],6.393880829113209e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300E,CMRF35-like molecule 2,4527,505,1.52 [1.28-1.80],2.024029034128679e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LF,CMRF35-like molecule 1,4543,508,1.19 [1.06-1.34],0.0046533573418855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LG,CMRF35-like molecule 9,4525,508,1.42 [1.17-1.72],0.0003096370004471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD302,CD302 antigen,4485,502,2.09 [1.72-2.55],3.0575661802732896e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD33,Myeloid cell surface antigen CD33,4513,505,1.02 [0.92-1.13],0.6628487291459968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD34,Hematopoietic progenitor cell antigen CD34,4529,505,1.16 [0.85-1.58],0.3570761172544224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD36,Platelet glycoprotein 4,3792,418,1.21 [1.00-1.47],0.0500969046193568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4485,502,1.40 [1.12-1.75],0.003073655848176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3D,T-cell surface glycoprotein CD3 delta chain,3781,416,1.06 [0.79-1.42],0.7146893443895435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,3845,412,0.98 [0.73-1.32],0.9147112663348532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,3792,418,0.97 [0.86-1.08],0.551235339736438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD4,T-cell surface glycoprotein CD4,4498,506,1.55 [1.23-1.94],0.000148415801594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40,Tumor necrosis factor receptor superfamily member 5,4510,504,1.29 [1.11-1.48],0.0005762843771272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40LG,CD40 ligand,4556,506,0.97 [0.88-1.07],0.5714644076829771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD46,Membrane cofactor protein,4488,499,2.00 [1.55-2.56],6.1756241665878e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD48,CD48 antigen,4520,504,1.98 [1.54-2.55],1.0618391101384449e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5,T-cell surface glycoprotein CD5,4538,507,1.81 [1.50-2.19],1.0881307761197932e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD55,Complement decay-accelerating factor,4350,485,1.93 [1.50-2.50],4.608917416540668e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD58,Lymphocyte function-associated antigen 3,4494,502,1.20 [0.78-1.85],0.4158609539681267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD59,CD59 glycoprotein,4336,488,2.20 [1.68-2.88],8.840452420024645e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5L,CD5 antigen-like,3898,422,0.99 [0.82-1.19],0.8923128496471976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD6,T-cell differentiation antigen CD6,4548,506,0.93 [0.80-1.08],0.3103268392846339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD63,CD63 antigen,4466,505,1.08 [0.92-1.28],0.3235675936506609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD69,Early activation antigen CD69,4487,503,0.97 [0.89-1.06],0.5460927250519528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD7,T-cell antigen CD7,3781,417,1.46 [1.19-1.78],0.0002345044868152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD70,CD70 antigen,4504,507,1.32 [1.11-1.58],0.002167101371676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD72,B-cell differentiation antigen CD72,3838,411,1.22 [0.99-1.50],0.0662204659944134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD74,HLA class II histocompatibility antigen gamma chain,4541,507,2.15 [1.75-2.63],1.9083980161996437e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,4556,506,1.70 [1.46-1.98],6.6196307662510615e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD80,T-lymphocyte activation antigen CD80,3900,420,1.65 [1.30-2.09],3.4942319505454495e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD82,CD82 antigen,3845,412,0.92 [0.73-1.16],0.4724493383315631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD83,CD83 antigen,4504,507,1.58 [1.29-1.94],1.0331761741673992e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD84,SLAM family member 5,4504,507,0.88 [0.69-1.12],0.310892016355321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD86,T-lymphocyte activation antigen CD86,3888,421,0.88 [0.65-1.19],0.4185723372212545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,4541,507,1.24 [1.07-1.43],0.0037017167039915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD93,Complement component C1q receptor,4363,484,1.52 [1.20-1.92],0.0004918434672565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99,CD99 antigen,4525,508,2.33 [1.62-3.35],4.777984980340456e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99L2,CD99 antigen-like protein 2,4525,508,1.48 [1.09-2.01],0.0111045840906624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDA,Cytidine deaminase,3896,420,0.77 [0.63-0.93],0.0084084991746373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDAN1,Codanin-1,3892,422,1.02 [0.69-1.49],0.9355373404550464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC123,Cell division cycle protein 123 homolog,3762,409,0.91 [0.78-1.07],0.2599292080672388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC25A,M-phase inducer phosphatase 1,3762,409,0.98 [0.75-1.28],0.8833076953811521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC26,Anaphase-promoting complex subunit CDC26,3881,419,1.03 [0.90-1.18],0.6512168688397562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC27,Cell division cycle protein 27 homolog,4377,493,1.09 [0.96-1.23],0.2081974619959101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC37,Hsp90 co-chaperone Cdc37,4513,505,1.00 [0.91-1.09],0.9416086034515294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,3888,421,0.97 [0.88-1.06],0.4845496693012371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDCP1,CUB domain-containing protein 1,4473,505,1.18 [1.03-1.34],0.0147706228065644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH1,Cadherin-1,4352,489,2.01 [1.77-2.27],5.5722728840699175e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH15,Cadherin-15,4532,506,1.20 [1.09-1.31],0.0001943778535818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH17,Cadherin-17,4508,505,1.51 [1.37-1.66],1.0734784285503577e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH2,Cadherin-2,4508,505,1.08 [0.88-1.31],0.4677922949809161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH22,Cadherin-22,3845,412,1.20 [0.87-1.67],0.2668197426751541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH23,Cadherin-23,3892,422,1.45 [1.02-2.06],0.0360076615821002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH3,Cadherin-3,4541,507,1.54 [1.27-1.87],9.205008190890953e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH4,Cadherin-4,3781,416,1.00 [0.82-1.22],0.9869883754310416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH5,Cadherin-5,4564,512,1.29 [1.02-1.65],0.0365214783792203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH6,Cadherin-6,4508,505,1.29 [1.07-1.56],0.007273642738356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR1,Cadherin-related family member 1,4377,495,1.02 [0.85-1.22],0.8512736299250495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR2,Cadherin-related family member 2,4485,502,0.84 [0.75-0.93],0.0011257985436556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR5,Cadherin-related family member 5,4508,505,0.88 [0.72-1.07],0.2051889650199905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDK1,Cyclin-dependent kinase 1,3762,409,1.08 [0.84-1.40],0.547082907619002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,3905,425,1.02 [0.87-1.19],0.824432232735676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKL5,Cyclin-dependent kinase-like 5,3781,416,1.12 [0.94-1.32],0.2077312231756791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,4485,502,1.01 [0.94-1.09],0.7246129085364914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,4485,502,0.98 [0.90-1.07],0.6703030492390469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDNF,Cerebral dopamine neurotrophic factor,4485,502,1.35 [1.13-1.61],0.0008664378485013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,4513,504,1.56 [1.17-2.07],0.0024657663216962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDSN,Corneodesmosin,4537,506,1.27 [1.07-1.51],0.0060363657007741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,4503,504,0.99 [0.77-1.28],0.9498978405300372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,3888,421,0.90 [0.81-1.01],0.0793358912698915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,3845,412,1.01 [0.90-1.14],0.8384228698655076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,3888,421,1.08 [0.86-1.36],0.5087304351824377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,3845,412,1.20 [0.98-1.46],0.070762317406075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,4504,507,1.16 [1.07-1.26],0.0005608512208388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,4377,493,1.04 [0.88-1.23],0.626826649881504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,4331,490,1.27 [1.13-1.43],7.931904060586732e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,3920,425,1.07 [0.85-1.34],0.5517867992370785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,4430,500,1.05 [0.90-1.23],0.4978560671689432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEBPA,CCAAT/enhancer-binding protein alpha,3792,418,0.98 [0.75-1.29],0.9085433655657752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEBPB,CCAAT/enhancer-binding protein beta,4430,500,0.81 [0.65-1.00],0.0467121056486745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELA2A,Chymotrypsin-like elastase family member 2A,3920,425,0.96 [0.84-1.09],0.5252469656464394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELA3A,Chymotrypsin-like elastase family member 3A,4558,512,1.00 [0.89-1.12],0.9632941839422562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,3838,411,0.89 [0.65-1.22],0.46781732865072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEMIP2,Cell surface hyaluronidase,3792,418,0.90 [0.67-1.22],0.507630792653474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,3781,416,1.05 [0.90-1.21],0.5400068207431032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CENPF,Centromere protein F,3845,412,0.97 [0.82-1.15],0.7278850072672784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CENPJ,Centromere protein J,3845,412,1.11 [0.98-1.25],0.1051743191150575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP112,Centrosomal protein of 112 kDa,3783,414,0.88 [0.69-1.11],0.2754337827765537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP152,Centrosomal protein of 152 kDa,3762,409,0.96 [0.76-1.20],0.7171463762693435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP164,Centrosomal protein of 164 kDa,4402,494,1.08 [0.97-1.21],0.1403090336422845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP170,Centrosomal protein of 170 kDa,3805,414,0.99 [0.87-1.13],0.8922443119558452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP20,Centrosomal protein 20,4377,493,1.03 [0.93-1.15],0.5329280465381436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP290,Centrosomal protein of 290 kDa,3845,412,1.00 [0.84-1.19],0.9857097137440992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP350,Centrosome-associated protein 350,3762,409,1.05 [0.80-1.37],0.7193683855332876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP43,Centrosomal protein 43,4400,494,1.02 [0.91-1.15],0.6904709482428683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP85,Centrosomal protein of 85 kDa,4377,493,0.94 [0.83-1.07],0.3501879472441794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CERT,Ceramide transfer protein,4377,495,1.00 [0.87-1.14],0.9634223076897503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES1,Liver carboxylesterase 1,4516,507,0.92 [0.86-1.00],0.0417039692123897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES2,Cocaine esterase,4485,502,1.29 [1.14-1.47],9.600591757254056e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES3,Carboxylesterase 3,4485,502,0.94 [0.84-1.05],0.2919397427489992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CETN2,Centrin-2,4377,495,1.01 [0.90-1.14],0.8348496639195286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CETN3,Centrin-3,3888,421,0.97 [0.86-1.09],0.6003348011055427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFB,Complement factor B,3845,414,1.10 [0.83-1.47],0.4977854795741162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFC1,Cryptic protein,4377,493,1.27 [1.10-1.48],0.0014269276900547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFD,Complement factor D,3917,422,1.31 [0.86-2.00],0.2063089642433601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFH,Complement factor H,3680,398,1.06 [0.69-1.61],0.7980298763991239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR2,Complement factor H-related protein 2,3889,419,1.22 [1.03-1.45],0.0248689433976822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR4,Complement factor H-related protein 4,3909,421,1.12 [0.98-1.27],0.101597740125669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR5,Complement factor H-related protein 5,3862,418,0.98 [0.79-1.20],0.8226844103031805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFI,Complement factor I,3917,422,0.96 [0.61-1.52],0.8750068877736803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFP,Properdin,3917,422,0.50 [0.33-0.76],0.0013572203704039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGA,Glycoprotein hormones alpha chain,4525,508,1.32 [1.19-1.47],2.808878330698062e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,3921,425,1.22 [1.06-1.41],0.0052502251657267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGN,Cingulin,3819,418,0.85 [0.66-1.10],0.2085701458754806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGREF1,Cell growth regulator with EF hand domain protein 1,4508,505,1.73 [1.48-2.03],8.27868722196763e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,4377,493,1.01 [0.88-1.16],0.8489189905698501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAD,Chondroadherin,3838,411,0.50 [0.42-0.59],1.6258716499302611e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",3892,422,1.83 [1.51-2.22],6.354932714368248e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD6,MICOS complex subunit MIC25,3890,418,1.26 [0.97-1.65],0.087915495916926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHEK2,Serine/threonine-protein kinase Chk2,4430,500,1.00 [0.79-1.28],0.9887353393424868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGA,Chromogranin-A,3920,425,1.18 [1.09-1.27],1.7514747195452346e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGB,Secretogranin-1,4522,505,1.56 [1.33-1.84],9.707960000164033e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHI3L1,Chitinase-3-like protein 1,4404,493,1.22 [1.12-1.33],6.1380252516873865e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHIT1,Chitotriosidase-1,4529,509,1.00 [0.95-1.04],0.8706932021693686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHL1,Neural cell adhesion molecule L1-like protein,4519,506,1.40 [1.11-1.78],0.0054084012456669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHM,Rab proteins geranylgeranyltransferase component A 1,3819,418,0.98 [0.84-1.15],0.8389606409806928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHMP1A,Charged multivesicular body protein 1a,4473,505,1.02 [0.92-1.13],0.7369554984884188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHMP6,Charged multivesicular body protein 6,3900,420,0.89 [0.76-1.05],0.1656668920539285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHP1,Calcineurin B homologous protein 1,3781,416,0.94 [0.82-1.08],0.3840311972337845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL1,Chordin-like protein 1,4520,504,1.76 [1.41-2.20],5.799185851565476e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL2,Chordin-like protein 2,4508,505,0.83 [0.72-0.97],0.0184747014473512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRM1,Muscarinic acetylcholine receptor M1,3819,418,1.12 [0.90-1.40],0.2981922132523831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIAPIN1,Anamorsin,4513,505,1.04 [0.92-1.19],0.5014891626445661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CILP,Cartilage intermediate layer protein 1,3920,425,1.61 [1.36-1.91],3.0326292424511417e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CINP,Cyclin-dependent kinase 2-interacting protein,3845,412,0.99 [0.80-1.22],0.923801262229162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIRBP,Cold-inducible RNA-binding protein,3888,421,0.99 [0.89-1.09],0.7793243811913335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIT,Citron Rho-interacting kinase,3819,418,1.03 [0.85-1.25],0.7736412375037729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKAP4,Cytoskeleton-associated protein 4,4539,506,2.23 [1.83-2.72],1.835953677140045e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKB,Creatine kinase B-type,3920,425,1.42 [1.23-1.63],9.232326373731764e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",4491,502,1.36 [1.21-1.54],8.619416704959524e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLASP1,CLIP-associating protein 1,3762,409,0.96 [0.85-1.10],0.5865137572238182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLC,Galectin-10,4501,505,1.15 [1.03-1.29],0.0127018223681665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC10A,C-type lectin domain family 10 member A,4473,505,1.37 [1.10-1.70],0.0042445683745466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC11A,C-type lectin domain family 11 member A,4516,507,0.86 [0.73-1.00],0.0492522736949344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC12A,C-type lectin domain family 12 member A,3792,418,0.81 [0.50-1.32],0.4040583996879693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC14A,C-type lectin domain family 14 member A,4525,508,1.86 [1.50-2.31],2.0047335748314604e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1A,C-type lectin domain family 1 member A,4430,500,1.61 [1.31-1.98],7.143036824894876e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1B,C-type lectin domain family 1 member B,4541,507,0.99 [0.91-1.08],0.8571244640033417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC2L,C-type lectin domain family 2 member L,3819,418,1.15 [0.97-1.37],0.1032202699768619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC3B,Tetranectin,3821,409,0.31 [0.21-0.47],1.3787805749321233e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4A,C-type lectin domain family 4 member A,4504,507,0.88 [0.71-1.08],0.2261321784055333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4C,C-type lectin domain family 4 member C,4504,507,0.83 [0.71-0.98],0.0250880106911612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4D,C-type lectin domain family 4 member D,4504,507,1.19 [1.06-1.33],0.0033940744752975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4G,C-type lectin domain family 4 member G,4504,507,1.04 [0.83-1.31],0.7140735233264728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4M,C-type lectin domain family 4 member M,3916,425,0.81 [0.66-0.99],0.0389462599263431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC5A,C-type lectin domain family 5 member A,4499,505,1.69 [1.34-2.14],1.305962121572752e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC6A,C-type lectin domain family 6 member A,4377,493,1.22 [1.04-1.43],0.0136396470094174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC7A,C-type lectin domain family 7 member A,4556,506,1.42 [1.22-1.66],6.867846170843786e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLGN,Calmegin,3819,418,1.26 [1.03-1.54],0.0264339894067776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLIC5,Chloride intracellular channel protein 5,3819,418,1.10 [0.85-1.43],0.4764450303776436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLINT1,Clathrin interactor 1,3762,409,0.98 [0.78-1.22],0.8388434967594456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLIP2,CAP-Gly domain-containing linker protein 2,4504,507,0.98 [0.92-1.05],0.6057841176589969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLMP,CXADR-like membrane protein,4543,508,2.04 [1.49-2.80],1.0150433568893466e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLNS1A,Methylosome subunit pICln,3819,418,0.90 [0.68-1.20],0.4796286421079118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",4464,504,1.05 [0.97-1.14],0.2181620326043177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLPS,Colipase,4516,508,1.04 [0.94-1.14],0.4707045789888808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSPN,Claspin,4368,494,0.86 [0.67-1.10],0.2351041688113948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN1,Calsyntenin-1,4377,495,0.87 [0.74-1.03],0.1084904003858505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN2,Calsyntenin-2,4556,506,1.25 [1.06-1.49],0.0097390953277445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN3,Calsyntenin-3,3892,422,0.96 [0.71-1.29],0.7971285610702747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLTA,Clathrin light chain A,4430,500,1.07 [0.90-1.28],0.425547567054634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLU,Clusterin,3917,422,1.25 [0.89-1.77],0.1981203696301822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLUL1,Clusterin-like protein 1,4500,504,0.86 [0.73-1.01],0.0732115709243397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CMC1,COX assembly mitochondrial protein homolog,3900,420,0.98 [0.88-1.08],0.6770605964467943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CMIP,C-Maf-inducing protein,3890,418,1.01 [0.90-1.12],0.926051137472364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNDP1,Beta-Ala-His dipeptidase,4526,507,1.19 [1.01-1.40],0.0433146903474477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,3781,416,1.01 [0.86-1.20],0.8672534128672418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",3796,413,1.00 [0.89-1.13],0.9377444597144136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNPY2,Protein canopy homolog 2,4430,500,0.91 [0.79-1.05],0.1978523795058441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNPY4,Protein canopy homolog 4,4485,502,1.03 [0.93-1.14],0.5761524385621468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNST,Consortin,4508,505,0.99 [0.92-1.06],0.8062862473734516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTF,Ciliary neurotrophic factor,3781,416,0.95 [0.72-1.25],0.6935533529522132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN1,Contactin-1,4564,512,1.66 [1.26-2.17],0.0002681617215145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN2,Contactin-2,4543,508,1.39 [1.18-1.64],8.77001760900234e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN3,Contactin-3,4525,508,1.26 [0.99-1.60],0.0617139811408374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN4,Contactin-4,4525,508,1.65 [1.20-2.26],0.0019921590602002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN5,Contactin-5,4512,503,0.79 [0.64-0.97],0.0229909686609044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTNAP2,Contactin-associated protein-like 2,4504,507,1.10 [0.93-1.31],0.2698114404188775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTNAP4,Contactin-associated protein-like 4,3819,418,1.03 [0.94-1.12],0.5805600393376986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COCH,Cochlin,3900,420,0.89 [0.73-1.08],0.2332372263514414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL15A1,Collagen alpha-1(XV) chain,3920,425,0.61 [0.45-0.84],0.002525213014995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL18A1,Collagen alpha-1(XVIII) chain,4524,509,2.78 [2.07-3.71],6.129065518396936e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL1A1,Collagen alpha-1(I) chain,4564,512,0.53 [0.39-0.73],9.928064950505363e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL24A1,Collagen alpha-1(XXIV) chain,3888,421,1.01 [0.87-1.18],0.8782923040601629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL28A1,Collagen alpha-1(XXVIII) chain,3819,418,1.08 [0.97-1.21],0.1547954972942967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL2A1,Collagen alpha-1(II) chain,3805,414,1.00 [0.89-1.12],0.9519333959780598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL3A1,Collagen alpha-1(III) chain,3920,425,0.95 [0.65-1.38],0.785906904799999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A1,Collagen alpha-1(IV) chain,4508,505,1.77 [1.52-2.06],3.071919659951779e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A4,Collagen alpha-4(IV) chain,3835,411,1.13 [0.94-1.36],0.2063276761746645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL5A1,Collagen alpha-1(V) chain,3838,411,1.08 [0.88-1.31],0.4702660163307106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL6A3,Collagen alpha-3(VI) chain,4564,512,1.82 [1.52-2.18],5.1244183262926654e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL9A1,Collagen alpha-1(IX) chain,4504,507,0.97 [0.83-1.13],0.6954463426919093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL9A2,Collagen alpha-2(IX) chain,3845,412,1.05 [0.85-1.30],0.6209858114456677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COLEC12,Collectin-12,4504,504,2.28 [1.78-2.91],4.4485203903141845e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMMD1,COMM domain-containing protein 1,3805,414,1.01 [0.86-1.18],0.91472913232255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMMD9,COMM domain-containing protein 9,3890,418,1.01 [0.81-1.28],0.90830599562838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMP,Cartilage oligomeric matrix protein,4462,500,0.76 [0.60-0.95],0.0153731907321004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMT,Catechol O-methyltransferase,4391,497,0.98 [0.89-1.09],0.7659069026391772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COPB2,Coatomer subunit beta',3783,414,1.00 [0.81-1.25],0.9751550922072846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COPE,Coatomer subunit epsilon,4377,495,1.02 [0.87-1.20],0.777394584937047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",3805,414,1.02 [0.81-1.29],0.8368390265853228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CORO1A,Coronin-1A,4419,493,1.02 [0.93-1.11],0.73742625193328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CORO6,Coronin-6,3781,416,1.18 [0.96-1.45],0.1174213963880944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",4485,502,1.08 [0.96-1.21],0.1878545905913563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COX6B1,Cytochrome c oxidase subunit 6B1,3900,420,1.07 [0.81-1.42],0.6188920936521742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA1,Carboxypeptidase A1,4564,512,0.91 [0.82-1.01],0.0623839925749656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA2,Carboxypeptidase A2,4529,506,1.52 [1.38-1.67],8.247087928357923e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA4,Carboxypeptidase A4,3745,398,0.77 [0.63-0.96],0.0171138725713523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPB1,Carboxypeptidase B,4564,512,0.94 [0.84-1.05],0.2719428178124931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPB2,Carboxypeptidase B2,3908,422,0.95 [0.63-1.42],0.8053362565385587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPE,Carboxypeptidase E,4504,502,0.90 [0.74-1.09],0.2926691250906292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPLX2,Complexin-2,3762,409,0.98 [0.72-1.34],0.9003847240282947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPM,Carboxypeptidase M,4514,501,1.45 [1.18-1.77],0.0003449054352517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",3792,418,0.62 [0.43-0.89],0.0093729159750855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,4541,507,1.00 [0.89-1.13],0.9486930556488532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPQ,Carboxypeptidase Q,3917,425,1.06 [0.84-1.33],0.6277596491976878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPTP,Ceramide-1-phosphate transfer protein,3783,414,1.14 [0.90-1.46],0.2704324612461747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPVL,Probable serine carboxypeptidase CPVL,4537,508,1.32 [1.08-1.61],0.0065161415728117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM1,Probable carboxypeptidase X1,4513,505,1.06 [0.95-1.19],0.2773914205274517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM2,Inactive carboxypeptidase-like protein X2,3900,420,1.75 [1.25-2.43],0.0009781907067494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CR1,Complement receptor type 1,3910,423,1.08 [0.84-1.38],0.5433883939384145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CR2,Complement receptor type 2,4526,507,1.26 [1.08-1.47],0.0038694492524045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,4377,493,0.97 [0.88-1.07],0.55254411763298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRADD,Death domain-containing protein CRADD,4464,504,1.00 [0.90-1.12],0.9681987587215226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREB3,Cyclic AMP-responsive element-binding protein 3,3762,409,0.91 [0.75-1.10],0.3287903997326676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREBZF,CREB/ATF bZIP transcription factor,3762,409,1.14 [0.79-1.66],0.483717950096317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREG1,Protein CREG1,4449,496,0.58 [0.48-0.70],1.3715843160520893e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRELD1,Protein disulfide isomerase CRELD1,3838,411,1.43 [1.13-1.81],0.002826018944464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRELD2,Protein disulfide isomerase CRELD2,4520,504,1.20 [1.04-1.38],0.0105302692046647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRH,Corticoliberin,4371,492,0.96 [0.87-1.05],0.3557008164493185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHBP,Corticotropin-releasing factor-binding protein,4504,504,1.59 [1.21-2.08],0.0008202501046755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHR1,Corticotropin-releasing factor receptor 1,4430,500,1.05 [0.93-1.19],0.4358470309670625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIM1,Cysteine-rich motor neuron 1 protein,4527,505,2.00 [1.41-2.85],0.0001013149832283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIP2,Cysteine-rich protein 2,4473,505,1.47 [1.20-1.79],0.0001484247375153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP2,Cysteine-rich secretory protein 2,4543,508,0.84 [0.74-0.95],0.004908505612352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP3,Cysteine-rich secretory protein 3,3882,420,0.41 [0.30-0.57],8.573460906527608e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRKL,Crk-like protein,4510,502,0.99 [0.92-1.07],0.8627741186383123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRLF1,Cytokine receptor-like factor 1,4527,505,1.20 [0.89-1.61],0.2377669065942922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRNN,Cornulin,4376,494,1.07 [0.96-1.20],0.2217999759737531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAC1,Cartilage acidic protein 1,4564,512,0.72 [0.56-0.91],0.0067628906884236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAM,Cytotoxic and regulatory T-cell molecule,4473,505,1.34 [1.15-1.56],0.0001446965127794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAP,Cartilage-associated protein,3819,418,1.07 [0.88-1.29],0.5022453505510542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRX,Cone-rod homeobox protein,4430,500,0.97 [0.89-1.05],0.4583734240609445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYBB1,Beta-crystallin B1,3900,420,1.04 [0.90-1.20],0.61450243864764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYBB2,Beta-crystallin B2,3892,422,1.02 [0.92-1.13],0.7138605415196725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYGD,Gamma-crystallin D,3892,422,1.00 [0.91-1.09],0.944816371928734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYM,Ketimine reductase mu-crystallin,3781,416,1.06 [0.94-1.20],0.3558280420245161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYZL1,Quinone oxidoreductase-like protein 1,3805,414,0.97 [0.87-1.08],0.6072073769237221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSDE1,Cold shock domain-containing protein E1,3783,414,1.03 [0.95-1.12],0.4641021919834749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1,Macrophage colony-stimulating factor 1,4527,505,1.89 [1.46-2.44],1.4731581226714914e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,3921,425,1.34 [1.08-1.66],0.0069465848405902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2,Granulocyte-macrophage colony-stimulating factor,3783,414,1.19 [0.93-1.51],0.1680936113604728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,4473,505,1.10 [0.97-1.26],0.1426198004475065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2RB,Cytokine receptor common subunit beta,3792,418,1.04 [0.84-1.30],0.706637404030627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF3,Granulocyte colony-stimulating factor,4402,494,0.81 [0.68-0.96],0.0129715500509499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF3R,Granulocyte colony-stimulating factor receptor,3792,418,0.83 [0.62-1.12],0.2209885534280851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSH1,Chorionic somatomammotropin hormone 1,3921,425,0.95 [0.69-1.31],0.7570442984014035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSNK1D,Casein kinase I isoform delta,3792,418,0.95 [0.81-1.12],0.5551476873780296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSNK2A1,Casein kinase II subunit alpha,3905,425,1.03 [0.83-1.27],0.8016635722609107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG4,Chondroitin sulfate proteoglycan 4,3920,425,1.46 [1.12-1.90],0.0049375236194815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG5,Chondroitin sulfate proteoglycan 5,3781,416,0.83 [0.67-1.03],0.0912510179952331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSRP3,Cysteine and glycine-rich protein 3,3783,414,1.07 [0.98-1.17],0.1545277652360799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST1,Cystatin-SN,3433,371,1.02 [0.92-1.12],0.7548732395646295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST3,Cystatin-C,4511,507,1.94 [1.55-2.43],7.016283348045964e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST5,Cystatin-D,4433,502,1.23 [1.08-1.41],0.0024592762727829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST6,Cystatin-M,4383,495,0.99 [0.85-1.15],0.8483149142801355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST7,Cystatin-F,4517,505,1.04 [0.96-1.13],0.3102936964947617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSTB,Cystatin-B,4455,500,1.25 [1.05-1.50],0.0132100730886178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,3837,412,0.87 [0.72-1.06],0.1756905439401703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTBS,Di-N-acetylchitobiase,3852,415,1.24 [0.89-1.71],0.2004731859964059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTF1,Cardiotrophin-1,4430,500,1.00 [0.91-1.10],0.9205752966165036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTHRC1,Collagen triple helix repeat-containing protein 1,3920,425,1.79 [1.36-2.37],3.637541579192034e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTLA4,Cytotoxic T-lymphocyte protein 4,3920,425,0.83 [0.61-1.12],0.2210240217577827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTNNA1,Catenin alpha-1,3781,416,1.20 [0.92-1.56],0.1806058968617378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRB1,Chymotrypsinogen B,4525,508,0.95 [0.85-1.07],0.4059030467796892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRC,Chymotrypsin-C,4508,504,0.86 [0.78-0.96],0.0053660256811906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRL,Chymotrypsin-like protease CTRL-1,3892,422,0.90 [0.80-1.02],0.0900236489348314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSB,Cathepsin B,4509,506,1.17 [1.01-1.36],0.0417754341405011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSC,Dipeptidyl peptidase 1,4500,501,0.91 [0.77-1.09],0.3168575527557861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSD,Cathepsin D,4235,475,1.15 [0.97-1.37],0.1148070908361419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSE,Cathepsin E,3838,411,1.47 [1.25-1.72],2.6618307440987685e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSF,Cathepsin F,4513,505,1.23 [1.02-1.49],0.0300533629982433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSH,Pro-cathepsin H,4424,500,1.14 [1.03-1.27],0.0141599585768552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSL,Cathepsin L1,4508,505,1.85 [1.38-2.49],4.041189290985535e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSO,Cathepsin O,4556,506,1.73 [1.37-2.18],3.1319264479595167e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSS,Cathepsin S,3542,376,2.51 [1.69-3.72],4.543670430132609e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSV,Cathepsin L2,4528,506,0.86 [0.72-1.02],0.0800143593555284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSZ,Cathepsin Z,4513,505,1.72 [1.38-2.15],1.380118412637482e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,3819,418,1.30 [1.14-1.49],0.0001386462437033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CWC15,Spliceosome-associated protein CWC15 homolog,3867,419,1.06 [0.92-1.22],0.4323833441313144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CX3CL1,Fractalkine,4473,505,1.71 [1.39-2.10],2.806122761600116e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXADR,Coxsackievirus and adenovirus receptor,4504,507,1.27 [1.09-1.47],0.0019730786890028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL1,Growth-regulated alpha protein,4510,504,1.05 [0.97-1.14],0.1913780345890871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL10,C-X-C motif chemokine 10,4527,505,1.02 [0.91-1.15],0.7168615452939285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL11,C-X-C motif chemokine 11,4541,507,0.98 [0.89-1.08],0.6736148221569891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL12,Stromal cell-derived factor 1,4402,494,1.02 [0.84-1.24],0.8398590518172675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL13,C-X-C motif chemokine 13,4541,507,1.07 [0.95-1.21],0.2541929526471947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL14,C-X-C motif chemokine 14,4402,494,1.01 [0.88-1.16],0.886377069396369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL16,C-X-C motif chemokine 16,4560,512,1.73 [1.27-2.34],0.0004381224627951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL17,C-X-C motif chemokine 17,4556,506,0.89 [0.75-1.07],0.2265167728364263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL3,C-X-C motif chemokine 3,4510,504,1.00 [0.92-1.09],0.972796207004716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL5,C-X-C motif chemokine 5,4497,504,1.02 [0.95-1.09],0.6374412512906447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL6,C-X-C motif chemokine 6,4556,506,1.10 [1.00-1.22],0.0557258214494259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL8,Interleukin-8,4463,498,1.17 [1.06-1.29],0.0014131608473825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL9,C-X-C motif chemokine 9,4527,505,1.29 [1.16-1.44],2.046119987734172e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYB5A,Cytochrome b5,3762,409,0.85 [0.73-0.99],0.0377035844387463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYB5R2,NADH-cytochrome b5 reductase 2,3846,420,1.07 [0.92-1.26],0.3848776580223765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",3783,414,0.96 [0.86-1.08],0.5239643313613602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTH3,Cytohesin-3,3762,409,1.04 [0.91-1.18],0.600131654148071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTL1,Cytokine-like protein 1,3920,425,0.54 [0.38-0.77],0.0007228390429912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAAM1,Disheveled-associated activator of morphogenesis 1,3838,411,0.96 [0.86-1.08],0.4978592682678128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAB2,Disabled homolog 2,4543,508,0.99 [0.92-1.06],0.8098445752253813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAG1,Dystroglycan,4527,505,1.29 [1.09-1.53],0.0027754378105802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAND5,DAN domain family member 5,3792,418,1.03 [0.90-1.20],0.6425360401110484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAPK2,Death-associated protein kinase 2,3792,418,0.97 [0.82-1.15],0.7171931862852559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,4504,507,0.98 [0.92-1.05],0.6288008271906631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",4464,504,0.94 [0.84-1.05],0.2827179847825932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBH,Dopamine beta-hydroxylase,3917,425,0.94 [0.87-1.02],0.1375909758250159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBI,Acyl-CoA-binding protein,4497,504,1.09 [0.98-1.21],0.1266707902280944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBN1,Drebrin,3792,418,1.00 [0.83-1.21],0.9914057446246952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBNL,Drebrin-like protein,4527,505,1.00 [0.92-1.09],0.9866973457462532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",4513,505,2.43 [1.99-2.98],4.9365646027735575e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCC,Netrin receptor DCC,3819,418,0.69 [0.43-1.13],0.1413494447114415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCDC2C,Doublecortin domain-containing protein 2C,3762,409,1.05 [0.90-1.22],0.5292165913012753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCLRE1C,Protein artemis,3762,409,0.65 [0.46-0.90],0.0107629332611606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCN,Decorin,4430,500,2.90 [2.16-3.89],1.3779493039818277e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTD,Deoxycytidylate deaminase,3838,411,0.97 [0.88-1.08],0.589044724470472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN1,Dynactin subunit 1,4543,508,0.92 [0.81-1.04],0.187665509738217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN2,Dynactin subunit 2,4485,502,1.01 [0.93-1.10],0.7880499661317906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN6,Dynactin subunit 6,4377,495,1.01 [0.90-1.12],0.9254180542670892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTPP1,dCTP pyrophosphatase 1,4508,505,0.84 [0.66-1.08],0.173162341548881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCUN1D1,DCN1-like protein 1,3781,416,0.98 [0.86-1.12],0.7904768444578185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCUN1D2,DCN1-like protein 2,3762,409,1.08 [0.97-1.21],0.1514319819842654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCXR,L-xylulose reductase,4513,505,0.79 [0.69-0.91],0.0008032503850982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDA1,DET1- and DDB1-associated protein 1,3783,414,0.88 [0.68-1.15],0.3534322078278847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",4485,502,1.17 [0.98-1.38],0.0749643811397809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDC,Aromatic-L-amino-acid decarboxylase,4506,503,0.97 [0.83-1.12],0.6747703454619586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDHD2,Phospholipase DDHD2,3905,425,0.97 [0.84-1.12],0.6564808881510122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDI2,Protein DDI1 homolog 2,3838,411,0.91 [0.81-1.03],0.1331013430795403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDR1,Epithelial discoidin domain-containing receptor 1,4541,507,1.69 [1.25-2.30],0.0007629372251173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDT,D-dopachrome decarboxylase,3920,425,0.87 [0.70-1.08],0.1974632367864847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX1,ATP-dependent RNA helicase DDX1,3888,421,1.11 [0.93-1.33],0.243409219580809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX25,ATP-dependent RNA helicase DDX25,3819,418,1.38 [1.13-1.69],0.0015901091714877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX39A,ATP-dependent RNA helicase DDX39A,3792,418,0.99 [0.66-1.50],0.9782043347781492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX4,Probable ATP-dependent RNA helicase DDX4,3792,418,0.81 [0.66-1.00],0.0504342136821639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX53,Probable ATP-dependent RNA helicase DDX53,3819,418,0.84 [0.65-1.11],0.2185367537999323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX58,Antiviral innate immune response receptor RIG-I,4377,493,0.89 [0.77-1.03],0.1182197502540618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",4504,507,1.01 [0.93-1.09],0.8769419679294059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFA1_DEFA1B,Neutrophil defensin 1,4416,500,1.17 [1.02-1.35],0.0211844744147129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB103A_DEFB103B,Beta-defensin 103,3771,416,1.25 [1.06-1.47],0.0078860948542839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB104A_DEFB104B,Beta-defensin 104,3781,416,0.96 [0.80-1.15],0.658237071496401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB116,Beta-defensin 116,3781,416,1.06 [0.95-1.20],0.3045893680421929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB118,Beta-defensin 118,3781,416,0.93 [0.78-1.11],0.4371101180143877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB4A_DEFB4B,Beta-defensin 4A,4453,500,1.03 [0.98-1.08],0.2752817928084286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DENND2B,DENN domain-containing protein 2B,3783,414,0.98 [0.79-1.20],0.8121732397403288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DENR,Density-regulated protein,3792,418,0.96 [0.81-1.13],0.6189490104086504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DFFA,DNA fragmentation factor subunit alpha,4556,506,1.02 [0.91-1.15],0.7173032453554937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGCR6,Protein DGCR6,3781,416,0.95 [0.74-1.20],0.64170553827658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGKA,Diacylglycerol kinase alpha,3792,418,1.05 [0.88-1.24],0.5983950652219416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGKZ,Diacylglycerol kinase zeta,4402,494,0.83 [0.66-1.05],0.1174061794018128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHODH,Dihydroorotate dehydrogenase,3783,414,1.03 [0.84-1.26],0.7751659899709761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHPS,Deoxyhypusine synthase,3890,418,1.13 [0.91-1.40],0.2814447275662303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,3892,422,1.06 [0.88-1.27],0.5665360266621691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIABLO,"Diablo homolog, mitochondrial",4499,505,0.98 [0.91-1.05],0.5249159330388273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIPK1C,Divergent protein kinase domain 1C,3819,418,1.05 [0.84-1.31],0.6614892986334786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIPK2B,Divergent protein kinase domain 2B,3838,411,0.94 [0.68-1.31],0.7243196603502079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK1,Dickkopf-related protein 1,4541,507,1.01 [0.88-1.15],0.9297652791561348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK3,Dickkopf-related protein 3,4564,512,1.27 [0.98-1.63],0.0670933195381533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK4,Dickkopf-related protein 4,4467,504,1.83 [1.59-2.11],1.132240710122497e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKKL1,Dickkopf-like protein 1,4485,502,0.99 [0.91-1.09],0.8842264973608503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLG4,Disks large homolog 4,3892,422,1.00 [0.88-1.14],0.9557648518153776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLGAP5,Disks large-associated protein 5,3905,425,0.86 [0.69-1.08],0.1859935866365722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLK1,Protein delta homolog 1,4564,512,0.97 [0.85-1.11],0.6361629977465675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL1,Delta-like protein 1,4513,505,2.77 [2.24-3.42],4.017750130433832e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL4,Delta-like protein 4,3805,414,1.01 [0.91-1.14],0.8041438804367922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMD,Dystrophin,3805,414,1.24 [1.04-1.47],0.0163912365738451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMP1,Dentin matrix acidic phosphoprotein 1,3805,414,0.61 [0.53-0.69],1.2918386758869294e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA1,DnaJ homolog subfamily A member 1,3762,409,0.94 [0.74-1.19],0.600148808786428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA2,DnaJ homolog subfamily A member 2,4547,506,1.00 [0.90-1.10],0.9271817422178362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA4,DnaJ homolog subfamily A member 4,3892,422,1.00 [0.88-1.13],0.9907668357264312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB1,DnaJ homolog subfamily B member 1,4485,502,1.01 [0.92-1.10],0.8819867734146362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB14,DnaJ homolog subfamily B member 14,3888,421,1.03 [0.89-1.19],0.6985174651604034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB2,DnaJ homolog subfamily B member 2,3838,411,0.94 [0.79-1.11],0.4468207906360441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB6,DnaJ homolog subfamily B member 6,3803,407,0.99 [0.88-1.11],0.8483440702617551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB8,DnaJ homolog subfamily B member 8,4430,500,0.99 [0.85-1.16],0.925276292781336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC21,DnaJ homolog subfamily C member 21,3892,422,1.04 [0.82-1.31],0.7619245106601582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,3805,414,0.99 [0.88-1.10],0.8093033386776252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC9,DnaJ homolog subfamily C member 9,3888,421,0.98 [0.86-1.11],0.721034670146866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,4498,503,0.90 [0.67-1.19],0.4542209500270698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNLZ,DNL-type zinc finger protein,3781,416,0.97 [0.85-1.09],0.5899206103327801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNM1,Dynamin-1,3888,421,1.00 [0.92-1.08],0.9562095856466044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNM3,Dynamin-3,3905,425,1.17 [1.00-1.38],0.0557320360520222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNMBP,Dynamin-binding protein,4473,505,1.04 [0.92-1.19],0.5141737626046438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNPEP,Aspartyl aminopeptidase,3892,422,0.97 [0.83-1.13],0.6801910840846822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,4517,503,0.94 [0.81-1.10],0.4431947638067515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOC2B,Double C2-like domain-containing protein beta,3819,418,0.74 [0.55-0.99],0.0443841512244243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOCK9,Dedicator of cytokinesis protein 9,3781,416,0.96 [0.88-1.05],0.3940034046493337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOK1,Docking protein 1,3892,422,1.00 [0.94-1.08],0.9170903740032894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOK2,Docking protein 2,4508,505,0.99 [0.93-1.06],0.8480851546472992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPEP1,Dipeptidase 1,4464,504,0.90 [0.77-1.05],0.1663750835937959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPEP2,Dipeptidase 2,4485,502,1.38 [1.07-1.78],0.0139816489279416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP10,Inactive dipeptidyl peptidase 10,4504,507,1.08 [0.90-1.30],0.4273922322132005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP4,Dipeptidyl peptidase 4,4440,488,1.01 [0.79-1.30],0.9185001129079076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,4485,502,1.99 [1.64-2.42],4.166680922451238e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP7,Dipeptidyl peptidase 2,4479,503,1.00 [0.88-1.13],0.974971644833062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPT,Dermatopontin,4564,512,1.62 [1.19-2.21],0.0022945228343673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPY30,Protein dpy-30 homolog,4529,507,1.20 [1.06-1.35],0.003871787324802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DRAXIN,Draxin,4473,505,1.23 [1.02-1.47],0.0264395570943264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DRG2,Developmentally-regulated GTP-binding protein 2,4485,502,1.00 [0.87-1.15],0.986382070155896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSC2,Desmocollin-2,4471,495,2.20 [1.89-2.55],7.231243929248674e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSCAM,Down syndrome cell adhesion molecule,3905,425,1.27 [1.01-1.61],0.0432703977858243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG2,Desmoglein-2,4525,508,2.30 [1.82-2.91],3.340638022935e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG3,Desmoglein-3,4528,506,0.97 [0.78-1.20],0.7739430949206021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG4,Desmoglein-4,4468,501,0.69 [0.59-0.80],1.683344825249649e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTD1,D-aminoacyl-tRNA deacylase 1,3838,411,1.00 [0.89-1.11],0.9655732495679052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTNB,Dystrobrevin beta,3883,416,1.32 [1.08-1.60],0.0056579859209715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,3819,418,0.84 [0.70-1.01],0.0567621338472952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,4485,502,1.97 [1.47-2.65],6.069431464272862e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTYMK,Thymidylate kinase,3900,420,0.96 [0.84-1.10],0.5967955874329078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUOX2,Dual oxidase 2,4430,500,0.99 [0.88-1.11],0.8664214486615082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,3890,418,0.82 [0.66-1.03],0.0837536756482393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP29,Dual specificity phosphatase 29,3819,418,0.96 [0.82-1.11],0.5635550073369111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP3,Dual specificity protein phosphatase 3,4377,495,1.02 [0.92-1.12],0.7386896988658158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",3888,421,1.02 [0.93-1.11],0.6959713629644668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DXO,Decapping and exoribonuclease protein,3892,422,1.12 [0.91-1.38],0.2683856702660457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,3890,418,0.99 [0.79-1.24],0.9217868536762026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNLT1,Dynein light chain Tctex-type 1,3819,418,0.98 [0.87-1.11],0.7680496551202654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNLT3,Dynein light chain Tctex-type 3,3890,418,0.95 [0.77-1.17],0.6075722701131754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,4473,505,0.99 [0.91-1.08],0.868606541620814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBI3_IL27,Interleukin-27,4535,508,1.85 [1.45-2.35],5.384678282720561e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECE1,Endothelin-converting enzyme 1,4377,495,0.82 [0.66-1.02],0.0772922280295282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",3900,420,0.99 [0.88-1.10],0.7932432626109335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",3805,414,1.00 [0.91-1.10],0.9597902036255002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECI2,Enoyl-CoA delta isomerase 2,3783,414,0.95 [0.82-1.11],0.5174850718007125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECM1,Extracellular matrix protein 1,3809,411,0.92 [0.71-1.18],0.5050787508004937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECSCR,Endothelial cell-specific chemotaxis regulator,3781,416,1.06 [0.87-1.28],0.5877005601670227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,4543,508,2.18 [1.88-2.54],1.9237387336235552e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,4504,507,1.07 [0.98-1.17],0.126473379017205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDDM3B,Epididymal secretory protein E3-beta,3890,418,0.94 [0.79-1.12],0.4994632043626907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,3783,414,1.27 [0.99-1.63],0.0581213030154578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDF1,Endothelial differentiation-related factor 1,3905,425,1.06 [0.92-1.22],0.3964555231359528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,4430,500,1.60 [1.30-1.96],8.472131459545562e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDN1,Endothelin-1,3805,414,1.90 [1.41-2.56],2.3631669140302224e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDNRB,Endothelin receptor type B,3792,418,1.09 [0.87-1.37],0.452062273717367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EEF1D,Elongation factor 1-delta,3900,420,0.98 [0.89-1.09],0.7129508121746075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,3888,421,2.05 [1.57-2.68],1.792500203342863e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB2,Dynein regulatory complex protein 8,3845,412,1.00 [0.76-1.31],0.9905642402327756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,4522,507,1.80 [1.45-2.25],1.4457791921251896e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFHD1,EF-hand domain-containing protein D1,3905,425,1.25 [0.99-1.57],0.0629147602207859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA1,Ephrin-A1,4520,507,2.61 [2.12-3.22],2.456100830052999e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA4,Ephrin-A4,4466,505,3.03 [2.52-3.63],1.5297479477479342e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNB2,Ephrin-B2,3819,418,1.23 [1.08-1.40],0.0013224161998655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGF,Pro-epidermal growth factor,4497,501,1.00 [0.93-1.08],0.967905450657888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFL7,Epidermal growth factor-like protein 7,4377,493,1.25 [1.03-1.53],0.0259356422116978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFLAM,Pikachurin,3888,421,1.13 [0.84-1.51],0.4254127030663323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFR,Epidermal growth factor receptor,4564,512,1.58 [1.01-2.47],0.0448717005304101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGLN1,Egl nine homolog 1,4504,507,1.01 [0.88-1.15],0.9194670587508432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EHBP1,EH domain-binding protein 1,3900,420,0.96 [0.84-1.09],0.4978555741334659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EHD3,EH domain-containing protein 3,3805,414,0.99 [0.91-1.07],0.8369223124538402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",3892,422,1.07 [0.91-1.25],0.4114383183920148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",3870,418,0.97 [0.89-1.06],0.5560432477946937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,3783,414,0.89 [0.77-1.04],0.1389927844306571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,3805,414,1.09 [0.87-1.36],0.4643408533337686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4B,Eukaryotic translation initiation factor 4B,4473,505,0.92 [0.80-1.06],0.2455705633555573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4E,Eukaryotic translation initiation factor 4E,3792,418,0.97 [0.87-1.08],0.5363045612745645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,4508,505,1.01 [0.90-1.14],0.836040345965992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,4556,506,0.99 [0.91-1.07],0.761362058305439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,3905,425,0.94 [0.82-1.08],0.3743107009367312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF5,Eukaryotic translation initiation factor 5,3783,414,0.95 [0.76-1.19],0.6649461468031319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF5A,Eukaryotic translation initiation factor 5A-1,4402,494,0.71 [0.53-0.94],0.0162100816898138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,3905,425,0.98 [0.88-1.10],0.7615153373548588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELAVL4,ELAV-like protein 4,3781,416,0.96 [0.85-1.08],0.4884241233705677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELN,Elastin,3900,420,1.23 [0.97-1.57],0.0879561753195438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELOA,Elongin-A,4485,502,0.91 [0.79-1.06],0.2162210833779152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELOB,Elongin-B,3783,414,1.18 [0.96-1.45],0.1168434312467103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENAH,Protein enabled homolog,4402,494,1.18 [1.01-1.39],0.0369257696944531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENDOU,Poly(U)-specific endoribonuclease,3606,395,1.05 [0.88-1.24],0.6190612137014309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENG,Endoglin,4564,512,1.61 [1.06-2.45],0.0255945585280784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO1,Alpha-enolase,4510,503,0.97 [0.87-1.07],0.5546845721856619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO2,Gamma-enolase,4541,507,1.00 [0.89-1.13],0.9641585335411502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO3,Beta-enolase,3805,414,0.77 [0.66-0.89],0.0006280805579542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENOPH1,Enolase-phosphatase E1,3890,418,0.88 [0.71-1.07],0.203612712039292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,3783,414,0.90 [0.65-1.25],0.5308279597364536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPEP,Glutamyl aminopeptidase,3783,414,1.13 [0.94-1.35],0.1996773920847593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,4564,512,1.04 [0.80-1.35],0.7792511691108981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,4527,505,0.88 [0.74-1.05],0.1515741865705133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,3805,414,1.64 [1.27-2.11],0.0001149491233156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,4350,481,0.93 [0.85-1.02],0.129971650215987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENSA,Alpha-endosulfine,3890,418,0.96 [0.81-1.15],0.6895570620903256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,4377,493,1.05 [0.89-1.24],0.5699401360725591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,4430,500,0.84 [0.59-1.21],0.3501313042273472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,4430,500,1.34 [0.97-1.86],0.0763611042735518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTR1,Endosome-associated-trafficking regulator 1,3805,414,0.91 [0.78-1.05],0.1899888074804798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EP300,Histone acetyltransferase p300,3792,418,0.99 [0.74-1.33],0.960256630261983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPB41L5,Band 4.1-like protein 5,3819,418,1.02 [0.88-1.18],0.7636079948796418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPCAM,Epithelial cell adhesion molecule,4504,503,0.99 [0.91-1.08],0.7971168484579532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPGN,Epigen,3890,418,1.00 [0.80-1.25],0.9931946361235646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA1,Ephrin type-A receptor 1,4517,503,1.29 [1.03-1.61],0.0273751228293923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA10,Ephrin type-A receptor 10,4377,495,1.02 [0.90-1.15],0.7598425915690588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA2,Ephrin type-A receptor 2,4340,487,2.58 [2.16-3.08],1.2163314692293734e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA4,Ephrin type-A receptor 4,3838,411,1.21 [0.88-1.66],0.2339639443061419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB4,Ephrin type-B receptor 4,4564,512,2.84 [2.23-3.61],3.04828522902083e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB6,Ephrin type-B receptor 6,4464,504,1.53 [1.23-1.91],0.0001288939974957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHX2,Bifunctional epoxide hydrolase 2,4430,500,0.92 [0.80-1.05],0.216284131924984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPN1,Epsin-1,3845,412,1.05 [0.84-1.32],0.6784761864052715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPO,Erythropoietin,4504,507,1.21 [1.11-1.33],2.052719873346776e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPPK1,Epiplakin,3805,414,1.07 [0.94-1.20],0.2992730237399925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,4537,507,1.52 [1.22-1.89],0.0001761734561175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,4513,505,0.79 [0.60-1.04],0.0899135346431631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,4493,502,1.73 [1.19-2.52],0.0043676915723364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,4513,505,2.23 [1.75-2.85],1.2161264375562772e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBIN,Erbin,4485,502,0.98 [0.91-1.06],0.6763021328720464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERC2,ERC protein 2,3819,418,1.03 [0.90-1.17],0.7139527012686433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERCC1,DNA excision repair protein ERCC-1,3762,409,0.88 [0.63-1.21],0.4241220754342132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EREG,Proepiregulin,4464,504,0.97 [0.88-1.07],0.5451424205257422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERI1,3'-5' exoribonuclease 1,3845,412,1.06 [0.80-1.40],0.7000089126536122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERMAP,Erythroid membrane-associated protein,3792,418,1.26 [1.02-1.55],0.032170505515287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,3890,418,0.90 [0.70-1.15],0.4078770883065262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERP29,Endoplasmic reticulum resident protein 29,3838,411,0.98 [0.91-1.06],0.665668451251051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERP44,Endoplasmic reticulum resident protein 44,4480,501,0.80 [0.59-1.08],0.1404505824736294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,3783,414,1.07 [0.86-1.33],0.5244971862515857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESAM,Endothelial cell-selective adhesion molecule,4564,512,1.72 [1.39-2.13],8.013112420306046e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESM1,Endothelial cell-specific molecule 1,4504,504,1.01 [0.81-1.25],0.960089940032222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESPL1,Separin,3762,409,1.16 [1.01-1.33],0.0301805821043067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESR1,Estrogen receptor,3792,418,0.81 [0.65-1.01],0.0595178599650013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESYT2,Extended synaptotagmin-2,3892,422,1.05 [0.94-1.18],0.3663177728142561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVI2B,Protein EVI2B,3762,409,1.05 [0.82-1.34],0.714033881390516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVI5,Ecotropic viral integration site 5 protein homolog,3792,418,0.99 [0.89-1.10],0.8433465784507349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVPL,Envoplakin,3845,412,1.16 [0.87-1.55],0.3024817839400854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EXOSC10,Exosome component 10,3783,414,0.71 [0.57-0.88],0.00182063150401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EXTL1,Exostosin-like 1,3783,414,1.08 [0.90-1.29],0.4159630755895471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EZR,Ezrin,4541,507,0.94 [0.68-1.29],0.701440888043122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F10,Coagulation factor X,3921,425,0.97 [0.71-1.32],0.834697236979862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F11,Coagulation factor XI,3868,418,1.77 [1.30-2.40],0.0002677448897515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F11R,Junctional adhesion molecule A,4525,508,1.08 [0.94-1.25],0.2569740613490345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F12,Coagulation factor XII,3917,422,1.03 [0.82-1.29],0.7912902405469686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F13B,Coagulation factor XIII B chain,3898,422,0.83 [0.59-1.17],0.2770323441461126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2,Prothrombin,3917,422,0.67 [0.36-1.21],0.1839452190912498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2R,Proteinase-activated receptor 1,4520,504,1.28 [1.12-1.47],0.0003989995087918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F3,Tissue factor,4514,506,1.70 [1.32-2.20],4.190146341944468e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F7,Coagulation factor VII,4520,507,1.01 [0.80-1.28],0.908853116673494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F9,Coagulation factor IX,4523,505,0.97 [0.63-1.50],0.8988554053796998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP1,"Fatty acid-binding protein, liver",4504,504,1.24 [1.15-1.34],2.2765698545921026e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP2,"Fatty acid-binding protein, intestinal",4508,505,1.18 [1.08-1.30],0.0002158620643488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP3,"Fatty acid-binding protein, heart",3900,420,1.49 [1.28-1.72],9.491147319397285e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP4,"Fatty acid-binding protein, adipocyte",4564,512,1.62 [1.44-1.83],1.5419843952043805e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP5,Fatty acid-binding protein 5,4529,504,1.18 [1.05-1.33],0.004990108094934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP6,Gastrotropin,4423,497,1.06 [0.93-1.21],0.35830074023588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP9,Fatty acid-binding protein 9,4504,507,0.91 [0.79-1.05],0.186666364308407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FADD,FAS-associated death domain protein,4508,505,0.97 [0.87-1.08],0.5818113808635892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM13A,Protein FAM13A,3888,421,1.01 [0.88-1.16],0.8741996448767069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM171A2,Protein FAM171A2,3905,425,0.98 [0.93-1.04],0.589159318718546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM171B,Protein FAM171B,3890,418,1.03 [0.72-1.47],0.8705541603725471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM172A,Cotranscriptional regulator FAM172A,3805,414,0.97 [0.83-1.14],0.7480638088141351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM20A,Pseudokinase FAM20A,3900,420,0.89 [0.64-1.23],0.4827019847751931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3B,Protein FAM3B,4485,502,2.11 [1.72-2.60],1.5572082902726662e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3C,Protein FAM3C,4506,503,3.04 [2.47-3.75],1.3446966456494204e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3D,Protein FAM3D,3888,421,1.44 [1.29-1.60],1.4586226614419378e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAP,Prolyl endopeptidase FAP,4564,512,1.05 [0.81-1.35],0.716148822738345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,3819,418,1.01 [0.88-1.16],0.8535790476080187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAS,Tumor necrosis factor receptor superfamily member 6,4554,512,1.50 [1.26-1.79],5.31733517581212e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FASLG,Tumor necrosis factor ligand superfamily member 6,4556,506,1.03 [0.83-1.27],0.7995898651824479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBLN2,Fibulin-2,3920,425,1.18 [0.92-1.51],0.2022014218873211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBN2,Fibrillin-2,3819,418,1.11 [0.94-1.32],0.2065045305587641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBP1,"Fructose-1,6-bisphosphatase 1",4508,505,0.89 [0.80-0.98],0.0178839995460421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,3900,420,1.09 [0.96-1.23],0.1853931523577562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCAR,Immunoglobulin alpha Fc receptor,4504,507,1.05 [0.90-1.23],0.537144798700639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,3905,425,1.26 [0.87-1.82],0.2213952050139098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,4525,508,1.27 [1.11-1.46],0.0007163379367876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,4501,501,1.10 [0.96-1.27],0.1730819876998535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,4377,493,0.97 [0.85-1.11],0.6886992280692645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,4517,507,0.94 [0.81-1.09],0.4137455026602921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN1,Ficolin-1,3917,425,0.93 [0.79-1.09],0.3954040697587534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN2,Ficolin-2,4491,501,0.69 [0.57-0.82],3.718061764022059e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL1,Fc receptor-like protein 1,4508,505,1.04 [0.88-1.23],0.6767582934899756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL2,Fc receptor-like protein 2,4535,502,1.23 [1.06-1.42],0.0049527448927667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL3,Fc receptor-like protein 3,4402,494,1.04 [0.90-1.19],0.6240819609846068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL5,Fc receptor-like protein 5,4525,508,1.11 [0.97-1.26],0.1233438793597563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL6,Fc receptor-like protein 6,4504,507,1.09 [0.97-1.22],0.1480318603164707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRLB,Fc receptor-like B,4377,493,1.17 [1.04-1.33],0.0114295347002301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FDX1,"Adrenodoxin, mitochondrial",3783,414,1.15 [1.00-1.32],0.0531507162163972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FDX2,"Ferredoxin-2, mitochondrial",3783,414,1.13 [0.95-1.34],0.1704349671300348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FEN1,Flap endonuclease 1,4377,493,0.96 [0.86-1.08],0.5356531314450674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FES,Tyrosine-protein kinase Fes/Fps,4377,493,0.90 [0.76-1.07],0.2369921924430478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FETUB,Fetuin-B,4523,505,1.02 [0.82-1.28],0.8333130251289181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGA,Fibrinogen alpha chain,3817,410,0.97 [0.71-1.32],0.8503459744246911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",3905,425,1.01 [0.90-1.13],0.9236327613504874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF12,Fibroblast growth factor 12,3792,418,0.95 [0.77-1.18],0.6475960091931371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF16,Fibroblast growth factor 16,3792,418,0.77 [0.62-0.95],0.0158087498095075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF19,Fibroblast growth factor 19,4527,505,0.96 [0.87-1.06],0.434651868987101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF2,Fibroblast growth factor 2,4504,507,1.03 [0.92-1.15],0.6534332716776645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF20,Fibroblast growth factor 20,3792,418,0.94 [0.75-1.19],0.6155755738080806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF21,Fibroblast growth factor 21,4535,508,1.02 [0.96-1.09],0.4591071421212622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF23,Fibroblast growth factor 23,4531,507,1.24 [1.11-1.39],0.0002184505943539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF3,Fibroblast growth factor 3,3792,418,1.26 [0.89-1.77],0.1957489274005784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF5,Fibroblast growth factor 5,4402,494,2.02 [1.65-2.46],4.749609933975656e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF6,Fibroblast growth factor 6,3792,418,1.05 [0.85-1.30],0.6489383157134379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF7,Fibroblast growth factor 7,3762,409,0.99 [0.87-1.12],0.8577977068284711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF9,Fibroblast growth factor 9,3756,409,1.11 [0.89-1.39],0.346761624112277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP1,Fibroblast growth factor-binding protein 1,4513,505,0.56 [0.46-0.69],1.4847280819493245e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP2,Fibroblast growth factor-binding protein 2,3920,425,0.61 [0.51-0.74],1.1251166687835752e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP3,Fibroblast growth factor-binding protein 3,3892,422,0.58 [0.45-0.74],1.6145433277513015e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFR2,Fibroblast growth factor receptor 2,4513,505,1.46 [1.09-1.96],0.012030599439171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFR4,Fibroblast growth factor receptor 4,3838,411,0.96 [0.80-1.14],0.6324375146736747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGL1,Fibrinogen-like protein 1,3921,425,1.43 [1.25-1.64],2.524607182293473e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGR,Tyrosine-protein kinase Fgr,4377,495,0.93 [0.81-1.06],0.2592404759384793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FH,"Fumarate hydratase, mitochondrial",3781,416,1.02 [0.92-1.14],0.661141853678755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,3783,414,0.91 [0.75-1.11],0.3695142028188507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FHIT,Bis(5'-adenosyl)-triphosphatase,4377,495,0.93 [0.83-1.04],0.1982435171302435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FIS1,Mitochondrial fission 1 protein,4507,503,1.01 [0.92-1.12],0.8029063640807196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,3905,425,1.01 [0.92-1.11],0.8261500530723953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,4516,498,1.00 [0.93-1.07],0.9874149887461876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,4473,505,1.10 [0.91-1.33],0.3381329728401507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,4473,505,1.03 [0.94-1.12],0.4984391369112725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,4368,494,1.12 [0.96-1.30],0.1418627696600795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBPL,FK506-binding protein-like,3888,421,0.96 [0.81-1.12],0.5878563837600173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLI1,Friend leukemia integration 1 transcription factor,4377,493,1.00 [0.93-1.08],0.9236682024095302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,4473,505,1.52 [1.19-1.96],0.0010168250640501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT1,Vascular endothelial growth factor receptor 1,4480,502,1.14 [0.83-1.56],0.417476460832841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,4377,493,1.08 [0.82-1.41],0.593978724644193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,4556,506,1.21 [0.96-1.52],0.1024911173169142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT4,Vascular endothelial growth factor receptor 3,4513,505,0.85 [0.69-1.06],0.1610389240255124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FMNL1,Formin-like protein 1,4377,495,0.99 [0.88-1.11],0.862660237433198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FMR1,Synaptic functional regulator FMR1,4377,493,1.01 [0.81-1.26],0.931676910096618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FN1,Fibronectin,3917,422,0.44 [0.31-0.62],2.228866553538071e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FNDC1,Fibronectin type III domain-containing protein 1,3892,422,0.86 [0.71-1.04],0.1211183137834292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,3890,418,0.95 [0.71-1.27],0.7298169204663392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLH1,Glutamate carboxypeptidase 2,3792,418,0.95 [0.85-1.06],0.3723858926310258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR1,Folate receptor alpha,4492,501,1.74 [1.36-2.21],6.954838540221249e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR2,Folate receptor beta,4541,507,1.40 [1.09-1.81],0.0086022503691352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR3,Folate receptor gamma,4498,504,1.02 [0.98-1.06],0.3675426122963935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOS,Proto-oncogene c-Fos,3756,409,0.88 [0.67-1.16],0.3801604032199853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOSB,Protein fosB,4377,495,0.91 [0.73-1.15],0.4276445243430282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXJ3,Forkhead box protein J3,3792,418,0.89 [0.72-1.10],0.3010924156258369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXO1,Forkhead box protein O1,4504,507,1.03 [0.94-1.13],0.536885180045554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXO3,Forkhead box protein O3,4377,493,1.04 [0.95-1.13],0.3618298460674124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRMD4B,FERM domain-containing protein 4B,3783,414,0.97 [0.85-1.12],0.7160705135563399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRMD7,FERM domain-containing protein 7,3819,418,1.17 [0.89-1.53],0.269355231626865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRZB,Secreted frizzled-related protein 3,4460,505,0.84 [0.63-1.12],0.2379356449605714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSHB,Follitropin subunit beta,3805,414,1.40 [1.18-1.65],7.772064688411056e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FST,Follistatin,4520,504,0.97 [0.82-1.14],0.6953235802283613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL1,Follistatin-related protein 1,3805,414,2.35 [1.60-3.46],1.4718328519389655e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL3,Follistatin-related protein 3,4501,501,1.85 [1.52-2.26],1.234824986491009e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FTCD,Formimidoyltransferase-cyclodeaminase,3885,420,0.89 [0.81-0.97],0.0104741981561021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUCA1,Tissue alpha-L-fucosidase,4543,510,1.04 [0.94-1.14],0.475331542016377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUOM,Fucose mutarotase,3838,411,0.82 [0.72-0.94],0.004646041941989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FURIN,Furin,4513,505,0.68 [0.55-0.84],0.0004171011256613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUS,RNA-binding protein FUS,4365,492,1.02 [0.83-1.26],0.8409945089638229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",3836,411,0.92 [0.79-1.08],0.3287253531724048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,4541,507,1.28 [1.09-1.50],0.0023093246095256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT8,"Alpha-(1,6)-fucosyltransferase",4473,505,0.95 [0.82-1.08],0.419409930925418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FXN,"Frataxin, mitochondrial",4543,508,1.01 [0.91-1.13],0.790073134568414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FXYD5,FXYD domain-containing ion transport regulator 5,4402,494,1.09 [0.97-1.23],0.1407948910088445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FYB1,FYN-binding protein 1,4516,508,0.98 [0.90-1.06],0.5737266943001632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FZD10,Frizzled-10,3819,418,1.07 [0.92-1.24],0.3839531959341424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FZD8,Frizzled-8,3781,416,1.00 [0.80-1.24],0.9778461331900258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,3890,418,0.99 [0.82-1.20],0.9551034054931208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,3845,412,1.05 [0.92-1.20],0.4371510374672703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,3781,416,0.97 [0.83-1.13],0.6798913919784899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAD1,Glutamate decarboxylase 1,3762,409,0.95 [0.65-1.38],0.7796787865409737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAD2,Glutamate decarboxylase 2,3792,418,0.89 [0.71-1.13],0.3451136113889061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,3845,412,0.95 [0.77-1.18],0.6417211534748206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,3805,414,1.02 [0.85-1.22],0.8440600474265434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAGE2A,G antigen 2A,3762,409,0.96 [0.82-1.11],0.5784594357427331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAL,Galanin peptides,4527,505,0.90 [0.80-1.01],0.0781697076436434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,4485,502,1.44 [1.10-1.88],0.0080994429171749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,4543,508,0.75 [0.57-0.99],0.0421654652247314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,4402,494,1.59 [1.34-1.88],9.087779988805953e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,3900,420,0.90 [0.65-1.23],0.5013632358901172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT7,N-acetylgalactosaminyltransferase 7,4485,502,1.89 [1.30-2.75],0.0008203869372357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAMT,Guanidinoacetate N-methyltransferase,3783,414,0.94 [0.72-1.24],0.6687234656101801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,3737,393,1.09 [0.76-1.54],0.6489712060590322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GART,Trifunctional purine biosynthetic protein adenosine-3,3905,425,0.95 [0.66-1.37],0.7905905040892327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAS2,Growth arrest-specific protein 2,3845,412,0.77 [0.63-0.95],0.0149749135494211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAS6,Growth arrest-specific protein 6,4538,509,1.46 [1.08-1.96],0.0128222336007306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GASK1A,Golgi-associated kinase 1A,3783,414,0.73 [0.59-0.90],0.0032351466470704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAST,Gastrin,3892,422,1.08 [1.02-1.14],0.0061926799024528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,3762,409,0.75 [0.52-1.09],0.1347135497855664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",3805,414,1.06 [0.94-1.19],0.3691277925456265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBA,Lysosomal acid glucosylceramidase,3819,418,1.09 [0.93-1.28],0.278360913175418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP1,Guanylate-binding protein 1,3886,421,0.91 [0.79-1.04],0.1557125581268282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP2,Guanylate-binding protein 2,4402,494,1.01 [0.88-1.16],0.8547299832353256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP4,Guanylate-binding protein 4,4377,495,0.98 [0.83-1.16],0.810956147874067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP6,Guanylate-binding protein 6,3783,414,0.98 [0.79-1.22],0.8532969766760188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GC,Vitamin D-binding protein,3917,422,0.91 [0.63-1.30],0.5905773134907214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCC1,GRIP and coiled-coil domain-containing protein 1,3892,422,0.98 [0.90-1.07],0.6153014065407436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCG,Pro-glucagon,4377,493,1.23 [1.16-1.31],2.290042671806098e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,3737,401,0.99 [0.82-1.20],0.9320239673361842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCLM,Glutamate--cysteine ligase regulatory subunit,3783,414,0.91 [0.74-1.13],0.4163075141468496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",4485,502,1.67 [1.35-2.08],3.338093193958408e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF15,Growth/differentiation factor 15,4564,512,2.13 [1.93-2.36],1.043757321828054e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF2,Growth/differentiation factor 2,4508,505,1.23 [1.00-1.52],0.05518409538312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDNF,Glial cell line-derived neurotrophic factor,4377,495,1.31 [1.08-1.60],0.0064673997141441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GET3,ATPase GET3,3900,420,0.92 [0.77-1.09],0.3256536239680192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFAP,Glial fibrillary acidic protein,4372,493,0.88 [0.74-1.05],0.1562066295663514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFER,FAD-linked sulfhydryl oxidase ALR,4377,493,1.01 [0.89-1.14],0.9019867334311628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,4377,493,1.03 [0.97-1.10],0.3793299713662206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA1,GDNF family receptor alpha-1,4535,508,2.78 [2.22-3.49],5.5334323592025875e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA2,GDNF family receptor alpha-2,4485,502,1.40 [0.97-2.04],0.074813509228338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA3,GDNF family receptor alpha-3,4461,502,1.69 [1.30-2.19],9.121010581615924e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRAL,GDNF family receptor alpha-like,3774,414,0.95 [0.82-1.11],0.5352960156283809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGA1,ADP-ribosylation factor-binding protein GGA1,4377,495,0.99 [0.88-1.12],0.9200079548573924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGACT,Gamma-glutamylaminecyclotransferase,3900,420,1.01 [0.88-1.15],0.919340392151888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGCT,Gamma-glutamylcyclotransferase,3897,420,0.95 [0.78-1.16],0.602771096660351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGH,Gamma-glutamyl hydrolase,4437,496,0.73 [0.57-0.92],0.0087042908635027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT1,Glutathione hydrolase 1 proenzyme,4520,507,0.92 [0.79-1.06],0.2338126633975717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT5,Glutathione hydrolase 5 proenzyme,4473,505,2.41 [1.82-3.19],7.152306197043472e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH1,Somatotropin,4506,503,1.09 [1.04-1.13],0.0002442728404636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH2,Growth hormone variant,4377,493,1.00 [0.95-1.05],0.9958018112860384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHR,Growth hormone receptor,3838,411,0.42 [0.31-0.58],5.779095972160268e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHRHR,Growth hormone-releasing hormone receptor,4377,495,1.01 [0.86-1.17],0.9492006260010908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHRL,Appetite-regulating hormone,4508,505,1.01 [0.93-1.11],0.760052715762952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GID8,Glucose-induced degradation protein 8 homolog,3905,425,1.26 [1.00-1.57],0.0453936572944162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIGYF2,GRB10-interacting GYF protein 2,3905,425,1.07 [0.94-1.20],0.3051845756304331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIMAP7,GTPase IMAP family member 7,3838,411,0.91 [0.67-1.23],0.5379725849831142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIMAP8,GTPase IMAP family member 8,3762,409,0.96 [0.79-1.17],0.689153073490377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIP,Gastric inhibitory polypeptide,3805,414,1.40 [1.20-1.65],3.3556732164767354e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC2,PDZ domain-containing protein GIPC2,3892,422,1.65 [1.26-2.16],0.0002432018877207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC3,PDZ domain-containing protein GIPC3,3888,421,0.99 [0.90-1.09],0.8925804854138817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPR,Gastric inhibitory polypeptide receptor,3792,418,1.19 [0.98-1.44],0.0750550900215477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIT1,ARF GTPase-activating protein GIT1,3792,418,0.96 [0.87-1.06],0.4296887352493016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GJA8,Gap junction alpha-8 protein,3762,409,1.14 [0.99-1.31],0.0646719494539121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GKN1,Gastrokine-1,4293,480,1.38 [1.04-1.82],0.0235958303351586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLA,Alpha-galactosidase A,3832,409,1.14 [0.89-1.45],0.3010311532308219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLB1,Beta-galactosidase,4473,505,1.05 [0.87-1.26],0.6344317826489119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLI2,Zinc finger protein GLI2,3792,418,0.77 [0.55-1.08],0.1337549849822033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLO1,Lactoylglutathione lyase,4430,500,1.06 [0.93-1.22],0.3882150117796694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLOD4,Glyoxalase domain-containing protein 4,4500,502,0.95 [0.75-1.19],0.6399613196041987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLP1R,Glucagon-like peptide 1 receptor,3781,416,1.35 [1.09-1.69],0.006840773870313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLRX,Glutaredoxin-1,4481,502,0.98 [0.86-1.12],0.7928451320847483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",3838,411,0.97 [0.87-1.08],0.5426028721927342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,4377,495,0.97 [0.82-1.15],0.728123284925696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLYR1,Putative oxidoreductase GLYR1,3890,418,0.97 [0.81-1.14],0.6854420726310124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GM2A,Ganglioside GM2 activator,3835,415,1.60 [1.30-1.98],1.0713192724061925e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMFG,Glia maturation factor gamma,3900,420,0.99 [0.87-1.13],0.8555512162547874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMPR,GMP reductase 1,4556,506,0.93 [0.80-1.09],0.3871394514983343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMPR2,GMP reductase 2,3838,411,0.95 [0.82-1.10],0.4776452423669839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNAS,Neuroendocrine secretory protein 55,3905,425,0.97 [0.87-1.08],0.5913694893017328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,4377,493,0.89 [0.78-1.01],0.0619512446203242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,3819,418,1.02 [0.86-1.21],0.8418306579024295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNLY,Granulysin,4525,508,0.94 [0.82-1.08],0.3691630602035217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,3805,414,0.93 [0.70-1.24],0.6152214988458546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,3838,411,0.70 [0.55-0.91],0.0066010634019594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOLGA3,Golgin subfamily A member 3,3905,425,1.03 [0.92-1.17],0.5920135262719062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOLM2,Protein GOLM2,4541,507,1.32 [1.01-1.72],0.0393495505807774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,4504,507,0.97 [0.90-1.05],0.4875916971475921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GORASP2,Golgi reassembly-stacking protein 2,3888,421,1.01 [0.83-1.23],0.9216391850560864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOT1,"Aspartate aminotransferase, cytoplasmic",3920,425,0.66 [0.54-0.81],7.054753040735657e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP1BA,Platelet glycoprotein Ib alpha chain,4494,501,0.83 [0.66-1.05],0.1243320872617586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP1BB,Platelet glycoprotein Ib beta chain,3783,414,0.96 [0.84-1.11],0.5894001442396957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,4375,497,1.14 [1.06-1.23],0.0007447710081521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP5,Platelet glycoprotein V,3838,411,0.86 [0.67-1.12],0.2732206823556053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP6,Platelet glycoprotein VI,4516,508,1.01 [0.92-1.10],0.894973048359589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPA33,Cell surface A33 antigen,4485,502,0.90 [0.84-0.95],0.0003491915003091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC1,Glypican-1,4543,508,1.60 [1.24-2.05],0.0002355370359948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC5,Glypican-5,4473,505,0.89 [0.77-1.02],0.086458915783363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPD1,Glycerol-3-phosphate dehydrogenase,3890,418,0.92 [0.79-1.07],0.2693015351146247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPHA2,Glycoprotein hormone alpha-2,3888,421,1.05 [0.86-1.28],0.618960614260907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPI,Glucose-6-phosphate isomerase,3921,425,0.92 [0.76-1.12],0.4130263490847723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,3888,421,1.14 [1.00-1.30],0.0563333723778083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPKOW,G-patch domain and KOW motifs-containing protein,4377,495,1.16 [0.92-1.46],0.2134929041976841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPNMB,Transmembrane glycoprotein NMB,4399,491,2.57 [1.98-3.34],1.7815547136563326e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR101,Probable G-protein coupled receptor 101,3781,416,1.09 [0.94-1.27],0.2630324672020824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR158,Probable G-protein coupled receptor 158,3905,425,1.16 [0.90-1.48],0.2493795072893303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR15L,Protein GPR15L,3888,421,1.07 [0.93-1.23],0.3618352481209754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR37,Prosaposin receptor GPR37,4430,500,1.36 [1.21-1.53],1.4840489011964e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPRC5C,G-protein coupled receptor family C group 5 member C,3890,418,1.12 [0.97-1.30],0.1249582226544633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRAP2,GRB2-related adapter protein 2,4508,505,0.99 [0.94-1.06],0.8553741366250072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,3900,420,1.02 [0.88-1.18],0.8350099646784734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",3905,425,0.87 [0.68-1.10],0.2412965966436278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",3781,416,1.03 [0.86-1.23],0.7518811854809708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRK5,G protein-coupled receptor kinase 5,4430,500,0.93 [0.79-1.09],0.3518515162878932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRN,Progranulin,4503,507,3.10 [2.31-4.14],2.4494901578757452e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRP,Gastrin-releasing peptide,3805,414,0.89 [0.76-1.05],0.1774566708160346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",4485,502,1.08 [0.96-1.23],0.1964550725156583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRSF1,G-rich sequence factor 1,3740,407,1.01 [0.90-1.14],0.805137031665041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSAP,Gamma-secretase-activating protein,4377,493,1.02 [0.93-1.12],0.7001208237890557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSN,Gelsolin,3906,423,0.57 [0.38-0.86],0.0068585555000966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSR,"Glutathione reductase, mitochondrial",3903,422,0.62 [0.44-0.87],0.0059235934143778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA1,Glutathione S-transferase A1,4501,505,0.85 [0.78-0.92],0.0001738658845575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA3,Glutathione S-transferase A3,4377,493,0.88 [0.80-0.97],0.0071254687588044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTM4,Glutathione S-transferase Mu 4,3783,414,1.01 [0.89-1.14],0.937681551978642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTP1,Glutathione S-transferase P,4349,492,1.08 [0.96-1.21],0.2120160862017807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTT2B,Glutathione S-transferase theta-2B,3892,422,0.98 [0.94-1.02],0.3159348340765677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,3845,412,1.10 [0.97-1.25],0.1436706457273202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GTPBP2,GTP-binding protein 2,3819,418,0.99 [0.88-1.11],0.8514134616584339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCA2A,Guanylin,4504,507,1.84 [1.53-2.20],5.013831678426596e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCY2C,Heat-stable enterotoxin receptor,3845,412,0.91 [0.80-1.04],0.1648752507649587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUK1,Guanylate kinase,3783,414,1.08 [0.83-1.41],0.5516639585876295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUSB,Beta-glucuronidase,4535,510,0.87 [0.78-0.97],0.0157525633834342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GYS1,"Glycogen [starch] synthase, muscle",4430,500,0.89 [0.82-0.97],0.0109234010383793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMA,Granzyme A,4556,506,1.07 [0.85-1.33],0.575605142792752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMB,Granzyme B,4504,507,0.86 [0.75-0.98],0.0212420749995469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMH,Granzyme H,4430,500,0.99 [0.89-1.11],0.8962969803237267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,H2AP,Huntingtin-interacting protein M,3762,409,0.86 [0.68-1.09],0.2101386069017708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",3783,414,1.10 [0.97-1.24],0.1564527029610159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",4530,507,0.95 [0.86-1.06],0.3717863003552518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAO1,Hydroxyacid oxidase 1,4543,508,0.97 [0.92-1.03],0.3125085218363579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",4525,508,0.99 [0.90-1.10],0.9189621345779412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR1,Hepatitis A virus cellular receptor 1,4538,507,1.69 [1.55-1.84],3.5995623656662625e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR2,Hepatitis A virus cellular receptor 2,4525,508,1.86 [1.53-2.27],8.431150824875131e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBEGF,Proheparin-binding EGF-like growth factor,4530,507,0.98 [0.88-1.08],0.6596414069810359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBQ1,Hemoglobin subunit theta-1,4543,508,0.91 [0.80-1.03],0.1408795037547267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBZ,Hemoglobin subunit zeta,3900,420,0.94 [0.86-1.03],0.188628374553168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HCG22,Protein PBMUCL2,3783,414,0.98 [0.83-1.15],0.7717712258474323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HCLS1,Hematopoietic lineage cell-specific protein,4556,506,0.91 [0.79-1.05],0.2132761227934742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDAC8,Histone deacetylase 8,3792,418,0.92 [0.76-1.11],0.385951660679498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDAC9,Histone deacetylase 9,3781,416,1.03 [0.89-1.19],0.7102221443909525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDDC2,5'-deoxynucleotidase HDDC2,3888,421,0.94 [0.76-1.16],0.5906921479277221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDGF,Hepatoma-derived growth factor,4535,508,1.02 [0.94-1.11],0.6373393637761371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,3892,422,1.03 [0.90-1.20],0.6444389854926289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEBP1,Heme-binding protein 1,4430,500,0.99 [0.85-1.16],0.8991492379856714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEG1,Protein HEG homolog 1,3838,411,1.43 [1.04-1.97],0.0262152152991001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPACAM2,HEPACAM family member 2,3892,422,0.88 [0.72-1.09],0.2492021428182566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPH,Hephaestin,3900,420,3.35 [2.38-4.71],3.9099593110683705e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEXIM1,Protein HEXIM1,4504,507,0.95 [0.86-1.06],0.3652718445714846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGF,Hepatocyte growth factor,4556,506,1.02 [0.83-1.26],0.8361748291046973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGFAC,Hepatocyte growth factor activator,3890,422,1.65 [1.17-2.33],0.0041093374364649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,4377,493,0.98 [0.88-1.09],0.7099309135179359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,3892,422,0.99 [0.87-1.12],0.8680677365354983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIF1A,Hypoxia-inducible factor 1-alpha,3792,418,0.92 [0.79-1.09],0.3458759245792546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIP1,Huntingtin-interacting protein 1,3783,414,0.95 [0.71-1.28],0.7415539384203558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIP1R,Huntingtin-interacting protein 1-related protein,3887,421,1.14 [0.97-1.33],0.101386565732197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HJV,Hemojuvelin,3905,425,1.12 [0.91-1.37],0.2807793681556479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HK2,Hexokinase-2,4430,500,0.97 [0.73-1.29],0.8122061261655776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",3905,425,1.57 [1.18-2.09],0.0019426690601957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",4491,505,1.36 [1.11-1.66],0.0025833532204292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",4504,507,1.96 [1.59-2.43],5.685846191422493e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMBS,Porphobilinogen deaminase,4543,508,0.84 [0.71-1.00],0.0568148696139003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMCN2,Hemicentin-2,3831,410,1.13 [0.96-1.33],0.1299417209548047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",3805,414,1.06 [0.87-1.28],0.5699765800980503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",3783,414,1.04 [0.84-1.28],0.7336538477402614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMMR,Hyaluronan mediated motility receptor,3755,407,1.00 [0.82-1.22],0.9716152711466608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX1,Heme oxygenase 1,4473,500,0.82 [0.70-0.96],0.0127104582045525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX2,Heme oxygenase 2,4377,495,1.09 [0.92-1.29],0.3388808024056295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNF1A,Hepatocyte nuclear factor 1-alpha,3819,418,1.01 [0.90-1.14],0.8689733526427419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNMT,Histamine N-methyltransferase,4454,504,1.05 [0.91-1.21],0.5198682077224814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,4420,500,1.01 [0.91-1.12],0.8928796367478586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,3905,425,1.05 [0.87-1.26],0.6132902829503554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPCAL1,Hippocalcin-like protein 1,4556,506,1.00 [0.90-1.11],0.9660779276334168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPGDS,Hematopoietic prostaglandin D synthase,4377,493,0.95 [0.77-1.18],0.647490000288249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPSE,Heparanase,3878,418,0.99 [0.90-1.09],0.8125476187230359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRAS,GTPase Hras,3835,411,0.93 [0.84-1.04],0.2074388801391901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,3805,414,1.40 [1.13-1.74],0.0021941158677805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRG,Histidine-rich glycoprotein,3898,422,1.41 [1.06-1.88],0.0175528486895018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS1BP3,HCLS1-binding protein 3,3805,414,1.02 [0.92-1.14],0.7217839545356377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,4485,502,1.10 [0.90-1.34],0.3350830407404954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,4543,508,0.97 [0.79-1.19],0.7632591374797502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,3792,418,1.18 [0.93-1.50],0.1653174025830036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSBP1,Heat shock factor-binding protein 1,3805,414,1.08 [0.98-1.20],0.1142061212163063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,4504,507,0.80 [0.67-0.96],0.0178114566873149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,3892,422,1.05 [0.91-1.21],0.5158717616524051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,3783,414,1.05 [0.87-1.27],0.5918285566491504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,3805,414,0.97 [0.79-1.18],0.7533281972213626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSP90B1,Endoplasmin,4360,492,0.99 [0.87-1.13],0.8663895257485381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPA1A,Heat shock 70 kDa protein 1A,4517,503,1.00 [0.90-1.12],0.966313456394912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPA2,Heat shock-related 70 kDa protein 2,3890,418,1.21 [0.96-1.54],0.1114065200262559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB1,Heat shock protein beta-1,4438,497,0.94 [0.84-1.05],0.2731093314393678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB6,Heat shock protein beta-6,4543,508,1.50 [1.26-1.79],6.098826428066079e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,4482,499,1.73 [1.37-2.19],4.499659801940284e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTR1A,5-hydroxytryptamine receptor 1A,3781,416,0.99 [0.88-1.12],0.8940094733454553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTR1B,5-hydroxytryptamine receptor 1B,3781,416,1.01 [0.81-1.25],0.958744994035531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTRA2,"Serine protease HTRA2, mitochondrial",4513,505,0.98 [0.87-1.12],0.8101846609798122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYAL1,Hyaluronidase-1,4476,499,1.77 [1.30-2.41],0.0002992640292038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYOU1,Hypoxia up-regulated protein 1,4564,512,1.86 [1.36-2.53],8.398915646244582e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICA1,Islet cell autoantigen 1,4402,494,0.97 [0.87-1.07],0.5308452318234016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM1,Intercellular adhesion molecule 1,4494,502,1.14 [0.89-1.46],0.3110182361027626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM2,Intercellular adhesion molecule 2,4564,512,1.63 [1.28-2.08],6.9376377787064e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM3,Intercellular adhesion molecule 3,4564,512,1.63 [1.25-2.14],0.0003133596843836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM4,Intercellular adhesion molecule 4,4504,507,0.92 [0.80-1.07],0.3068630118981352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM5,Intercellular adhesion molecule 5,4508,505,1.09 [0.92-1.28],0.3423112897666859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICOSLG,ICOS ligand,4485,502,1.46 [0.98-2.17],0.061403883640697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ID4,DNA-binding protein inhibitor ID-4,3845,412,1.01 [0.82-1.25],0.8942509109346035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,4377,495,1.03 [0.88-1.20],0.7397632861743872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDO1,"Indoleamine 2,3-dioxygenase 1",3805,414,0.99 [0.86-1.14],0.8916044919395084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDS,Iduronate 2-sulfatase,4556,506,0.74 [0.32-1.74],0.4922481174660116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDUA,Alpha-L-iduronidase,4543,508,1.07 [0.91-1.26],0.4286770952297718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,3791,412,1.16 [0.91-1.48],0.2250261928399285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,3845,412,1.03 [0.86-1.24],0.7428622493321121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,3845,412,0.91 [0.71-1.17],0.4628443985363643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNAR1,Interferon alpha/beta receptor 1,3888,421,0.92 [0.63-1.35],0.6807913115274045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNG,Interferon gamma,4402,494,1.05 [0.98-1.13],0.1606122896532006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR1,Interferon gamma receptor 1,4527,505,2.12 [1.52-2.94],7.69904975586534e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR2,Interferon gamma receptor 2,4473,505,1.11 [0.96-1.27],0.1578285319647296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNL1,Interferon lambda-1,4377,495,1.11 [0.94-1.31],0.2133235311217347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNL2,Interferon lambda-2,3781,416,1.11 [0.96-1.28],0.1611596292243694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNLR1,Interferon lambda receptor 1,4504,507,1.18 [0.95-1.46],0.133791517299413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNW1,Interferon omega-1,3783,414,0.93 [0.70-1.23],0.5990932455390949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFT20,Intraflagellar transport protein 20 homolog,3819,418,1.15 [0.93-1.42],0.2092185649768629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGBP1,Immunoglobulin-binding protein 1,3905,425,0.98 [0.85-1.15],0.845627133269815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,3781,416,1.11 [0.92-1.33],0.2889050031675587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,3920,425,1.16 [0.83-1.61],0.3776181466598937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF1R,Insulin-like growth factor 1 receptor,4485,502,2.34 [1.73-3.18],4.0485097562654343e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,3783,414,1.03 [0.83-1.28],0.8045195494094463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF2R,Cation-independent mannose-6-phosphate receptor,4525,508,1.46 [1.05-2.01],0.0227647707273008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP1,Insulin-like growth factor-binding protein 1,4559,511,1.13 [1.07-1.21],8.616776742082872e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP2,Insulin-like growth factor-binding protein 2,4557,512,1.43 [1.28-1.59],1.2122942700716575e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP3,Insulin-like growth factor-binding protein 3,4526,507,0.66 [0.55-0.80],9.254341144300397e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP4,Insulin-like growth factor-binding protein 4,4469,500,1.75 [1.54-1.99],5.464746319276142e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP6,Insulin-like growth factor-binding protein 6,4500,502,1.66 [1.36-2.03],8.57247440345699e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP7,Insulin-like growth factor-binding protein 7,4564,512,1.56 [1.29-1.90],6.895490634548091e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,4508,505,1.26 [1.04-1.52],0.0164597283053055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFL4,Insulin growth factor-like family member 4,3792,418,0.96 [0.84-1.10],0.5288112725753451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGHMBP2,DNA-binding protein SMUBP-2,3783,414,1.26 [1.08-1.47],0.0037170319191672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGLC2,Immunoglobulin lambda constant 2,3904,419,1.50 [1.08-2.07],0.0149651384155449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGLON5,IgLON family member 5,3762,409,0.98 [0.87-1.09],0.6791211815075651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF21,Immunoglobulin superfamily member 21,3805,414,0.99 [0.79-1.25],0.9402827852510972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF3,Immunoglobulin superfamily member 3,4485,502,1.29 [1.09-1.53],0.0029547540943889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF8,Immunoglobulin superfamily member 8,4508,505,1.70 [1.37-2.10],1.3546580193128283e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF9,Protein turtle homolog A,3900,420,0.93 [0.84-1.02],0.1322680179310364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IKBKG,NF-kappa-B essential modulator,4504,507,0.97 [0.89-1.06],0.4630776428096331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IKZF2,Zinc finger protein Helios,4377,493,1.01 [0.92-1.11],0.8321030354777694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10,Interleukin-10,4402,494,1.15 [1.05-1.25],0.001741853542832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RA,Interleukin-10 receptor subunit alpha,4402,494,0.97 [0.84-1.12],0.6780190962630162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RB,Interleukin-10 receptor subunit beta,4527,505,1.85 [1.46-2.34],2.9994320820195813e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL11,Interleukin-11,4402,494,1.09 [0.97-1.22],0.1618464233565399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12A_IL12B,Interleukin-12,4485,502,1.16 [1.05-1.27],0.0020455287143003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12B,Interleukin-12 subunit beta,4556,506,1.22 [1.07-1.39],0.0038403532695727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB1,Interleukin-12 receptor subunit beta-1,4402,494,1.43 [1.17-1.75],0.0005872355728584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB2,Interleukin-12 receptor subunit beta-2,3792,418,1.13 [0.90-1.41],0.3010318411240275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13,Interleukin-13,4402,494,0.89 [0.75-1.07],0.2339984562744739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,4447,497,1.21 [0.87-1.68],0.2587219036501857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,3781,416,1.02 [0.73-1.43],0.8862104219009586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15,Interleukin-15,4504,507,1.70 [1.39-2.08],1.891512656280021e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15RA,Interleukin-15 receptor subunit alpha,4402,494,1.59 [1.28-1.96],1.947532623947784e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL16,Pro-interleukin-16,4556,506,1.06 [0.89-1.26],0.5039777143331328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17A,Interleukin-17A,4394,493,1.20 [1.02-1.40],0.0267812076690377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17C,Interleukin-17C,4402,494,1.37 [1.26-1.49],1.804797305281615e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17D,Interleukin-17D,4402,494,1.17 [0.97-1.42],0.0993537247936073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17F,Interleukin-17F,4402,494,1.08 [0.97-1.20],0.1535561641389577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RA,Interleukin-17 receptor A,4525,508,1.22 [1.03-1.45],0.0226679854308166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RB,Interleukin-17 receptor B,4454,502,1.32 [1.15-1.53],0.0001210540728949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18,Interleukin-18,4492,502,1.30 [1.10-1.54],0.001707373274419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18BP,Interleukin-18-binding protein,4526,507,2.03 [1.65-2.52],5.2801736510654376e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18R1,Interleukin-18 receptor 1,4556,506,1.68 [1.36-2.07],1.10536637103247e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18RAP,Interleukin-18 receptor accessory protein,4441,502,0.94 [0.90-0.99],0.018701915327186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL19,Interleukin-19,4409,495,1.21 [1.10-1.32],9.308234404543556e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1A,Interleukin-1 alpha,4402,494,1.08 [0.96-1.23],0.2148214426648164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1B,Interleukin-1 beta,4380,492,1.04 [0.91-1.19],0.544585468158531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R1,Interleukin-1 receptor type 1,4520,507,4.50 [3.48-5.84],5.354363676467239e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R2,Interleukin-1 receptor type 2,4498,504,1.31 [0.92-1.86],0.129648252834663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RAP,Interleukin-1 receptor accessory protein,4525,508,1.20 [1.01-1.42],0.0331664387041124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL1,Interleukin-1 receptor-like 1,4554,512,1.59 [1.34-1.88],1.03602611067133e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL2,Interleukin-1 receptor-like 2,4402,494,1.04 [0.84-1.28],0.7179546474300619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RN,Interleukin-1 receptor antagonist protein,4497,502,1.09 [0.96-1.23],0.1834349373199678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2,Interleukin-2,4402,494,1.04 [0.81-1.34],0.7669115540923894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20,Interleukin-20,4402,494,0.94 [0.79-1.11],0.4387173249733956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20RA,Interleukin-20 receptor subunit alpha,4402,494,1.12 [0.95-1.33],0.1721208929222457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20RB,Interleukin-20 receptor subunit beta,3792,418,0.90 [0.72-1.13],0.3798189834777028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL21R,Interleukin-21 receptor,3792,418,1.00 [0.85-1.18],0.9929401428208976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL22,Interleukin-22,3890,418,1.08 [0.95-1.24],0.2449408029687472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,4402,494,1.18 [0.99-1.41],0.0605890629976667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL24,Interleukin-24,4402,494,1.02 [0.87-1.19],0.8339031202904313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL25,Interleukin-25,3750,408,1.09 [0.82-1.44],0.545167249534061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RA,Interleukin-2 receptor subunit alpha,4483,502,1.67 [1.41-1.98],4.298169039583157e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RB,Interleukin-2 receptor subunit beta,4402,494,1.09 [0.90-1.31],0.3909322993557762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RG,Cytokine receptor common subunit gamma,3890,418,1.23 [1.00-1.52],0.050613872213115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL3,Interleukin-3,3762,409,1.08 [0.91-1.27],0.3902621572406518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL31,Interleukin-31,3792,418,0.91 [0.76-1.09],0.2892852892845247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL31RA,Interleukin-31 receptor subunit alpha,3775,415,0.98 [0.77-1.25],0.877449806266937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL32,Interleukin-32,4504,507,1.00 [0.86-1.16],0.9733980021202664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL33,Interleukin-33,4402,494,1.02 [0.84-1.25],0.8133007005645515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL34,Interleukin-34,4370,494,0.99 [0.79-1.23],0.9016945091633404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL36A,Interleukin-36 alpha,3792,418,1.00 [0.86-1.17],0.9989558819885952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL36G,Interleukin-36 gamma,3785,418,0.99 [0.87-1.13],0.8987818971696473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL3RA,Interleukin-3 receptor subunit alpha,4402,494,1.23 [0.97-1.57],0.084345529389031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4,Interleukin-4,4402,494,1.04 [0.95-1.13],0.3851398338542874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4R,Interleukin-4 receptor subunit alpha,4504,507,1.69 [1.41-2.04],3.3618119151398985e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL5,Interleukin-5,4402,494,1.00 [0.94-1.06],0.9943640873031588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL5RA,Interleukin-5 receptor subunit alpha,4504,507,1.18 [1.03-1.34],0.0154741907625881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6,Interleukin-6,4485,502,0.96 [0.87-1.07],0.4731130460741858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6R,Interleukin-6 receptor subunit alpha,4488,501,1.34 [1.07-1.68],0.0102297197005415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6ST,Interleukin-6 receptor subunit beta,4508,505,2.46 [1.62-3.73],2.5502692358295025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL7,Interleukin-7,4504,507,0.93 [0.82-1.05],0.245959070537053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL7R,Interleukin-7 receptor subunit alpha,4525,508,1.05 [0.90-1.22],0.5227843655837976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL9,Interleukin-9,3845,412,1.04 [0.89-1.22],0.6096841116381686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,4369,494,1.07 [0.93-1.22],0.3256728945570847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMMT,MICOS complex subunit MIC60,3890,418,1.24 [1.03-1.48],0.0199776864530342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPA1,Inositol monophosphatase 1,4473,505,0.94 [0.83-1.08],0.3958820352754333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPACT,Protein IMPACT,3892,422,0.90 [0.76-1.07],0.2272421223412183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,3781,416,1.10 [0.83-1.47],0.5028796363922731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ING1,Inhibitor of growth protein 1,4368,494,0.97 [0.82-1.15],0.7088302926071774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INHBB,Inhibin beta B chain,3838,411,1.28 [1.09-1.51],0.0028072593296232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INHBC,Inhibin beta C chain,4525,508,0.97 [0.79-1.18],0.7424060529005169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP1,Inositol polyphosphate 1-phosphatase,4485,502,1.02 [0.88-1.18],0.8088635530081063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",3805,414,1.07 [0.90-1.26],0.4521336334038242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",3905,425,1.06 [0.84-1.33],0.6311205799651438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",4485,502,0.98 [0.90-1.06],0.627953504477662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL3,Insulin-like 3,3892,422,0.93 [0.84-1.04],0.2183737820757411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL4,Early placenta insulin-like peptide,3890,418,1.40 [1.20-1.63],1.373697725555158e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL5,Insulin-like peptide INSL5,3888,421,1.13 [1.04-1.24],0.0050088178793938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSR,Insulin receptor,3792,418,2.08 [1.23-3.51],0.0063615010461348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,4466,505,1.05 [0.96-1.14],0.332459482602521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,4485,502,1.03 [0.89-1.18],0.7145548783724452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",4430,500,0.97 [0.89-1.06],0.5448232622674302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAK1,Interleukin-1 receptor-associated kinase 1,4402,494,1.03 [0.92-1.16],0.6189452699993722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAK4,Interleukin-1 receptor-associated kinase 4,4504,507,0.99 [0.92-1.07],0.8098855979028159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,4310,483,1.05 [0.85-1.30],0.651765710125351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISM1,Isthmin-1,4504,507,0.87 [0.72-1.05],0.1607289683814658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISM2,Isthmin-2,3920,425,1.18 [0.98-1.41],0.080745823732433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IST1,IST1 homolog,3859,419,1.01 [0.91-1.11],0.8680898805788997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA11,Integrin alpha-11,4504,507,0.98 [0.79-1.21],0.8191239541614928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA2,Integrin alpha-2,3838,411,0.89 [0.69-1.16],0.3953727120344925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA5,Integrin alpha-5,4525,508,1.25 [0.95-1.66],0.1110795851683237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA6,Integrin alpha-6,4504,507,0.84 [0.72-0.99],0.0348780462253931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAL,Integrin alpha-L,3792,418,1.01 [0.82-1.25],0.9208359804171552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAM,Integrin alpha-M,4525,508,1.60 [1.28-1.99],3.55096973413972e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAV,Integrin alpha-V,4543,508,0.82 [0.53-1.26],0.3607147345349785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAX,Integrin alpha-X,3845,412,1.07 [0.89-1.28],0.4610226750211783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1,Integrin beta-1,4509,507,1.32 [0.94-1.85],0.1099317001875783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1BP1,Integrin beta-1-binding protein 1,4377,493,1.13 [0.93-1.37],0.227892595294825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1BP2,Integrin beta-1-binding protein 2,4430,500,1.01 [0.94-1.08],0.8156248369866261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB2,Integrin beta-2,4495,507,1.87 [1.47-2.37],2.910280392513369e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB5,Integrin beta-5,4513,505,1.18 [0.99-1.42],0.071433487498462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB6,Integrin beta-6,4402,494,2.11 [1.64-2.71],6.7571357228429086e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB7,Integrin beta-7,4543,508,1.45 [1.24-1.69],2.634209939574101e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGBL1,Integrin beta-like protein 1,3920,425,1.26 [1.06-1.50],0.0087625754094846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,3917,422,1.05 [0.65-1.72],0.8318315546097583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,4526,507,1.90 [1.55-2.32],4.4725694043020607e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,3917,422,0.93 [0.65-1.33],0.7002443783799119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,3890,418,1.01 [0.81-1.25],0.9588464035181152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITM2A,Integral membrane protein 2A,4504,507,1.11 [0.98-1.26],0.0990891743619948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPA,Inosine triphosphate pyrophosphatase,3783,414,0.92 [0.80-1.06],0.2556400988786819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",3805,414,1.09 [0.96-1.24],0.2058444322388714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",3781,416,1.12 [0.91-1.37],0.2800778297001076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",4377,495,0.99 [0.84-1.16],0.9181136259405004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IZUMO1,Izumo sperm-egg fusion protein 1,3762,409,1.05 [0.86-1.28],0.6459561066507308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM2,Junctional adhesion molecule B,4541,507,2.77 [2.20-3.49],4.9177923030564484e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM3,Junctional adhesion molecule C,3838,411,1.18 [1.00-1.39],0.0567990290131393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JCHAIN,Immunoglobulin J chain,4402,494,1.08 [0.95-1.23],0.2376577905104482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,3762,409,1.08 [0.91-1.27],0.3948646879132583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JPT2,Jupiter microtubule associated homolog 2,3888,421,1.02 [0.91-1.14],0.7234447827434192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JUN,Transcription factor AP-1,4402,494,1.12 [0.97-1.29],0.1367702914195905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,4485,502,1.24 [1.04-1.48],0.0152067044155765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KAZN,Kazrin,3888,421,0.99 [0.90-1.08],0.7683306326227263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,3781,416,0.86 [0.71-1.05],0.1331089327714946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,3819,418,1.02 [0.91-1.15],0.7119390066149455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNIP4,Kv channel-interacting protein 4,4377,495,0.98 [0.84-1.15],0.8256480946530151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCTD5,BTB/POZ domain-containing protein KCTD5,3823,411,0.97 [0.80-1.19],0.8038833038374114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KDM3A,Lysine-specific demethylase 3A,3792,418,1.00 [0.89-1.12],0.946059533116921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KDR,Vascular endothelial growth factor receptor 2,4513,505,0.93 [0.69-1.26],0.6580832507731973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KEL,Kell blood group glycoprotein,4377,495,1.08 [0.87-1.34],0.4799654630851313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KHDC3L,KH domain-containing protein 3,3762,409,1.09 [0.96-1.24],0.1751513197046239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KHK,Ketohexokinase,3805,414,0.87 [0.76-1.01],0.0619681547794342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA0319,Dyslexia-associated protein KIAA0319,3892,422,1.12 [0.83-1.50],0.471196824089121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA1549,UPF0606 protein KIAA1549,3845,412,0.99 [0.86-1.13],0.8608359189672893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA1549L,UPF0606 protein KIAA1549L,3845,412,0.90 [0.64-1.28],0.5664737184206567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA2013,Uncharacterized protein KIAA2013,3890,418,0.91 [0.75-1.11],0.3605174009678151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF1C,Kinesin-like protein KIF1C,3783,414,1.39 [1.07-1.81],0.0150873975673337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF20B,Kinesin-like protein KIF20B,3781,416,1.02 [0.90-1.14],0.7994505001902938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF22,Kinesin-like protein KIF22,3783,414,0.99 [0.91-1.07],0.811972241036499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIFBP,KIF-binding protein,4485,502,1.01 [0.92-1.11],0.8019792237081805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,3890,418,1.07 [0.97-1.19],0.1633749866550741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,4377,493,1.06 [0.96-1.16],0.2463884288465513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,3888,421,1.01 [0.96-1.07],0.688789776495077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,4377,493,1.03 [0.97-1.10],0.3570518768656391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,3762,409,0.91 [0.79-1.04],0.1497333231917404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIRREL1,Kin of IRRE-like protein 1,3781,416,1.15 [0.98-1.35],0.093583166127054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIRREL2,Kin of IRRE-like protein 2,4377,495,1.12 [0.93-1.35],0.250169437795474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIT,Mast/stem cell growth factor receptor Kit,4523,505,1.16 [0.90-1.50],0.2403715542003011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KITLG,Kit ligand,4508,505,1.40 [1.16-1.70],0.0005269033963896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLB,Beta-klotho,4377,495,1.26 [1.14-1.40],8.065406298128545e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLF4,Krueppel-like factor 4,3781,416,1.02 [0.81-1.29],0.8644432901073853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLHL41,Kelch-like protein 41,3905,425,1.10 [0.92-1.31],0.299906302118862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK1,Kallikrein-1,4460,494,0.97 [0.91-1.03],0.2951556847042004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK10,Kallikrein-10,4499,504,1.09 [0.90-1.32],0.3662873754529574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK11,Kallikrein-11,4463,500,1.87 [1.53-2.30],2.006275682963988e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK12,Kallikrein-12,4377,493,1.05 [0.99-1.11],0.1126941545677617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK13,Kallikrein-13,4393,494,0.91 [0.78-1.07],0.2424058932852659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK14,Kallikrein-14,4543,508,0.93 [0.79-1.10],0.3943324862677146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK15,Kallikrein-15,3883,418,1.03 [0.85-1.25],0.7284359909383054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK3,Prostate-specific antigen,3920,425,0.89 [0.82-0.98],0.0170078311242213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK4,Kallikrein-4,4543,508,1.61 [1.47-1.78],2.142689974193454e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK6,Kallikrein-6,4506,504,1.20 [0.95-1.52],0.117453007531183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK7,Kallikrein-7,3734,400,0.64 [0.50-0.82],0.0005055034148296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK8,Kallikrein-8,4340,485,1.19 [0.97-1.46],0.0952007135104666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLKB1,Plasma kallikrein,3837,419,0.99 [0.68-1.44],0.9653909875807242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,4556,506,2.34 [1.98-2.78],8.487844156791457e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,3781,416,0.96 [0.81-1.13],0.5930998567549688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRD1,Natural killer cells antigen CD94,4556,506,1.50 [1.28-1.77],8.472880795277155e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,3792,418,1.12 [0.95-1.30],0.1691748937266984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRK1,NKG2-D type II integral membrane protein,3892,422,1.44 [1.17-1.77],0.0005629403421516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT14,"Keratin, type I cytoskeletal 14",4243,474,1.07 [0.81-1.40],0.644829996443048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT17,"Keratin, type I cytoskeletal 17",3783,414,1.13 [0.90-1.43],0.2814888133167729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT18,"Keratin, type I cytoskeletal 18",4485,502,1.01 [0.93-1.09],0.8431463164691659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT19,"Keratin, type I cytoskeletal 19",4495,506,1.56 [1.42-1.72],3.5565298038371755e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT5,"Keratin, type II cytoskeletal 5",4377,495,0.93 [0.80-1.08],0.3486398457758829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT6C,"Keratin, type II cytoskeletal 6C",3783,414,1.06 [0.84-1.34],0.6169602060222565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT8,"Keratin, type II cytoskeletal 8",3781,416,1.06 [0.99-1.13],0.1195468958222364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,4504,505,0.88 [0.77-1.01],0.0781017749952453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYNU,Kynureninase,4556,506,0.76 [0.66-0.89],0.0005915935265173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,L1CAM,Neural cell adhesion molecule L1,4513,505,1.11 [0.86-1.42],0.4147232723452343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,3900,420,0.99 [0.89-1.10],0.871432963590205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LACRT,Extracellular glycoprotein lacritin,3875,417,0.96 [0.78-1.19],0.7388326542578987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LACTB2,Endoribonuclease LACTB2,4508,505,0.96 [0.85-1.09],0.5283579368202115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAG3,Lymphocyte activation gene 3 protein,4485,502,1.65 [1.43-1.90],1.1034390489447824e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,4504,504,1.65 [1.45-1.89],2.145676153822958e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,4473,505,1.03 [0.96-1.11],0.4101300628692909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMA1,Laminin subunit alpha-1,3783,414,0.84 [0.68-1.04],0.101577275037047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMA4,Laminin subunit alpha-4,4527,505,1.15 [0.92-1.43],0.2092459480024027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMB1,Laminin subunit beta-1,3805,414,1.61 [1.20-2.16],0.0016562809614205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP1,Lysosome-associated membrane glycoprotein 1,3824,416,1.34 [0.95-1.90],0.0974479905081913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP2,Lysosome-associated membrane glycoprotein 2,4382,485,0.89 [0.60-1.32],0.5474183255008869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP3,Lysosome-associated membrane glycoprotein 3,4548,506,1.12 [0.97-1.29],0.1235089563628066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMTOR5,Ragulator complex protein LAMTOR5,3890,418,0.71 [0.55-0.92],0.0092661337447494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAP3,Cytosol aminopeptidase,4402,494,0.86 [0.72-1.03],0.0972623923481937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LARP1,La-related protein 1,3890,418,0.98 [0.84-1.14],0.763958541147267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAT,Linker for activation of T-cells family member 1,4556,506,1.02 [0.92-1.13],0.7543052177909385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAT2,Linker for activation of T-cells family member 2,4485,502,1.02 [0.96-1.08],0.5782001201795532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LATS1,Serine/threonine-protein kinase LATS1,3792,418,1.00 [0.89-1.12],0.9739654779761122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAYN,Layilin,4464,504,2.41 [2.05-2.82],2.7187166302642548e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LBP,Lipopolysaccharide-binding protein,4526,507,1.14 [1.00-1.31],0.0509553899919365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LBR,Delta(14)-sterol reductase LBR,4541,507,1.07 [0.96-1.18],0.2328960182707469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCAT,Phosphatidylcholine-sterol acyltransferase,3921,425,0.88 [0.58-1.33],0.5440922094349667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN15,Lipocalin-15,3905,425,1.36 [1.22-1.50],8.747909274334868e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN2,Neutrophil gelatinase-associated lipocalin,4381,496,1.42 [1.19-1.69],8.135413021264348e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCP1,Plastin-2,3920,425,0.76 [0.62-0.92],0.0065768267395923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LDLR,Low-density lipoprotein receptor,4520,506,0.81 [0.70-0.94],0.0045570202175229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,3905,425,1.01 [0.92-1.11],0.8550476701667337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LECT2,Leukocyte cell-derived chemotaxin-2,3900,420,1.02 [0.89-1.16],0.8191072114529687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEFTY2,Left-right determination factor 2,4535,508,1.07 [0.92-1.23],0.3814060606818498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEG1,Protein LEG1 homolog,3708,402,1.03 [0.90-1.18],0.6560535683227544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LELP1,Late cornified envelope-like proline-rich protein 1,3781,416,0.94 [0.82-1.09],0.4366005624508606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEO1,RNA polymerase-associated protein LEO1,3905,425,1.10 [0.84-1.44],0.4926541788354884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEP,Leptin,4508,505,0.87 [0.77-0.98],0.0232211214047016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEPR,Leptin receptor,4508,505,1.93 [1.53-2.42],1.6210910868691106e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LETM1,Mitochondrial proton/calcium exchanger protein,3905,425,1.23 [1.04-1.44],0.0134386029619952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS1,Galectin-1,4508,505,1.31 [1.06-1.62],0.0127885324987041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3,Galectin-3,4512,506,1.90 [1.48-2.44],5.225280912938591e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3BP,Galectin-3-binding protein,3917,422,1.04 [0.78-1.37],0.8056913550844735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS4,Galectin-4,4504,504,1.78 [1.59-2.00],1.227252369691705e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS7_LGALS7B,Galectin-7,4498,500,1.15 [0.97-1.37],0.1096457373679358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS8,Galectin-8,4541,507,1.10 [0.97-1.26],0.1279325639961378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS9,Galectin-9,4510,504,1.50 [1.19-1.90],0.0006057457637789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGMN,Legumain,4527,505,1.32 [1.07-1.63],0.0097637920812288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHB,Lutropin subunit beta,4377,493,1.07 [0.98-1.17],0.135883538328363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,4507,502,0.93 [0.81-1.06],0.2554481862847791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIF,Leukemia inhibitory factor,4377,495,1.01 [0.86-1.19],0.8716922273187051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIFR,Leukemia inhibitory factor receptor,4504,507,3.89 [3.03-5.00],2.785704626377311e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,4525,508,0.96 [0.78-1.17],0.6855771276348936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,3920,425,1.03 [0.96-1.10],0.447281726630953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,3783,414,0.97 [0.80-1.18],0.7695240112977183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,4506,503,1.41 [1.11-1.79],0.0051809729053336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,3900,420,1.12 [1.00-1.27],0.0585905786400314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,4564,512,1.08 [0.83-1.42],0.5671514027147128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,4547,512,1.38 [1.10-1.72],0.0048297694190241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,4402,494,1.29 [1.09-1.53],0.0031873729582387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,4564,512,1.08 [0.96-1.21],0.2162782689990054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIPF,Gastric triacylglycerol lipase,3805,414,1.08 [0.94-1.23],0.2901484529508388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMNB1,Lamin-B1,3881,421,0.89 [0.77-1.03],0.1229103014865431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMNB2,Lamin-B2,3892,422,1.20 [0.88-1.64],0.2567412591434221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD1,Leiomodin-1,3905,425,1.83 [1.48-2.26],2.945881113785292e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD2,Leiomodin-2,3781,416,0.94 [0.80-1.11],0.4791772593816316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LONP1,"Lon protease homolog, mitochondrial",3805,414,1.06 [0.95-1.18],0.2801339907463853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPA,Apolipoprotein(a),3818,413,1.03 [0.98-1.09],0.2325521358640591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,4485,502,1.07 [0.92-1.24],0.4121716704452841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPL,Lipoprotein lipase,4508,505,0.94 [0.80-1.10],0.4552924437327932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPO,Lactoperoxidase,4362,495,1.44 [1.28-1.61],4.761257566293098e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPP,Lipoma-preferred partner,3783,414,1.03 [0.89-1.19],0.7269238713550559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,3783,414,1.00 [0.87-1.16],0.9479806206917384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,3819,418,1.09 [0.90-1.33],0.365298280160573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRG1,Leucine-rich alpha-2-glycoprotein,3917,422,1.47 [1.04-2.08],0.0289061278625823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,4530,507,1.53 [1.24-1.88],8.466429754808486e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,3779,415,1.15 [0.85-1.57],0.3703182208270945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,4485,502,1.15 [0.86-1.53],0.349948018338439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP11,Low-density lipoprotein receptor-related protein 11,4508,505,1.58 [1.30-1.91],2.966150567847184e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP2,Low-density lipoprotein receptor-related protein 2,3819,418,1.09 [0.84-1.42],0.5264129503626394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP2BP,LRP2-binding protein,3819,418,1.04 [0.94-1.16],0.4508492282876313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,4541,507,0.99 [0.86-1.14],0.8583434294236135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC25,Leucine-rich repeat-containing protein 25,4485,502,1.06 [0.88-1.28],0.5247063415969309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,3888,421,1.12 [0.91-1.38],0.2979078534095921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC38,Leucine-rich repeat-containing protein 38,3819,418,1.17 [0.96-1.43],0.1099887311279872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC59,Leucine-rich repeat-containing protein 59,3900,420,0.97 [0.80-1.18],0.7798194098581759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,3890,418,0.92 [0.76-1.12],0.4256440047851954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRN1,Leucine-rich repeat neuronal protein 1,4402,494,0.77 [0.64-0.94],0.009341803663167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,3819,418,1.13 [0.91-1.40],0.2878156259089782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,3905,425,0.71 [0.50-1.02],0.067292819325715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,4377,493,1.03 [0.89-1.19],0.6965628389124028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,3845,412,1.01 [0.91-1.12],0.8431140926625498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSP1,Lymphocyte-specific protein 1,4504,507,1.02 [0.84-1.24],0.8388073596949897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTA,Lymphotoxin-alpha,4504,507,0.98 [0.80-1.19],0.8052932873902517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTA4H,Leukotriene A-4 hydrolase,4543,508,0.95 [0.83-1.08],0.438062371238831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTB,Lymphotoxin-beta,3890,418,1.07 [0.82-1.39],0.6355994815303723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,4564,512,2.04 [1.66-2.52],2.1115636539182947e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,4377,493,1.20 [1.06-1.36],0.0030794314256775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBR,Tumor necrosis factor receptor superfamily member 3,4484,502,1.79 [1.43-2.24],3.2266523438676497e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTO1,Protein LTO1 homolog,4402,494,1.08 [0.88-1.31],0.4786085667677866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LUZP2,Leucine zipper protein 2,3890,418,1.13 [0.95-1.35],0.1731495941050783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LXN,Latexin,4446,504,0.91 [0.81-1.02],0.100521446783678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY6D,Lymphocyte antigen 6D,4479,499,1.39 [1.18-1.65],0.0001293908340109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY75,Lymphocyte antigen 75,4504,507,1.25 [1.02-1.52],0.0290031122448434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY9,T-lymphocyte surface antigen Ly-9,4449,494,1.79 [1.41-2.29],2.607387749984936e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY96,Lymphocyte antigen 96,4473,505,1.23 [1.00-1.52],0.0464483337118509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYAR,Cell growth-regulating nucleolar protein,4377,493,0.99 [0.85-1.16],0.943643882287484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYN,Tyrosine-protein kinase Lyn,4485,502,1.03 [0.93-1.13],0.5896914079502401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD1,Ly6/PLAUR domain-containing protein 1,4377,495,0.91 [0.79-1.05],0.2104485998889167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD3,Ly6/PLAUR domain-containing protein 3,4467,501,1.43 [1.16-1.78],0.000921666607209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD8,Ly6/PLAUR domain-containing protein 8,4377,493,1.21 [1.09-1.34],0.0003578027297761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPLA2,Acyl-protein thioesterase 2,3781,416,0.94 [0.85-1.03],0.1614447825953746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,3819,418,0.93 [0.84-1.03],0.1447856265293634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,3917,422,1.59 [1.01-2.51],0.0474624583320661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYZL2,Lysozyme-like protein 2,3762,409,1.02 [0.78-1.33],0.8947247929961861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LZTFL1,Leucine zipper transcription factor-like protein 1,3838,411,0.98 [0.86-1.12],0.7709062979955502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,M6PR,Cation-dependent mannose-6-phosphate receptor,3805,414,0.88 [0.68-1.13],0.3036233112229078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,4453,504,1.09 [0.95-1.25],0.2179197491560863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAEA,E3 ubiquitin-protein transferase MAEA,4377,493,0.82 [0.66-1.03],0.0846461497935784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAG,Myelin-associated glycoprotein,3819,418,0.76 [0.63-0.93],0.0077986699687902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAGEA3,Melanoma-associated antigen 3,3845,412,1.10 [0.98-1.24],0.1093612401433439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAGED1,Melanoma-associated antigen D1,4377,493,1.00 [0.85-1.18],0.9919582930381344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC2,MAM domain-containing protein 2,3900,420,1.82 [1.45-2.29],2.3105322566459065e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC4,Apical endosomal glycoprotein,3890,418,1.08 [0.92-1.27],0.3439596592215577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",3805,414,1.61 [1.11-2.33],0.0120983936107995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAN2B2,Epididymis-specific alpha-mannosidase,3900,420,0.93 [0.79-1.08],0.3150398078800682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",3762,409,1.04 [0.86-1.25],0.7005811682376626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,4527,505,0.99 [0.92-1.05],0.6691163687034292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC1,MANSC domain-containing protein 1,4513,505,1.53 [1.18-1.99],0.0013887719670227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC4,MANSC domain-containing protein 4,3783,414,0.94 [0.82-1.07],0.3488928078941828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,3781,416,0.82 [0.61-1.12],0.2076887983292719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,3783,414,1.03 [0.90-1.18],0.6798681150133561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2,Microtubule-associated protein 2,3892,422,1.11 [0.91-1.34],0.2929810468104513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,3888,421,1.01 [0.87-1.17],0.8910751751280924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,4504,507,1.01 [0.93-1.10],0.7680776135577145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,4377,493,0.95 [0.88-1.04],0.2750528334714242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,4464,504,1.00 [0.93-1.07],0.9893739742402894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPK13,Mitogen-activated protein kinase 13,3762,409,0.98 [0.80-1.21],0.8666500709225763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPK9,Mitogen-activated protein kinase 9,4504,507,0.94 [0.79-1.12],0.4925451307396802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPKAPK2,MAP kinase-activated protein kinase 2,3845,412,0.99 [0.87-1.12],0.8401446687342249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,3762,409,1.02 [0.96-1.09],0.4695082518880578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPT,Microtubule-associated protein tau,4377,495,1.11 [0.95-1.29],0.2077685334634951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MARCO,Macrophage receptor MARCO,4508,505,1.15 [0.86-1.53],0.3534538826342907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",3832,409,0.97 [0.87-1.09],0.6029523820204234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MASP1,Mannan-binding lectin serine protease 1,4464,504,0.82 [0.59-1.14],0.2314417824168766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MATN2,Matrilin-2,4513,504,0.99 [0.77-1.27],0.913681356943655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MATN3,Matrilin-3,4466,505,0.77 [0.61-0.97],0.0280528375244173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAVS,Mitochondrial antiviral-signaling protein,4377,493,0.98 [0.90-1.08],0.7072481753522416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAX,Protein max,4377,495,0.99 [0.92-1.07],0.8356364743482175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MB,Myoglobin,4564,512,1.11 [0.97-1.26],0.1298360163897844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MBL2,Mannose-binding protein C,3859,415,0.99 [0.91-1.08],0.8527996167197652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCAM,Cell surface glycoprotein MUC18,4526,507,1.80 [1.48-2.20],6.432930893357683e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",3905,425,0.95 [0.75-1.19],0.6410752513817066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCEMP1,Mast cell-expressed membrane protein 1,3792,418,1.01 [0.91-1.13],0.8012483416195543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCFD2,Multiple coagulation factor deficiency protein 2,4484,502,1.15 [0.96-1.36],0.1222387077788008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCTS1,Malignant T-cell-amplified sequence 1,3888,421,0.86 [0.59-1.25],0.4327090246586292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,4473,505,1.16 [1.04-1.29],0.0068201524094179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDH1,"Malate dehydrogenase, cytoplasmic",3900,423,0.90 [0.71-1.15],0.4041891854805277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDK,Midkine,4501,504,1.52 [1.34-1.72],6.347291936675922e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDM1,Nuclear protein MDM1,3819,418,1.09 [0.80-1.48],0.5807643229564622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",3805,414,1.03 [0.93-1.15],0.5163529990391772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MED18,Mediator of RNA polymerase II transcription subunit 18,4377,493,1.02 [0.92-1.14],0.6950863470357886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MED21,Mediator of RNA polymerase II transcription subunit 21,3783,414,0.97 [0.79-1.19],0.7813623368738009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,4504,504,1.13 [0.94-1.37],0.1971857813643804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,3783,414,1.07 [0.78-1.47],0.6760222033069772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,4554,512,1.04 [0.72-1.51],0.8281392756265131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MELTF,Melanotransferrin,3900,420,1.17 [0.87-1.58],0.2945084179275152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MENT,Protein MENT,3838,411,0.91 [0.62-1.33],0.630109414078988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEP1A,Meprin A subunit alpha,3888,421,1.07 [0.95-1.21],0.2354544652471544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEP1B,Meprin A subunit beta,4508,505,0.93 [0.87-0.99],0.033041180406494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEPE,Matrix extracellular phosphoglycoprotein,4504,504,0.48 [0.37-0.62],3.666983344087192e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MERTK,Tyrosine-protein kinase Mer,4556,506,1.55 [1.17-2.05],0.0019878528082346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MESD,LRP chaperone MESD,4525,508,1.00 [0.94-1.06],0.942405125137194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MET,Hepatocyte growth factor receptor,4524,506,1.54 [1.07-2.24],0.0215282049771739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP1,Methionine aminopeptidase 1,4377,495,0.93 [0.71-1.23],0.6183221744800714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",4504,507,1.00 [0.91-1.10],0.9813461356619274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP2,Methionine aminopeptidase 2,4535,508,1.02 [0.88-1.18],0.823253369671045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP3,Microfibril-associated glycoprotein 3,4430,500,0.96 [0.81-1.13],0.601815189589517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP3L,Microfibrillar-associated protein 3-like,3819,418,0.87 [0.73-1.03],0.097673889541976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP4,Microfibril-associated glycoprotein 4,3838,411,1.80 [1.37-2.35],1.8138807575106903e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP5,Microfibrillar-associated protein 5,4564,512,1.14 [0.95-1.36],0.1653942323983946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFGE8,Lactadherin,4525,508,1.36 [1.17-1.58],4.802465669906767e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MGLL,Monoglyceride lipase,4520,504,0.97 [0.89-1.07],0.5752036049269045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,4504,507,0.99 [0.92-1.05],0.6970236156278907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MIA,Melanoma-derived growth regulatory protein,4513,505,0.96 [0.79-1.18],0.6989631464917396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICALL2,MICAL-like protein 2,3819,418,1.01 [0.87-1.16],0.9438165677598128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,4504,507,1.10 [1.04-1.16],0.0013318797353282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MIF,Macrophage migration inhibitory factor,4516,506,0.94 [0.84-1.06],0.3413528254616032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MILR1,Allergin-1,4402,494,1.25 [1.08-1.45],0.003037626614868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,3890,418,0.96 [0.88-1.05],0.3452366631345801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MINK1,Misshapen-like kinase 1,3892,422,0.97 [0.88-1.08],0.5766296312389012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MITD1,MIT domain-containing protein 1,4473,505,0.99 [0.91-1.07],0.7798191257710373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MKI67,Proliferation marker protein Ki-67,3792,418,0.93 [0.73-1.19],0.5563190231560508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MLLT1,Protein ENL,3762,409,0.92 [0.78-1.07],0.2666974023157821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MLN,Promotilin,4504,507,1.14 [1.04-1.24],0.0049958898237825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MME,Neprilysin,4485,502,1.01 [0.92-1.10],0.8959251286634284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP1,Interstitial collagenase,4363,489,1.23 [1.12-1.34],8.190649172884917e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP10,Stromelysin-2,4499,503,1.38 [1.22-1.56],2.441307784431804e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP12,Macrophage metalloelastase,4509,504,1.46 [1.28-1.66],2.1344867624592322e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP13,Collagenase 3,4377,495,1.34 [1.06-1.71],0.0156203369457011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP15,Matrix metalloproteinase-15,3900,420,1.15 [0.97-1.36],0.0995196095939184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP3,Stromelysin-1,4525,508,1.33 [1.15-1.52],6.724916195411308e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP7,Matrilysin,4425,500,1.70 [1.45-1.99],9.7574041316815e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP8,Neutrophil collagenase,4535,507,1.05 [0.95-1.16],0.3311568123394187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP9,Matrix metalloproteinase-9,4521,508,1.06 [0.93-1.20],0.3912940905463464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",3783,414,1.16 [0.96-1.40],0.1257660010227363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MN1,Transcriptional activator MN1,3819,418,0.93 [0.78-1.10],0.3783629044251285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MNAT1,CDK-activating kinase assembly factor MAT1,3845,412,0.95 [0.76-1.18],0.6253641954757062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MNDA,Myeloid cell nuclear differentiation antigen,4501,505,0.94 [0.87-1.02],0.1239097221997684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MOCS2,Molybdopterin synthase catalytic subunit,3838,411,0.95 [0.82-1.10],0.4764540508556435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MOG,Myelin-oligodendrocyte glycoprotein,4543,508,1.17 [0.95-1.43],0.1473747214478224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORC3,MORC family CW-type zinc finger protein 3,3892,422,1.02 [0.74-1.41],0.8846943790858016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORF4L1,Mortality factor 4-like protein 1,3845,412,0.82 [0.63-1.05],0.1167611561007522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORF4L2,Mortality factor 4-like protein 2,3762,409,1.11 [0.87-1.42],0.4057241117012033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORN4,MORN repeat-containing protein 4,3762,409,0.98 [0.87-1.09],0.6680476577410651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPHOSPH8,M-phase phosphoprotein 8,4430,500,1.03 [0.92-1.14],0.6366729482046612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPI,Mannose-6-phosphate isomerase,4485,502,1.03 [0.93-1.13],0.5997376124798881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,4520,504,0.98 [0.88-1.08],0.6751256531121473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPO,Myeloperoxidase,4525,508,0.99 [0.83-1.17],0.8753513361390676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPRIP,Myosin phosphatase Rho-interacting protein,3881,417,0.80 [0.64-0.99],0.0432813091380252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRC1,Macrophage mannose receptor 1,3921,425,1.79 [1.33-2.41],0.0001379004250427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRI1,Methylthioribose-1-phosphate isomerase,3819,418,0.97 [0.84-1.10],0.6131401975371127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL24,"39S ribosomal protein L24, mitochondrial",3783,414,0.82 [0.63-1.08],0.1619497685018552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL28,"39S ribosomal protein L28, mitochondrial",3905,425,1.02 [0.80-1.31],0.8582826342339647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL46,"39S ribosomal protein L46, mitochondrial",4377,495,0.86 [0.64-1.16],0.3271820449289043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL52,"39S ribosomal protein L52, mitochondrial",3755,407,1.20 [0.84-1.71],0.3235220644401318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",3905,425,1.00 [0.88-1.13],0.9612293193942448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPS16,"28S ribosomal protein S16, mitochondrial",3792,418,0.79 [0.55-1.15],0.2174575240264067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSLN,Mesothelin,4472,499,1.12 [0.99-1.27],0.0698763179145235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSLNL,Mesothelin-like protein,3819,418,0.97 [0.74-1.28],0.8495949795795017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSMB,Beta-microseminoprotein,4506,502,1.18 [1.06-1.31],0.0032318848676824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSR1,Macrophage scavenger receptor types I and II,4541,507,1.46 [1.24-1.73],5.117628448658139e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,4513,505,0.98 [0.88-1.09],0.7187847800959202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MST1,Hepatocyte growth factor-like protein,3860,421,1.05 [0.90-1.22],0.5147621118311251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSTN,Growth/differentiation factor 8,4430,500,0.98 [0.85-1.14],0.8246293962355328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTDH,Protein LYRIC,3792,418,1.05 [0.95-1.16],0.3516529558029554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",3892,422,1.21 [0.87-1.69],0.2538506597917117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,3845,412,0.99 [0.91-1.08],0.8330619687413093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",3888,421,1.02 [0.92-1.13],0.7262504254117417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTPN,Myotrophin,4430,500,0.88 [0.67-1.16],0.3671520196407598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTR,Methionine synthase,3783,414,0.94 [0.81-1.10],0.4594020328995485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTSS1,Protein MTSS 1,3888,421,0.98 [0.90-1.07],0.6801645679794242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTSS2,Protein MTSS 2,3890,418,0.99 [0.90-1.08],0.7851973301197958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTUS1,Microtubule-associated tumor suppressor 1,3845,412,0.84 [0.71-0.99],0.0361684689905582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC13,Mucin-13,4377,495,1.76 [1.58-1.96],2.600620738714185e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC16,Mucin-16,4485,502,1.00 [0.96-1.05],0.928933585469842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC2,Mucin-2,3920,425,1.10 [1.00-1.21],0.0429855266773954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUCL3,Mucin-like protein 3,3762,409,1.02 [0.82-1.26],0.8845962760447997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MVK,Mevalonate kinase,4402,494,1.03 [0.95-1.13],0.455205253066089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MXRA8,Matrix remodeling-associated protein 8,3838,411,0.77 [0.57-1.03],0.0803348897500895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYBPC1,"Myosin-binding protein C, slow-type",3900,420,1.16 [1.03-1.30],0.0123011968860526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYBPC2,"Myosin-binding protein C, fast-type",3805,414,1.08 [0.98-1.19],0.1371685211805797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,3905,425,0.93 [0.80-1.07],0.3089572983041934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYDGF,Myeloid-derived growth factor,3900,420,0.98 [0.89-1.08],0.7486590654430132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH4,Myosin-4,3783,414,1.00 [0.81-1.24],0.9984525344237694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH7B,Myosin-7B,3762,409,1.06 [0.85-1.32],0.605533119359299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH9,Myosin-9,3920,425,1.01 [0.93-1.09],0.8730529117305061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",3783,414,1.06 [0.87-1.29],0.5470149618229743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL3,Myosin light chain 3,3805,414,1.15 [1.02-1.30],0.0217381569932184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL4,Myosin light chain 4,3805,414,1.25 [1.07-1.47],0.0055504834320591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL6B,Myosin light chain 6B,3819,418,0.99 [0.89-1.10],0.7984001073879127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",3819,418,1.22 [1.05-1.42],0.0100371428712121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYO6,Unconventional myosin-VI,3905,425,1.02 [0.79-1.30],0.9061272753223616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYO9B,Unconventional myosin-IXb,4402,494,1.01 [0.89-1.14],0.8956916334334698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOC,Myocilin,4525,508,1.11 [0.94-1.31],0.205825594264993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM1,Myomesin-1,3781,416,0.90 [0.71-1.13],0.3565318406583215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM2,Myomesin-2,3783,414,1.17 [1.00-1.37],0.0562358071254144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM3,Myomesin-3,3838,411,1.10 [1.00-1.21],0.0600406666321372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MZB1,Marginal zone B- and B1-cell-specific protein,4520,505,1.10 [0.95-1.28],0.2104117034947379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MZT1,Mitotic-spindle organizing protein 1,4377,493,0.86 [0.73-1.02],0.0791769485340653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAA10,N-alpha-acetyltransferase 10,3783,414,1.02 [0.85-1.22],0.8566746441785892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAA80,N-alpha-acetyltransferase 80,3819,418,1.00 [0.92-1.08],0.933705917715732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,4455,505,0.96 [0.84-1.10],0.5645309401454278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NACC1,Nucleus accumbens-associated protein 1,3890,418,0.96 [0.81-1.14],0.6629006411586943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NADK,NAD kinase,4508,505,1.00 [0.87-1.15],0.983456640173756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGA,Alpha-N-acetylgalactosaminidase,3781,417,0.98 [0.81-1.18],0.8170982774412588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGK,N-acetyl-D-glucosamine kinase,3796,413,0.79 [0.67-0.93],0.0052718497549842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,3838,411,1.91 [1.28-2.84],0.0015157498414302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAMPT,Nicotinamide phosphoribosyltransferase,4377,493,0.95 [0.82-1.10],0.4655212670477979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAP1L4,Nucleosome assembly protein 1-like 4,3881,419,1.01 [0.80-1.27],0.9635785025763896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAPRT,Nicotinate phosphoribosyltransferase,3892,422,0.98 [0.75-1.28],0.9049493206055854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",3905,425,1.04 [0.85-1.26],0.7158373457149811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,4513,505,2.21 [1.72-2.83],4.5975860614625004e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBN,Nibrin,4402,494,0.93 [0.79-1.09],0.3820867236581338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAM1,Neural cell adhesion molecule 1,4526,507,1.05 [0.83-1.33],0.6573277569656172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAM2,Neural cell adhesion molecule 2,4525,508,1.01 [0.76-1.33],0.9649731540753832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAN,Neurocan core protein,4541,507,0.53 [0.44-0.64],9.117089176004392e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCF2,Neutrophil cytosol factor 2,4497,507,0.95 [0.87-1.04],0.2680984299455393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCK2,Cytoplasmic protein NCK2,4527,505,1.01 [0.94-1.09],0.819704849037613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCLN,Nicalin,4402,494,1.04 [0.89-1.22],0.6060616960032216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR1,Natural cytotoxicity triggering receptor 1,4500,506,1.94 [1.61-2.33],3.736153210920101e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,3888,421,2.02 [1.59-2.57],1.2127597417206082e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCS1,Neuronal calcium sensor 1,4543,508,2.17 [1.69-2.77],9.639633541705496e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDRG1,Protein NDRG1,4377,495,1.02 [0.90-1.14],0.8037025258801128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,3890,418,1.04 [0.90-1.20],0.5913468342410955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,3786,418,1.15 [0.88-1.50],0.292234613418496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,3888,421,0.98 [0.88-1.09],0.6845288838318899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",4377,493,1.15 [1.05-1.26],0.0034613157338941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEB,Nebulin,3783,414,1.09 [0.84-1.41],0.5118437237177853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECAP2,Adaptin ear-binding coat-associated protein 2,3783,414,1.07 [0.93-1.24],0.3310906455479426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN1,Nectin-1,3792,418,0.85 [0.63-1.15],0.2964202597659339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN2,Nectin-2,4506,503,2.34 [1.90-2.87],9.220943526712165e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN4,Nectin-4,4513,505,1.95 [1.66-2.29],5.643307591468919e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,3792,418,0.95 [0.78-1.16],0.6071426534466726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEDD9,Enhancer of filamentation 1,3792,418,1.08 [0.83-1.42],0.5694748055506722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEFL,Neurofilament light polypeptide,4363,493,2.07 [1.83-2.35],6.7197870989077e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEK7,Serine/threonine-protein kinase Nek7,3845,412,1.01 [0.89-1.14],0.9164664962587228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL1,Protein kinase C-binding protein NELL1,4513,505,0.60 [0.51-0.71],3.7428986199279856e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL2,Protein kinase C-binding protein NELL2,4527,505,1.17 [0.91-1.51],0.2161973516115166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NENF,Neudesin,3890,418,1.01 [0.92-1.10],0.8785223957054041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEO1,Neogenin,3905,425,1.16 [0.80-1.70],0.4279982576135419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEXN,Nexilin,3921,425,0.96 [0.84-1.09],0.5119311501290253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFASC,Neurofascin,4556,506,2.80 [2.24-3.51],2.269518380250945e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFAT5,Nuclear factor of activated T-cells 5,3792,418,0.99 [0.89-1.11],0.8764811425505052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",4504,507,0.95 [0.88-1.03],0.2590741844158318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",4402,494,0.98 [0.87-1.12],0.8073664677871099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFE2,Transcription factor NF-E2 45 kDa subunit,3805,414,1.02 [0.90-1.16],0.7602937590109798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFIC,Nuclear factor 1 C-type,3905,425,1.03 [0.83-1.28],0.7851365735933848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,3783,414,0.97 [0.85-1.10],0.6101444521252861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,3845,412,0.96 [0.79-1.16],0.667007493218905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKBIE,NF-kappa-B inhibitor epsilon,4377,493,1.02 [0.87-1.20],0.8210178380967712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",3888,421,1.02 [0.93-1.11],0.7348037206556368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFX1,Transcriptional repressor NF-X1,3783,414,0.97 [0.84-1.11],0.6223704010207203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFYA,Nuclear transcription factor Y subunit alpha,3783,414,0.98 [0.77-1.25],0.8693628474827392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGF,Beta-nerve growth factor,4473,505,2.25 [1.21-4.20],0.0108245398293858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGFR,Tumor necrosis factor receptor superfamily member 16,3900,420,1.38 [1.07-1.77],0.01201478908202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGRN,Neugrin,3892,422,1.10 [0.71-1.69],0.6811935176147876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NHLRC3,NHL repeat-containing protein 3,3739,398,1.45 [1.08-1.97],0.0151009270708623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NID1,Nidogen-1,4517,503,1.02 [0.83-1.25],0.8625247729104824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NID2,Nidogen-2,4525,508,0.98 [0.88-1.09],0.7138406081343975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NINJ1,Ninjurin-1,4377,493,1.10 [0.96-1.26],0.176202050434201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NIT1,Deaminated glutathione amidase,3805,414,0.80 [0.65-0.98],0.0347637272772521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NIT2,Omega-amidase NIT2,3879,419,0.95 [0.84-1.09],0.4918559255408548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NLGN1,Neuroligin-1,3819,418,1.02 [0.89-1.16],0.8181983797832378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NLGN2,Neuroligin-2,3781,416,1.04 [0.85-1.28],0.7062006422365736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NME1,Nucleoside diphosphate kinase A,3792,418,0.70 [0.44-1.11],0.1306058932629192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NME3,Nucleoside diphosphate kinase 3,4513,504,0.99 [0.72-1.38],0.9698015182397772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMI,N-myc-interactor,3875,418,0.97 [0.85-1.11],0.6343087201029325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,4473,505,0.99 [0.89-1.09],0.7911541195181293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMRK2,Nicotinamide riboside kinase 2,3762,409,0.89 [0.68-1.16],0.399921821093243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,3905,425,1.10 [0.96-1.26],0.1651013363283907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOMO1,Nodal modulator 1,4525,508,0.82 [0.59-1.13],0.2178693489088901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOP56,Nucleolar protein 56,3783,414,1.04 [0.96-1.13],0.3284472864509587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS1,"Nitric oxide synthase, brain",4377,495,1.19 [1.04-1.36],0.0108078333017766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS2,"Nitric oxide synthase, inducible",3783,414,0.89 [0.69-1.15],0.3865341470999585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS3,"Nitric oxide synthase, endothelial",4377,495,1.20 [1.05-1.37],0.0059477425726029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH1,Neurogenic locus notch homolog protein 1,4564,512,4.04 [2.57-6.35],1.303600401204157e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH2,Neurogenic locus notch homolog protein 2,3920,425,1.76 [1.24-2.49],0.0015800903844181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH3,Neurogenic locus notch homolog protein 3,4564,512,1.16 [0.94-1.43],0.1608473734836495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPC2,NPC intracellular cholesterol transporter 2,3866,417,2.14 [1.65-2.78],9.8701313839607e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPDC1,Neural proliferation differentiation and control protein 1,4508,505,1.65 [1.36-1.98],1.7751195575686973e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPHS1,Nephrin,3792,418,0.75 [0.57-1.00],0.049867374524823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPHS2,Podocin,3792,418,0.97 [0.89-1.07],0.5791173393439812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPL,N-acetylneuraminate lyase,3900,420,0.96 [0.79-1.16],0.6748463204389143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPPB,Natriuretic peptides B,4430,500,1.08 [1.02-1.14],0.0047347210402768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPPC,C-type natriuretic peptide,4504,507,0.93 [0.82-1.07],0.3175455546668947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPR1,Atrial natriuretic peptide receptor 1,3783,414,1.01 [0.79-1.29],0.9673707256836042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTN,Neuroplastin,4377,493,1.00 [0.90-1.12],0.9445053875375128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTX1,Neuronal pentraxin-1,4525,508,1.17 [0.98-1.40],0.0806968531658346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTX2,Neuronal pentraxin-2,3920,425,1.08 [0.83-1.40],0.5868394665967048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTXR,Neuronal pentraxin receptor,4508,505,0.82 [0.67-1.02],0.073449687958082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPY,Pro-neuropeptide Y,4543,508,1.30 [1.16-1.47],1.0259092065320356e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRCAM,Neuronal cell adhesion molecule,4508,505,2.01 [1.61-2.52],1.0864604283733647e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRGN,Neurogranin,3921,425,1.01 [0.91-1.11],0.9180037505519072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRN1,Neuritin,3905,425,0.85 [0.63-1.15],0.2809828616244728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP1,Neuropilin-1,4530,508,2.15 [1.65-2.80],1.1272697353450941e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP2,Neuropilin-2,4525,508,1.06 [0.82-1.39],0.6448513075340047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRTN,Neurturin,4402,494,0.92 [0.78-1.08],0.3048158305734995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRXN3,Neurexin-3,3819,418,0.99 [0.75-1.31],0.9477246047195976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NSFL1C,NSFL1 cofactor p47,4541,507,0.99 [0.87-1.11],0.8228855718490419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",3900,420,1.07 [0.94-1.22],0.2907519763084638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,3892,422,1.29 [1.02-1.63],0.0302962133782885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,4498,506,0.97 [0.88-1.06],0.472392543544669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5E,5'-nucleotidase,4513,505,0.97 [0.84-1.12],0.7001098300711656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTF3,Neurotrophin-3,4504,507,1.31 [1.08-1.59],0.0059110436574514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTF4,Neurotrophin-4,4377,493,1.01 [0.81-1.25],0.9470821575204592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTRK2,BDNF/NT-3 growth factors receptor,4508,505,1.42 [1.07-1.89],0.0166839318342548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTRK3,NT-3 growth factor receptor,4541,507,1.35 [0.96-1.89],0.0857183146703608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,4508,505,1.14 [1.07-1.21],1.689900554688748e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUB1,NEDD8 ultimate buster 1,4504,507,1.00 [0.91-1.10],0.978010573425877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,3890,418,1.00 [0.91-1.11],0.954367983136336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUCB2,Nucleobindin-2,4538,508,1.28 [1.04-1.56],0.0174445802414279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDC,Nuclear migration protein nudC,4556,506,1.00 [0.88-1.13],0.9394836832053536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,3805,414,1.06 [0.74-1.50],0.7559265889862699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,3783,414,0.91 [0.75-1.11],0.348000565268587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT16,U8 snoRNA-decapping enzyme,3883,421,1.03 [0.93-1.15],0.5760310656327902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],4485,502,0.91 [0.79-1.05],0.2038179186359522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT5,ADP-sugar pyrophosphatase,4525,508,1.09 [0.94-1.28],0.2542752766121811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUMB,Protein numb homolog,3792,418,0.96 [0.85-1.07],0.4385242966046696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUP50,Nuclear pore complex protein Nup50,3783,414,0.99 [0.74-1.33],0.954126698525482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPE4,NXPE family member 4,3783,414,1.05 [0.81-1.37],0.7076700944657828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPH1,Neurexophilin-1,4377,495,0.91 [0.74-1.12],0.3532237698311312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPH3,Neurexophilin-3,3792,418,1.07 [0.79-1.46],0.6655781137304067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OBP2B,Odorant-binding protein 2b,4461,504,0.98 [0.86-1.10],0.7012856610484117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OCLN,Occludin,3905,425,1.29 [1.06-1.57],0.0109071764853887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ODAM,Odontogenic ameloblast-associated protein,4370,494,1.11 [0.97-1.26],0.1398605643178459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OFD1,Oral-facial-digital syndrome 1 protein,3845,412,0.96 [0.82-1.11],0.5467576865760002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGA,Protein O-GlcNAcase,3888,421,1.04 [0.91-1.19],0.5823520634181159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGFR,Opioid growth factor receptor,4485,502,1.01 [0.80-1.29],0.9069828574813524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGN,Mimecan,4525,508,1.65 [1.41-1.93],6.184750330518732e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,3845,412,1.00 [0.85-1.17],0.9748884089737474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OLFM4,Olfactomedin-4,3692,394,1.09 [1.01-1.18],0.0293758773863603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OLR1,Oxidized low-density lipoprotein receptor 1,4476,504,1.06 [0.93-1.20],0.3717549956455461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMD,Osteomodulin,4527,505,0.69 [0.59-0.81],6.805281014949253e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMG,Oligodendrocyte-myelin glycoprotein,4485,502,0.81 [0.72-0.90],0.0001396444320683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMP,Olfactory marker protein,3781,416,1.07 [0.89-1.30],0.4747255903526596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPHN1,Oligophrenin-1,3892,422,0.97 [0.89-1.06],0.5168519801152465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPLAH,5-oxoprolinase,3805,414,1.07 [0.93-1.23],0.3168885124083092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPTC,Opticin,4485,502,0.99 [0.82-1.18],0.882128037805321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ORM1,Alpha-1-acid glycoprotein 1,3907,421,0.92 [0.58-1.44],0.7055848497991384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSBPL2,Oxysterol-binding protein-related protein 2,3892,422,0.88 [0.68-1.15],0.3501860488664602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,4513,504,1.26 [1.01-1.57],0.0431410963712586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSM,Oncostatin-M,4487,507,1.01 [0.91-1.13],0.7903351325613639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSMR,Oncostatin-M-specific receptor subunit beta,4530,508,1.95 [1.36-2.80],0.0002940196365971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSTN,Osteocrin,3819,418,1.10 [0.91-1.35],0.3272472626663787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTOA,Otoancorin,3781,416,1.01 [0.86-1.19],0.9039617609866032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTUD6B,Deubiquitinase OTUD6B,3888,421,0.99 [0.84-1.16],0.8692121988529014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTUD7B,OTU domain-containing protein 7B,3905,425,1.06 [0.92-1.23],0.4251607373742212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",3805,414,1.00 [0.87-1.14],0.9899010385168162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OXT,Oxytocin-neurophysin 1,4541,507,0.98 [0.92-1.03],0.3679795688009821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,P4HB,Protein disulfide-isomerase,4476,503,1.19 [0.97-1.45],0.0930946166756765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PACS2,Phosphofurin acidic cluster sorting protein 2,3783,414,1.00 [0.86-1.17],0.9802188310905436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PADI2,Protein-arginine deiminase type-2,4402,494,1.11 [0.98-1.27],0.1053289347948583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PADI4,Protein-arginine deiminase type-4,4370,494,0.88 [0.79-0.99],0.0260076045657473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAEP,Glycodelin,4473,505,0.98 [0.91-1.05],0.5493987017787926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,3905,425,1.01 [0.93-1.10],0.7856326235223027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",3845,412,1.01 [0.83-1.23],0.8834492861833144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,4430,500,1.12 [0.97-1.29],0.1115179397025283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,3805,414,1.10 [0.89-1.35],0.3842057468120294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,3756,409,0.96 [0.80-1.15],0.6332044845473601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAK4,Serine/threonine-protein kinase PAK 4,4377,495,1.02 [0.90-1.16],0.7671606600264955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALLD,Palladin,3792,418,0.86 [0.66-1.13],0.2699222778932967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM,Paralemmin-1,3868,418,1.54 [1.19-2.01],0.0012346718682721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM2,Paralemmin-2,3892,422,1.52 [1.24-1.87],7.161508044192238e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM3,Paralemmin-3,3783,414,1.07 [0.94-1.21],0.3263892066232752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,4543,508,1.06 [0.81-1.38],0.6791735385154993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAMR1,Inactive serine protease PAMR1,4525,508,0.87 [0.66-1.14],0.3106791911436991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAPPA,Pappalysin-1,4402,494,0.77 [0.65-0.92],0.0030543263361273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARD3,Partitioning defective 3 homolog,3845,412,0.92 [0.81-1.06],0.2558957294264922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARK7,Parkinson disease protein 7,4525,508,0.99 [0.85-1.16],0.9382151715825662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARP1,Poly [ADP-ribose] polymerase 1,4504,507,0.99 [0.86-1.13],0.8512072406831992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAXX,Protein PAXX,3838,411,0.97 [0.79-1.19],0.7465795932135388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,3762,409,0.89 [0.66-1.21],0.4657728130676902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBLD,Phenazine biosynthesis-like domain-containing protein,4377,495,0.83 [0.72-0.96],0.01272762291595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,3888,421,1.31 [0.97-1.78],0.080753350873029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCARE,Photoreceptor cilium actin regulator,3781,416,0.95 [0.85-1.07],0.4035352545104499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,3831,409,0.79 [0.66-0.94],0.0066639626649458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCBP2,Poly(rC)-binding protein 2,3905,425,1.01 [0.89-1.15],0.8389105051999134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH1,Protocadherin-1,4536,506,1.71 [1.24-2.36],0.000999280881239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH12,Protocadherin-12,3905,425,1.65 [1.18-2.31],0.0037161286467729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH17,Protocadherin-17,4508,505,1.44 [1.20-1.73],9.152451097910845e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH7,Protocadherin-7,3888,421,1.69 [1.39-2.06],2.1580778074490776e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH9,Protocadherin-9,3888,421,0.77 [0.60-0.99],0.0384327497665554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDHB15,Protocadherin beta-15,3890,418,1.29 [1.05-1.60],0.0179253993919784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCNA,Proliferating cell nuclear antigen,3762,409,0.99 [0.85-1.14],0.8805970740533297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,3890,418,0.86 [0.70-1.06],0.1494115581167514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,4564,512,1.30 [1.07-1.57],0.007642647036835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,3888,421,1.02 [0.90-1.16],0.7281504784853157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,3900,420,1.02 [0.93-1.13],0.6378350167910032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1,Programmed cell death protein 1,4537,506,1.36 [1.16-1.59],0.0001904030310933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1LG2,Programmed cell death 1 ligand 2,4485,502,2.35 [1.89-2.90],5.615530470783089e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD5,Programmed cell death protein 5,4541,507,1.08 [0.94-1.24],0.2911629471300488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD6,Programmed cell death protein 6,4508,505,1.17 [1.03-1.33],0.0180293775291652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCL2,Phosducin-like protein 2,3762,409,0.95 [0.78-1.15],0.5703292086544698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",3762,409,1.08 [0.91-1.28],0.3612775214867637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",3783,414,0.98 [0.83-1.15],0.7706035993328795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",3838,411,0.99 [0.90-1.08],0.7584085870808509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFA,Platelet-derived growth factor subunit A,4564,512,0.96 [0.87-1.07],0.4555319913796409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFB,Platelet-derived growth factor subunit B,4527,505,0.99 [0.90-1.08],0.7850368123964839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFC,Platelet-derived growth factor C,4377,493,1.06 [0.81-1.39],0.6653256587471765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRA,Platelet-derived growth factor receptor alpha,4508,505,1.97 [1.54-2.52],5.350100915017122e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRB,Platelet-derived growth factor receptor beta,4564,512,1.21 [0.97-1.51],0.099195105808122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA2,Protein disulfide-isomerase A2,3762,409,0.99 [0.77-1.27],0.9520614170597144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA3,Protein disulfide-isomerase A3,3838,411,1.06 [0.73-1.54],0.772486240474549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA4,Protein disulfide-isomerase A4,3920,425,0.96 [0.83-1.12],0.6338874464323294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA5,Protein disulfide-isomerase A5,3762,409,0.92 [0.78-1.08],0.3202627002173004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDLIM5,PDZ and LIM domain protein 5,3905,425,1.00 [0.92-1.08],0.9816455238207064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDLIM7,PDZ and LIM domain protein 7,4527,505,1.02 [0.96-1.08],0.586360115518249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",4377,493,1.10 [0.95-1.28],0.204200101832267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDRG1,p53 and DNA damage-regulated protein 1,3819,418,0.96 [0.80-1.16],0.6674450512810436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,3762,409,1.01 [0.87-1.17],0.939540225844485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDZD2,PDZ domain-containing protein 2,3783,414,0.95 [0.81-1.11],0.5012997104266814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,3792,418,0.99 [0.82-1.19],0.9051050967958556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEAR1,Platelet endothelial aggregation receptor 1,4564,512,1.86 [1.33-2.59],0.000265318504538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEBP1,Phosphatidylethanolamine-binding protein 1,4525,508,1.06 [0.92-1.21],0.4204056057667208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PECAM1,Platelet endothelial cell adhesion molecule,4525,508,1.04 [0.81-1.33],0.767603725521828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,3805,414,1.05 [0.73-1.50],0.8026448191718144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PENK,Proenkephalin-A,3838,411,1.21 [0.92-1.58],0.1745676480700427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEPD,Xaa-Pro dipeptidase,3921,425,0.66 [0.47-0.91],0.0119065020211043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PER3,Period circadian protein homolog 3,3792,418,0.94 [0.87-1.02],0.113776168302793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PF4,Platelet factor 4,3893,422,0.98 [0.89-1.08],0.7194227593486289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN2,Prefoldin subunit 2,4377,495,1.07 [0.92-1.24],0.4042859027514062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN4,Prefoldin subunit 4,3762,409,1.11 [0.93-1.32],0.2426653002653946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN6,Prefoldin subunit 6,3819,418,1.04 [0.90-1.21],0.5791420817117865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",4480,501,1.01 [0.92-1.12],0.7902564592703352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGA4,Pepsin A-4,3921,425,1.11 [0.99-1.23],0.0637257509341466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",3900,420,1.08 [0.91-1.28],0.4023964207618858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGF,Placenta growth factor,4556,506,2.02 [1.57-2.61],5.382955372563484e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP1,Peptidoglycan recognition protein 1,4547,512,1.11 [0.93-1.32],0.2391149731642253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,3874,418,1.48 [1.07-2.05],0.0178740859682882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP4,Peptidoglycan recognition protein 4,3783,414,1.01 [0.86-1.20],0.8897862313278568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGM2,Phosphoglucomutase-2,3819,418,0.90 [0.75-1.09],0.2803720911814718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGR,Progesterone receptor,3792,418,1.00 [0.91-1.11],0.9785768245530124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHACTR2,Phosphatase and actin regulator 2,3905,425,0.98 [0.90-1.06],0.5757417822974333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB1,Pleckstrin homology-like domain family B member 1,3888,421,1.37 [1.15-1.63],0.0003777758281711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB2,Pleckstrin homology-like domain family B member 2,3762,409,1.01 [0.92-1.12],0.7832214053951059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,4473,505,1.50 [1.16-1.93],0.0019827200728543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,3838,411,0.85 [0.69-1.05],0.132865770954197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI16,Peptidase inhibitor 16,3921,425,1.27 [0.88-1.83],0.1957195680249746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI3,Elafin,4456,504,1.25 [1.11-1.41],0.0002502209830611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",3905,425,0.98 [0.87-1.11],0.7726849196842589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIGR,Polymeric immunoglobulin receptor,4461,498,1.88 [1.57-2.25],9.746359108419004e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,4504,507,0.92 [0.81-1.04],0.1753738473212221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,4525,508,2.84 [2.32-3.48],6.487190743065575e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,3792,418,0.93 [0.78-1.12],0.4531944993268908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,4525,508,1.72 [1.43-2.06],8.274059701168134e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,4508,505,1.39 [1.21-1.61],6.0889542135700365e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,3838,411,0.83 [0.73-0.95],0.0075074812839919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PITHD1,PITH domain-containing protein 1,3756,409,0.96 [0.86-1.08],0.5465185552989877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD1,Polycystin-1,3900,420,2.72 [1.97-3.76],1.4024887205656992e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD2,Polycystin-2,3783,414,0.99 [0.84-1.17],0.8730235144085264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKLR,Pyruvate kinase PKLR,4510,502,0.97 [0.86-1.09],0.5825340437566134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKN3,Serine/threonine-protein kinase N3,3845,412,0.98 [0.86-1.12],0.7743661039200682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G10,Group 10 secretory phospholipase A2,4473,505,1.49 [1.31-1.70],1.5055743832306547e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G15,Phospholipase A2 group XV,4513,505,1.18 [0.91-1.54],0.2193727777734759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G1B,Phospholipase A2,4559,512,1.00 [0.86-1.16],0.9874191389147698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G2A,"Phospholipase A2, membrane associated",4494,502,0.97 [0.84-1.12],0.6784855440902806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G4A,Cytosolic phospholipase A2,4527,505,1.00 [0.92-1.09],0.9989961445268948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G7,Platelet-activating factor acetylhydrolase,4525,508,0.45 [0.37-0.54],4.6822382006596425e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAT,Tissue-type plasminogen activator,4554,512,0.73 [0.64-0.84],8.832287169210128e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAU,Urokinase-type plasminogen activator,4525,508,0.79 [0.61-1.02],0.07585439520813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAUR,Urokinase plasminogen activator surface receptor,4485,504,2.17 [1.68-2.80],2.150480793625498e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLB1,"Phospholipase B1, membrane-associated",3892,422,0.72 [0.61-0.84],4.781962372096214e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",3792,418,0.92 [0.73-1.17],0.5018888916296068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",3892,422,0.98 [0.89-1.08],0.688952421818843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,3892,422,1.06 [0.93-1.21],0.3866283200858629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLG,Plasminogen,3817,411,1.53 [0.99-2.35],0.0545059159151429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLIN1,Perilipin-1,4377,495,1.03 [0.84-1.28],0.7627942507617489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLIN3,Perilipin-3,4508,505,1.25 [1.05-1.49],0.0138152480197994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLPBP,Pyridoxal phosphate homeostasis protein,4508,505,0.95 [0.84-1.07],0.3909097586817063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLSCR3,Phospholipid scramblase 3,3883,420,1.13 [0.96-1.33],0.1447732466750654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLTP,Phospholipid transfer protein,4548,511,1.04 [0.86-1.27],0.6875957069616142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXDC1,Plexin domain-containing protein 1,4377,493,1.20 [0.95-1.52],0.1355548194279952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXDC2,Plexin domain-containing protein 2,3892,422,1.24 [0.91-1.68],0.1726422638791361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNA4,Plexin-A4,4504,507,0.99 [0.90-1.09],0.8038553805693546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB2,Plexin-B2,4543,510,3.76 [3.01-4.70],3.229610572911468e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB3,Plexin-B3,4490,501,0.97 [0.82-1.15],0.7586364668776333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,4491,500,1.01 [0.97-1.05],0.6796170553029579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMCH,Pro-MCH,3783,414,0.98 [0.86-1.11],0.7497918695853287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMM2,Phosphomannomutase 2,3783,414,1.02 [0.87-1.20],0.7891454559530674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMS1,PMS1 protein homolog 1,3819,418,1.02 [0.85-1.21],0.8416554583436251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMVK,Phosphomevalonate kinase,4372,494,0.98 [0.91-1.05],0.558885761630547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIP,Pancreatic triacylglycerol lipase,3921,425,1.09 [0.97-1.23],0.1613814801612281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,3892,422,1.08 [0.98-1.20],0.1192353896930044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIPRP2,Pancreatic lipase-related protein 2,4504,504,1.00 [0.97-1.02],0.7374107096792969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNMA1,Paraneoplastic antigen Ma1,3805,414,1.03 [0.87-1.20],0.7580760336660292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNMA2,Paraneoplastic antigen Ma2,3781,416,0.98 [0.80-1.22],0.8808261945970477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",4402,494,1.03 [0.96-1.10],0.4439555315142712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PODXL,Podocalyxin,4485,502,0.94 [0.57-1.55],0.8217844497513928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PODXL2,Podocalyxin-like protein 2,4513,505,1.26 [0.97-1.64],0.0783163171809214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POF1B,Protein POF1B,3792,418,1.60 [1.37-1.86],1.328215158992462e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,3792,418,0.90 [0.65-1.26],0.5403282187918342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",4485,502,1.34 [1.12-1.61],0.0015231244960615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POMC,Pro-opiomelanocortin,3805,414,0.92 [0.80-1.04],0.1864383372653066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON1,Serum paraoxonase/arylesterase 1,3921,425,0.66 [0.50-0.87],0.0034197338860201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON2,Serum paraoxonase/arylesterase 2,4430,500,0.91 [0.74-1.13],0.4047405319398109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON3,Serum paraoxonase/lactonase 3,4527,505,0.77 [0.61-0.96],0.0186632574783226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POSTN,Periostin,3920,425,0.83 [0.65-1.06],0.1333354888283165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPBP,Platelet basic protein,3888,422,0.99 [0.89-1.11],0.8732808509026843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,4541,507,0.89 [0.76-1.05],0.1782463662529521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,4515,508,1.01 [0.93-1.10],0.8029150274309093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,3845,412,0.97 [0.83-1.14],0.7116326813197327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",3920,425,0.96 [0.83-1.11],0.595478211382372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPL,Periplakin,3792,418,0.95 [0.72-1.26],0.7262924087671523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1A,Protein phosphatase 1A,4377,493,1.08 [0.85-1.36],0.5186826166867949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1B,Protein phosphatase 1B,3792,418,0.91 [0.75-1.09],0.3106815624020108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1F,Protein phosphatase 1F,3900,420,1.00 [0.84-1.19],0.9852149211187792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPME1,Protein phosphatase methylesterase 1,4485,502,0.99 [0.87-1.12],0.8488498778347101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,3890,418,0.95 [0.85-1.07],0.4277488032049076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,4513,505,1.01 [0.93-1.09],0.8140909067629265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,3845,412,0.97 [0.85-1.12],0.7005414016563719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,3905,425,1.02 [0.91-1.15],0.7383096752723787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,3905,425,1.53 [1.27-1.84],5.628962498108068e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R2,Protein phosphatase inhibitor 2,4508,505,1.00 [0.90-1.10],0.9346940211956972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R9B,Neurabin-2,4556,506,1.03 [0.95-1.12],0.4589926690017899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,3888,421,1.02 [0.95-1.10],0.5829796037055592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP3R1,Calcineurin subunit B type 1,4473,505,1.11 [0.92-1.35],0.2568247428236534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPT1,Palmitoyl-protein thioesterase 1,3819,418,0.94 [0.82-1.08],0.376680929214129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPY,Pancreatic prohormone,4490,497,1.20 [1.12-1.29],2.971504100515832e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PQBP1,Polyglutamine-binding protein 1,4377,493,1.01 [0.88-1.17],0.8417268374793951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAME,Melanoma antigen preferentially expressed in tumors,3762,409,0.83 [0.57-1.22],0.3439688377290181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAP1,Proline-rich acidic protein 1,3920,425,1.94 [1.53-2.47],7.118414427748846e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRC1,Protein regulator of cytokinesis 1,3890,418,0.87 [0.69-1.09],0.226273538515244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRCP,Lysosomal Pro-X carboxypeptidase,4540,510,1.69 [1.37-2.08],6.347232093272087e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX1,Peroxiredoxin-1,4372,498,0.96 [0.88-1.05],0.3855509278020326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX2,Peroxiredoxin-2,3855,421,0.89 [0.77-1.03],0.1266475807386559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",4402,494,1.10 [0.98-1.22],0.102480015626994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX5,"Peroxiredoxin-5, mitochondrial",4556,506,0.92 [0.82-1.04],0.1696914788388544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX6,Peroxiredoxin-6,4543,508,0.87 [0.77-0.99],0.0413832087063833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PREB,Prolactin regulatory element-binding protein,4402,494,1.36 [1.06-1.75],0.0148344988271632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRELP,Prolargin,4504,504,1.84 [1.34-2.53],0.0001823060824936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRG2,Bone marrow proteoglycan,3920,425,1.25 [1.07-1.47],0.0063392789832182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRG3,Proteoglycan 3,3920,425,0.97 [0.82-1.16],0.7725610949105794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,4402,494,1.07 [0.93-1.24],0.3541509200370529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,3819,418,1.16 [0.88-1.52],0.2906821997399408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,4508,505,0.98 [0.90-1.08],0.747043044677989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,3884,418,0.98 [0.86-1.10],0.7045884240497102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKCQ,Protein kinase C theta type,4402,494,0.95 [0.79-1.14],0.5753571724770439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKD2,Serine/threonine-protein kinase D2,3783,414,1.15 [0.92-1.44],0.2174550574619735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKG1,cGMP-dependent protein kinase 1,3838,411,0.96 [0.89-1.04],0.3093785241807746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,4377,493,1.04 [0.92-1.17],0.5135607778230022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRL,Prolactin,4541,507,1.11 [1.01-1.22],0.0302390727636766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRND,Prion-like protein doppel,3892,422,0.95 [0.80-1.13],0.5803965780717406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROC,Vitamin K-dependent protein C,4523,505,0.97 [0.72-1.30],0.8300243800665128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROCR,Endothelial protein C receptor,3783,414,1.12 [0.86-1.46],0.4103783370922026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROK1,Prokineticin-1,4504,507,1.02 [0.89-1.16],0.7813172522746481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROS1,Vitamin K-dependent protein S,3917,422,0.85 [0.59-1.21],0.3601499527662858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRR4,Proline-rich protein 4,3804,407,1.05 [0.92-1.20],0.4563633319128657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRR5,Proline-rich protein 5,3792,418,1.04 [0.87-1.26],0.6573374396871141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRRT3,Proline-rich transmembrane protein 3,3805,414,1.29 [1.04-1.60],0.0205043571941372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS2,Trypsin-2,4526,507,1.08 [0.96-1.21],0.2128283470343111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS22,Brain-specific serine protease 4,3792,418,1.40 [1.10-1.77],0.006378365828208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS27,Serine protease 27,4499,505,1.62 [1.35-1.95],2.304393448243707e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS53,Serine protease 53,3892,422,0.65 [0.52-0.81],0.0001125911837529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS8,Prostasin,4493,502,1.77 [1.49-2.11],1.3583660445685474e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,4377,495,0.97 [0.90-1.04],0.3880490190118667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTG,Protogenin,4543,508,1.50 [1.11-2.02],0.0079609482454453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTN3,Myeloblastin,4402,497,1.00 [0.86-1.18],0.9679869690511144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRUNE2,Protein prune homolog 2,3845,412,0.79 [0.57-1.11],0.1700738071925053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAP,Prosaposin,3894,423,2.24 [1.63-3.08],6.620769734039533e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAPL1,Proactivator polypeptide-like 1,3888,421,0.96 [0.80-1.14],0.6341147005686978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSCA,Prostate stem cell antigen,3888,421,1.02 [0.98-1.05],0.3679345632952009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,4473,505,1.28 [1.19-1.38],7.5623859778227e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSIP1,PC4 and SFRS1-interacting protein,4504,507,1.00 [0.89-1.13],0.9941543456860946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMA1,Proteasome subunit alpha type-1,4377,493,0.97 [0.80-1.17],0.75002735435511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMC3,26S proteasome regulatory subunit 6A,3762,409,0.88 [0.64-1.20],0.4243770730301058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,3905,425,0.99 [0.82-1.19],0.933287451954004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,3819,418,1.06 [0.89-1.26],0.5364711428585499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,4485,502,0.94 [0.82-1.08],0.3709312322533606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSME1,Proteasome activator complex subunit 1,4470,505,0.89 [0.72-1.10],0.2847629585550956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSME2,Proteasome activator complex subunit 2,4449,501,1.04 [0.83-1.29],0.7552272096675021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMG3,Proteasome assembly chaperone 3,4504,507,0.95 [0.81-1.10],0.4831090684506315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMG4,Proteasome assembly chaperone 4,3792,418,0.97 [0.82-1.14],0.70315506541904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSPN,Persephin,4504,507,1.08 [1.00-1.17],0.0534950900477524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSRC1,Proline/serine-rich coiled-coil protein 1,4377,493,1.12 [0.99-1.26],0.082714779430599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,3714,391,0.99 [0.91-1.09],0.8562190983829292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",4377,495,1.05 [0.81-1.36],0.7253251252154007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGDS,Prostaglandin-H2 D-isomerase,4477,500,1.88 [1.55-2.29],1.2100887552691993e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGES2,Prostaglandin E synthase 2,3765,415,1.01 [0.85-1.21],0.8712605410071943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGR1,Prostaglandin reductase 1,3900,420,0.95 [0.86-1.05],0.3328102879799081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH,Parathyroid hormone,3819,418,0.87 [0.79-0.97],0.0147095719016576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,4504,507,1.30 [1.11-1.52],0.0010252707071679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTK7,Inactive tyrosine-protein kinase 7,4377,495,1.59 [1.30-1.96],7.452160478520317e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTN,Pleiotrophin,4430,500,0.93 [0.79-1.09],0.3608613854222761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,3792,418,0.89 [0.73-1.08],0.2249026995249819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,4473,505,1.01 [0.91-1.11],0.902753986096696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,4520,504,1.00 [0.91-1.09],0.9250983735244472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,3789,418,1.03 [0.81-1.32],0.8110682999109595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,3900,420,1.77 [1.32-2.37],0.0001523003602007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,3920,425,1.41 [0.95-2.10],0.0906754755938501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,4564,512,1.38 [1.06-1.78],0.0153123865223903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,3888,421,1.38 [1.16-1.64],0.0002133670276866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,3888,421,1.21 [0.83-1.77],0.3171712405900749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,4495,506,1.34 [1.00-1.81],0.0534230757416167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,4458,503,1.56 [1.27-1.92],2.4482351032316645e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,3892,422,0.87 [0.69-1.10],0.2588185285514222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,4564,512,1.34 [1.00-1.79],0.0491858441797479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,3900,420,0.95 [0.71-1.27],0.725950896211696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,3838,411,0.91 [0.77-1.07],0.241258907150489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,4357,491,0.93 [0.82-1.05],0.2429447397321983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTTG1,Securin,3845,412,0.96 [0.76-1.21],0.7249799721034692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTX3,Pentraxin-related protein PTX3,4504,507,1.35 [1.13-1.60],0.0008022189662269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PVALB,Parvalbumin alpha,4523,507,0.99 [0.93-1.06],0.8295318413084023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PVR,Poliovirus receptor,4541,507,1.30 [1.08-1.56],0.005211995292779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PXDNL,Peroxidasin-like protein,3890,418,0.98 [0.83-1.17],0.8283769388208074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PXN,Paxillin,4377,495,1.01 [0.87-1.18],0.886464528178268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYDC1,Pyrin domain-containing protein 1,3805,414,1.05 [0.84-1.31],0.6733111381637048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYY,Peptide YY,3783,414,1.32 [1.22-1.42],9.963560126947985e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PZP,Pregnancy zone protein,3917,422,0.85 [0.70-1.03],0.092245573566115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QDPR,Dihydropteridine reductase,4490,503,0.87 [0.72-1.05],0.1457428140968448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QPCT,Glutaminyl-peptide cyclotransferase,4521,510,1.96 [1.48-2.60],2.944905528031644e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QSOX1,Sulfhydryl oxidase 1,3830,410,1.23 [0.98-1.53],0.0705046156545993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB10,Ras-related protein Rab-10,3900,420,0.92 [0.77-1.10],0.3483656059597328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB11FIP3,Rab11 family-interacting protein 3,3900,420,0.99 [0.91-1.07],0.7297575632851323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB27B,Ras-related protein Rab-27B,3900,420,0.94 [0.84-1.06],0.3011002411825528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB2B,Ras-related protein Rab-2B,3890,418,0.92 [0.79-1.08],0.3089356442536876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB33A,Ras-related protein Rab-33A,3783,414,0.99 [0.86-1.15],0.9280836036753736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB37,Ras-related protein Rab-37,4402,494,1.03 [0.93-1.13],0.5677354610369336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB39B,Ras-related protein Rab-39B,3783,414,0.92 [0.82-1.04],0.1760045818707497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,3781,416,1.05 [0.89-1.24],0.530569262450237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB44,Ras-related protein Rab-44,3890,418,0.92 [0.75-1.13],0.4309037780546356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6A,Ras-related protein Rab-6A,4504,507,0.69 [0.59-0.82],1.5082632384991465e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6B,Ras-related protein Rab-6B,4377,495,1.01 [0.86-1.19],0.8838193067813259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABEP1,Rab GTPase-binding effector protein 1,3838,411,0.95 [0.84-1.08],0.4395944729305824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABEPK,Rab9 effector protein with kelch motifs,4377,493,1.04 [0.91-1.19],0.5199178755274498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABGAP1L,Rab GTPase-activating protein 1-like,4402,494,1.00 [0.88-1.14],0.9724200826978314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAC3,Ras-related C3 botulinum toxin substrate 3,3819,418,1.14 [1.00-1.29],0.0437720112499558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAD23B,UV excision repair protein RAD23 homolog B,4377,493,1.01 [0.85-1.20],0.885066547036411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAD51,DNA repair protein RAD51 homolog 1,3845,412,1.16 [0.97-1.38],0.1092329381613432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RALB,Ras-related protein Ral-B,3792,418,0.94 [0.68-1.30],0.7068411092731908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RALY,RNA-binding protein Raly,3890,418,1.03 [0.85-1.24],0.783638360742309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANBP1,Ran-specific GTPase-activating protein,3805,414,0.97 [0.81-1.16],0.7528407960174697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANBP2,E3 SUMO-protein ligase RanBP2,3781,416,1.00 [0.74-1.34],0.9898969785465068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANGAP1,Ran GTPase-activating protein 1,4377,493,1.02 [0.86-1.20],0.819167773445102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAP1A,Ras-related protein Rap-1A,3792,418,0.95 [0.82-1.10],0.4744083098106023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,3845,412,1.03 [0.86-1.24],0.7389687211946512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES1,Retinoic acid receptor responder protein 1,4377,493,1.53 [1.25-1.88],3.358393415766616e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES2,Retinoic acid receptor responder protein 2,4530,508,1.23 [1.06-1.43],0.0066513367818537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASA1,Ras GTPase-activating protein 1,4377,495,1.03 [0.81-1.31],0.8066286271495127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,3762,409,1.10 [0.90-1.35],0.3470557366661642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASSF2,Ras association domain-containing protein 2,4377,493,1.06 [0.94-1.20],0.3610221820481099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBFOX3,RNA binding protein fox-1 homolog 3,3905,425,1.61 [1.35-1.92],7.145722483849604e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBKS,Ribokinase,4409,502,0.74 [0.66-0.83],7.610515367844351e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM17,Splicing factor 45,3905,425,1.04 [0.92-1.17],0.5682888444484469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM19,Probable RNA-binding protein 19,3783,414,1.02 [0.81-1.29],0.8359171610994045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM25,RNA-binding protein 25,3762,409,1.07 [0.87-1.30],0.5324212043300766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP1,Retinol-binding protein 1,3819,418,1.14 [1.02-1.29],0.0257682683152748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP2,Retinol-binding protein 2,4485,502,1.26 [1.15-1.38],6.171283725906262e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP5,Retinol-binding protein 5,4485,502,1.05 [0.93-1.18],0.4264382805894584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP7,Retinoid-binding protein 7,3888,421,1.24 [1.09-1.40],0.0010646434720531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBPMS,RNA-binding protein with multiple splicing,3792,418,1.08 [0.94-1.25],0.2763873134284154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBPMS2,RNA-binding protein with multiple splicing 2,3805,414,1.00 [0.92-1.10],0.9279813052877922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RCC1,Regulator of chromosome condensation,3890,418,1.06 [0.89-1.26],0.5325987914839281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RCOR1,REST corepressor 1,4430,500,1.08 [0.91-1.28],0.3970272341832932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,3805,414,1.18 [0.75-1.83],0.4756619859972459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REEP4,Receptor expression-enhancing protein 4,3905,425,1.01 [0.87-1.17],0.9314894374663608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1A,Lithostathine-1-alpha,4485,500,2.03 [1.82-2.27],6.19056246806358e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1B,Lithostathine-1-beta,4564,512,1.66 [1.49-1.85],1.092210574362691e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3A,Regenerating islet-derived protein 3-alpha,4564,512,1.49 [1.35-1.65],3.1192906799112145e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3G,Regenerating islet-derived protein 3-gamma,3890,418,1.10 [0.88-1.37],0.4178816474653318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG4,Regenerating islet-derived protein 4,4513,504,2.06 [1.83-2.31],3.91972829157956e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELB,Transcription factor RelB,3792,418,0.99 [0.81-1.21],0.9435376291551812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELT,Tumor necrosis factor receptor superfamily member 19L,4525,508,1.73 [1.37-2.18],4.300965812384002e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REN,Renin,4508,505,1.49 [1.39-1.60],4.268071400355856e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REPS1,RalBP1-associated Eps domain-containing protein 1,3792,418,0.92 [0.71-1.19],0.5083046193234619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REST,RE1-silencing transcription factor,3762,409,1.08 [0.83-1.41],0.5783382698571504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,4485,502,1.05 [0.87-1.28],0.6131992392895407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RETN,Resistin,4512,511,1.22 [1.04-1.44],0.0171879027906264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REXO2,"Oligoribonuclease, mitochondrial",3783,414,0.85 [0.67-1.08],0.1807960074141368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RFC4,Replication factor C subunit 4,3890,418,0.90 [0.58-1.38],0.6273423586565899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGCC,Regulator of cell cycle RGCC,3905,425,0.95 [0.84-1.07],0.4014518185955881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,3845,412,1.17 [1.03-1.33],0.0151208602561678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMA,Repulsive guidance molecule A,4541,507,1.61 [1.28-2.03],4.313759512422086e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMB,RGM domain family member B,4541,507,1.63 [1.27-2.09],0.0001414424897341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGS10,Regulator of G-protein signaling 10,3905,425,1.00 [0.85-1.17],0.9516414636430968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGS8,Regulator of G-protein signaling 8,4402,494,1.01 [0.90-1.14],0.8160483277229651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RHOC,Rho-related GTP-binding protein RhoC,4453,504,1.01 [0.94-1.08],0.7634908584748168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RICTOR,Rapamycin-insensitive companion of mTOR,3792,418,0.91 [0.74-1.11],0.3506107791369478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,3838,411,0.97 [0.82-1.15],0.7338964273299631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RILP,Rab-interacting lysosomal protein,4530,507,0.93 [0.82-1.06],0.2710725960265138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RILPL2,RILP-like protein 2,3900,420,0.99 [0.90-1.09],0.7849361996431706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,3783,414,1.05 [0.92-1.19],0.5081422665746519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RLN1,Prorelaxin H1,3905,425,1.18 [1.03-1.35],0.0163191051537716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RLN2,Prorelaxin H2,3828,411,0.98 [0.86-1.11],0.7108358518517152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE1,Ribonuclease pancreatic,3921,425,2.14 [1.57-2.91],1.3816299112267611e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE10,Inactive ribonuclease-like protein 10,3805,414,1.25 [1.05-1.51],0.0144612717412033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE3,Eosinophil cationic protein,4492,505,0.98 [0.92-1.05],0.5891389620867289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE4,Ribonuclease 4,3780,411,1.76 [1.30-2.40],0.0002894448963081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE6,Ribonuclease K6,3888,420,1.68 [1.40-2.00],9.707655755930604e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASEH2A,Ribonuclease H2 subunit A,3905,425,0.96 [0.79-1.17],0.7148464437604591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASET2,Ribonuclease T2,4550,512,2.35 [1.93-2.87],3.200250181263067e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF149,E3 ubiquitin-protein ligase RNF149,3805,414,2.26 [1.75-2.93],6.10148933622655e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF168,E3 ubiquitin-protein ligase RNF168,3792,418,0.82 [0.63-1.07],0.1432924810987594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF31,E3 ubiquitin-protein ligase RNF31,3792,418,0.94 [0.73-1.20],0.6044811759944304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF4,E3 ubiquitin-protein ligase RNF4,3845,412,0.96 [0.82-1.12],0.6033903157457954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF41,E3 ubiquitin-protein ligase NRDP1,4377,493,0.96 [0.85-1.09],0.5282745365466031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF43,E3 ubiquitin-protein ligase RNF43,3845,412,1.02 [0.86-1.21],0.8268271992860965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF5,E3 ubiquitin-protein ligase RNF5,3805,414,0.89 [0.78-1.02],0.0956502587897135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO1,Roundabout homolog 1,4513,504,1.51 [1.16-1.96],0.0022925728788801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO2,Roundabout homolog 2,4541,507,0.98 [0.71-1.34],0.877932154619907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO4,Roundabout homolog 4,3805,414,1.72 [1.02-2.90],0.0407222941844545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,4508,505,1.57 [1.26-1.96],5.807090068755618e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RP2,Protein XRP2,4485,502,0.94 [0.78-1.12],0.4917022410450252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPA2,Replication protein A 32 kDa subunit,3792,418,1.09 [0.82-1.45],0.5715413454080684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPE,Ribulose-phosphate 3-epimerase,3845,412,0.96 [0.84-1.10],0.54142988283469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,3819,418,1.03 [0.83-1.26],0.8115716524946577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPL14,60S ribosomal protein L14,3805,414,1.05 [0.83-1.35],0.6675324388688308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPS10,40S ribosomal protein S10,3783,414,1.02 [0.80-1.29],0.8963669430683772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRAS,Ras-related protein R-Ras,3819,418,1.01 [0.94-1.09],0.6881143479551877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,4377,493,1.07 [0.93-1.23],0.3575913653189725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,4377,493,1.00 [0.89-1.12],0.9626791613984748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRP15,RRP15-like protein,3781,416,0.97 [0.87-1.07],0.5348125463056552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO1,R-spondin-1,4473,505,1.14 [0.91-1.44],0.2464451475470234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO3,R-spondin-3,4543,508,1.60 [1.26-2.04],0.0001022174126879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTBDN,Retbindin,4485,502,1.21 [0.94-1.55],0.1403987863341081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTKN2,Rhotekin-2,3783,414,1.06 [0.89-1.26],0.4955156968356521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",3905,425,1.01 [0.92-1.12],0.7833832349323464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4R,Reticulon-4 receptor,4543,508,1.92 [1.55-2.39],3.910446269944272e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RUVBL1,RuvB-like 1,4377,493,0.99 [0.92-1.08],0.8821980619627174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RWDD1,RWD domain-containing protein 1,4541,507,1.01 [0.89-1.15],0.8668382577363196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RYR1,Ryanodine receptor 1,3783,414,1.00 [0.76-1.30],0.9745544979368664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A11,Protein S100-A11,4467,502,1.05 [0.90-1.22],0.5579854014986043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A12,Protein S100-A12,4441,497,1.00 [0.90-1.11],0.9375267780230516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A13,Protein S100-A13,3792,418,0.85 [0.65-1.11],0.2381648437328832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A14,Protein S100-A14,3905,425,0.80 [0.66-0.95],0.0138080285054264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A16,Protein S100-A16,4370,494,0.91 [0.80-1.05],0.1910719809313522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A3,Protein S100-A3,3890,418,0.94 [0.76-1.15],0.5398990028930845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A4,Protein S100-A4,4513,505,0.95 [0.83-1.09],0.4843225917400333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100G,Protein S100-G,3905,425,0.69 [0.57-0.85],0.0003321375794786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100P,Protein S100-P,4430,500,1.28 [1.15-1.43],6.835719993297276e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAA4,Serum amyloid A-4 protein,3917,422,0.56 [0.35-0.90],0.0170731689772364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAFB2,Scaffold attachment factor B2,3905,425,1.16 [0.83-1.64],0.3837542059107682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAG,S-arrestin,3781,416,1.00 [0.83-1.20],0.9744386571797724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,4504,507,1.03 [0.92-1.15],0.614342926550855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAP18,Histone deacetylase complex subunit SAP18,3845,412,1.05 [0.93-1.18],0.4508466776909616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SARG,Specifically androgen-regulated gene protein,3890,419,1.02 [0.94-1.11],0.6086060374115706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,3783,414,1.21 [0.96-1.51],0.1001112878488271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAT1,Diamine acetyltransferase 1,3783,414,1.02 [0.84-1.24],0.8342873982359358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAT2,Thialysine N-epsilon-acetyltransferase,3845,412,0.90 [0.78-1.03],0.1277614523435725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SATB1,DNA-binding protein SATB1,3905,425,0.93 [0.67-1.30],0.6768948355233535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SBSN,Suprabasin,3911,424,1.02 [0.79-1.30],0.897779380270981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCAMP3,Secretory carrier-associated membrane protein 3,4485,502,1.02 [0.93-1.12],0.730063088437306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARA5,Scavenger receptor class A member 5,4541,507,2.91 [2.35-3.60],1.322999037789524e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB1,Scavenger receptor class B member 1,4377,495,1.07 [0.93-1.22],0.3610548114353206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB2,Lysosome membrane protein 2,4382,499,2.13 [1.77-2.57],8.736895111929734e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF1,Scavenger receptor class F member 1,4564,512,1.29 [1.08-1.55],0.0045730362260147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF2,Scavenger receptor class F member 2,4541,507,2.27 [1.81-2.85],9.809993808911226e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG2,Secretogranin-2,4525,507,2.30 [1.89-2.81],2.1969108450449423e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG3,Secretogranin-3,4513,504,1.10 [0.88-1.38],0.3965797416620549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB1A1,Uteroglobin,4513,504,1.31 [1.13-1.51],0.0002354495525966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB2A2,Mammaglobin-A,3783,414,0.86 [0.61-1.22],0.3989026153000625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB3A1,Secretoglobin family 3A member 1,3838,411,0.98 [0.68-1.40],0.901325617969724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB3A2,Secretoglobin family 3A member 2,4520,504,1.07 [0.99-1.16],0.086531368672462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGN,Secretagogin,4402,494,1.87 [1.64-2.13],1.756517951203143e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCIN,Adseverin,3781,416,1.00 [0.88-1.13],0.9528596158614696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCLY,Selenocysteine lyase,4530,507,0.80 [0.69-0.93],0.0034360118024351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN2A,Sodium channel protein type 2 subunit alpha,3781,416,0.99 [0.82-1.21],0.9432320129181327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN2B,Sodium channel subunit beta-2,3819,418,1.17 [0.85-1.62],0.3316099075308208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN3A,Sodium channel protein type 3 subunit alpha,3819,418,0.94 [0.72-1.22],0.6262018364622954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN3B,Sodium channel subunit beta-3,3781,416,1.01 [0.82-1.24],0.9326055031238182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN4B,Sodium channel subunit beta-4,3805,414,1.27 [1.04-1.54],0.0175731527907018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCP2,Non-specific lipid-transfer protein,4377,493,1.02 [0.91-1.13],0.7700326537704316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,3794,412,1.12 [0.93-1.35],0.2310483346638763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRG1,Scrapie-responsive protein 1,3900,420,1.03 [0.76-1.42],0.8308746346798799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRIB,Protein scribble homolog,3805,414,1.05 [0.94-1.16],0.394744850568671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRN1,Secernin-1,4504,507,1.04 [0.90-1.19],0.622946029393729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCT,Secretin,3819,418,1.39 [1.16-1.67],0.0003251297122434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDC1,Syndecan-1,4508,505,1.12 [0.93-1.34],0.2272177465002231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDC4,Syndecan-4,4508,505,0.78 [0.66-0.92],0.0023309889975212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDCCAG8,Serologically defined colon cancer antigen 8,3890,418,0.97 [0.89-1.06],0.5065606822860419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDHB,Succinate dehydrogenase,3888,421,0.96 [0.82-1.12],0.5948308439382415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDK2,Protein sidekick-2,3838,411,0.94 [0.74-1.21],0.6455912635639074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEC31A,Protein transport protein Sec31A,3805,414,1.01 [0.89-1.15],0.867155216696939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEL1L,Protein sel-1 homolog 1,3805,414,1.69 [1.40-2.03],2.8814188384409323e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELE,E-selectin,4564,512,1.25 [1.09-1.44],0.0014565933556684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELENOP,Selenoprotein P,3917,422,1.12 [0.76-1.65],0.5604682237868469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELL,L-selectin,3917,422,0.64 [0.43-0.95],0.0276511741612859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELP,P-selectin,4526,507,1.03 [0.90-1.18],0.6428452487969103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELPLG,P-selectin glycoprotein ligand 1,4504,507,1.42 [1.10-1.84],0.0074327316982623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3F,Semaphorin-3F,4508,505,1.49 [1.14-1.96],0.0035878415135306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3G,Semaphorin-3G,3838,411,1.29 [1.07-1.55],0.0068362686265809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA4C,Semaphorin-4C,4485,502,1.18 [0.95-1.45],0.1331024427439024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA4D,Semaphorin-4D,4541,507,1.10 [0.85-1.44],0.4647945118900106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA6C,Semaphorin-6C,3792,418,1.09 [0.78-1.54],0.6131237283650788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA7A,Semaphorin-7A,4554,512,2.02 [1.63-2.52],2.5630171281575703e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN3,Neuronal-specific septin-3,3905,425,0.91 [0.81-1.03],0.1449210649645864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN7,Septin-7,3845,412,0.99 [0.83-1.19],0.9112698875520582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN8,Septin-8,3884,422,1.53 [1.21-1.93],0.000334032610848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN9,Septin-9,4485,502,0.99 [0.76-1.29],0.9550090228874936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA1,Alpha-1-antitrypsin,3847,416,1.98 [0.62-6.40],0.2512897111054376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA11,Serpin A11,4564,512,0.98 [0.82-1.18],0.8659393878300985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA12,Serpin A12,4403,493,0.93 [0.87-1.00],0.0372531068648234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA3,Alpha-1-antichymotrypsin,3900,419,1.12 [0.61-2.05],0.7156873526872402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA4,Kallistatin,3831,412,1.19 [0.81-1.74],0.3769978926940922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA5,Plasma serine protease inhibitor,3855,416,0.85 [0.63-1.16],0.3134770979735242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA6,Corticosteroid-binding globulin,3917,422,2.23 [1.29-3.84],0.0038955127751974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA7,Thyroxine-binding globulin,3917,422,1.05 [0.64-1.73],0.8497368622939608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA9,Serpin A9,4465,501,1.05 [0.94-1.16],0.3727894606047709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB1,Leukocyte elastase inhibitor,4512,506,1.00 [0.92-1.09],0.9656572906063609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB5,Serpin B5,4430,500,0.99 [0.84-1.16],0.885363954082563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB6,Serpin B6,4527,505,1.08 [0.95-1.24],0.2489019221044308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB8,Serpin B8,4556,506,1.01 [0.89-1.14],0.9248209135708372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB9,Serpin B9,4473,505,0.93 [0.72-1.19],0.5463639635893807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINC1,Antithrombin-III,3908,422,2.65 [1.48-4.73],0.0010191111903597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPIND1,Heparin cofactor 2,3908,422,1.16 [0.85-1.58],0.3503008522412857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINE1,Plasminogen activator inhibitor 1,4564,512,0.91 [0.81-1.02],0.0965884946761943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINE2,Glia-derived nexin,3900,420,0.93 [0.81-1.08],0.3379534066598734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINF1,Pigment epithelium-derived factor,3852,418,1.34 [0.96-1.88],0.088210540406963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINF2,Alpha-2-antiplasmin,3834,417,1.47 [0.77-2.79],0.2395889756645376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPING1,Plasma protease C1 inhibitor,3908,422,1.74 [1.08-2.81],0.0228806487376309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINH1,Serpin H1,3845,412,1.03 [0.95-1.10],0.4935021484647484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINI1,Neuroserpin,3832,409,0.59 [0.42-0.81],0.0013697164534529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINI2,Serpin I2,3888,421,1.09 [0.94-1.27],0.2607254261952213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,4377,495,0.98 [0.87-1.11],0.7523865529415399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,4457,503,0.64 [0.49-0.85],0.0016099728428335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6,Seizure protein 6 homolog,3819,418,1.10 [0.83-1.47],0.4908458005672066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L,Seizure 6-like protein,4513,505,1.72 [1.33-2.23],3.5716542068853524e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L2,Seizure 6-like protein 2,4485,502,1.14 [0.83-1.55],0.4175463190277432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SF3B4,Splicing factor 3B subunit 4,4485,502,0.99 [0.89-1.10],0.7916446521894371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFRP1,Secreted frizzled-related protein 1,4460,504,1.30 [1.10-1.54],0.0025622180298171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFRP4,Secreted frizzled-related protein 4,3838,411,0.89 [0.71-1.11],0.2954299756213535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPA1,Pulmonary surfactant-associated protein A1,4377,493,1.10 [0.97-1.26],0.1390765641698829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPA2,Pulmonary surfactant-associated protein A2,4377,493,0.91 [0.78-1.06],0.2318904605422708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPD,Pulmonary surfactant-associated protein D,4508,505,1.08 [0.96-1.21],0.1843948746532763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SGSH,N-sulphoglucosamine sulphohydrolase,3844,417,0.99 [0.84-1.17],0.915173777462183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH2B3,SH2B adapter protein 3,4377,493,0.99 [0.91-1.07],0.8128184342058615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH2D1A,SH2 domain-containing protein 1A,4504,507,1.00 [0.87-1.15],0.9833613421815942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,3781,416,1.01 [0.86-1.18],0.9340726633537793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3BP1,SH3 domain-binding protein 1,3888,421,0.91 [0.75-1.10],0.3350468935163268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GL3,Endophilin-A3,3821,411,1.07 [0.95-1.20],0.2671338744519725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GLB2,Endophilin-B2,3892,422,1.02 [0.89-1.17],0.7751305045048535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHBG,Sex hormone-binding globulin,3921,425,0.99 [0.84-1.17],0.9348641626615938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHC1,SHC-transforming protein 1,3762,409,1.01 [0.93-1.10],0.7895681327861098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHD,SH2 domain-containing adapter protein D,3772,413,1.04 [0.95-1.15],0.3862498627638276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHH,Sonic hedgehog protein,3792,418,1.00 [0.80-1.24],0.9976195101790092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHISA5,Protein shisa-5,3920,425,1.88 [1.44-2.46],4.152356850898194e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",4520,504,0.95 [0.87-1.04],0.2788066313067171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHPK,Sedoheptulokinase,3845,412,1.02 [0.81-1.28],0.8637428366935431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIAE,Sialate O-acetylesterase,4509,505,1.20 [1.02-1.41],0.0316065836381829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC1,Sialoadhesin,4527,505,1.49 [1.25-1.78],8.232613337455621e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,4504,507,1.70 [1.38-2.08],3.609904911908648e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,4377,495,1.02 [0.92-1.13],0.7138327535468696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,4525,508,1.03 [0.96-1.09],0.4406166619398041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,4543,508,2.34 [1.86-2.93],2.199535183314624e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,4508,505,1.56 [1.20-2.04],0.0010368433773894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,3805,414,1.18 [0.98-1.43],0.085716119631618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,4538,507,1.00 [0.78-1.29],0.9737100850473712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIL1,Nucleotide exchange factor SIL1,3805,414,1.03 [0.78-1.37],0.8162181252093154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,4515,508,1.30 [1.13-1.51],0.0004004879462077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPB1,Signal-regulatory protein beta-1,4494,502,1.65 [1.41-1.93],3.3387999888311953e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,3792,418,1.01 [0.89-1.14],0.92849297284694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,4485,502,0.97 [0.88-1.06],0.4891086968595244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",4377,495,0.91 [0.78-1.06],0.232688336947993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,4402,494,1.18 [1.03-1.36],0.0201163114260398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKAP1,Src kinase-associated phosphoprotein 1,4464,504,0.99 [0.89-1.11],0.8921789972751273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKAP2,Src kinase-associated phosphoprotein 2,4527,505,0.99 [0.91-1.07],0.7441298065544341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKIV2L,Helicase SKI2W,3783,414,1.05 [0.82-1.34],0.7057006432820292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLA2,Src-like-adapter 2,3905,425,1.01 [0.92-1.10],0.8206278660789904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF1,Signaling lymphocytic activation molecule,4402,494,1.35 [1.18-1.54],1.128123910615766e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF6,SLAM family member 6,4377,493,1.29 [1.07-1.57],0.0080766119662709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF7,SLAM family member 7,4504,507,1.31 [1.15-1.49],4.145322613482805e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF8,SLAM family member 8,4377,493,1.29 [1.11-1.49],0.0008183730564915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC12A2,Solute carrier family 12 member 2,3783,414,1.12 [0.79-1.60],0.5192347272054241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC13A1,Solute carrier family 13 member 1,3890,418,1.06 [0.91-1.24],0.4257833205847624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC16A1,Monocarboxylate transporter 1,4377,495,1.15 [1.01-1.30],0.0363121243031517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC1A4,Neutral amino acid transporter A,3819,418,1.08 [0.89-1.30],0.424802725398878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC27A4,Long-chain fatty acid transport protein 4,4377,495,0.94 [0.83-1.07],0.3492188398252477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC28A1,Sodium/nucleoside cotransporter 1,3762,409,1.07 [0.92-1.25],0.3950892431039442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,3762,409,0.91 [0.73-1.13],0.3954681387878328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A14,Zinc transporter ZIP14,4377,495,1.41 [1.18-1.68],0.0001169491106283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A5,Zinc transporter ZIP5,4504,507,1.13 [0.98-1.29],0.0871053080695737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC44A4,Choline transporter-like protein 4,3819,418,0.95 [0.82-1.10],0.4714737411229974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC4A1,Band 3 anion transport protein,3920,425,1.18 [0.97-1.43],0.1051233437450029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC51B,Organic solute transporter subunit beta,3783,414,0.91 [0.79-1.04],0.1773860391328733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,3838,411,0.99 [0.88-1.11],0.8289447727171105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,3888,421,1.14 [0.97-1.33],0.1208078659962997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",3762,409,1.14 [0.98-1.33],0.0818898154939864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLIT2,Slit homolog 2 protein,4377,495,1.02 [0.87-1.18],0.8290285217719848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK1,SLIT and NTRK-like protein 1,3792,418,0.68 [0.51-0.91],0.008693277232206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK2,SLIT and NTRK-like protein 2,4543,508,1.54 [1.27-1.86],7.670409875629017e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK6,SLIT and NTRK-like protein 6,4430,500,1.80 [1.50-2.17],4.5473284770048605e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLK,STE20-like serine/threonine-protein kinase,3845,412,0.91 [0.79-1.05],0.2075456513567319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLMAP,Sarcolemmal membrane-associated protein,3888,421,1.08 [0.97-1.20],0.1502042329547373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,3884,420,1.19 [0.92-1.53],0.1778933587267781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD1,Mothers against decapentaplegic homolog 1,4377,493,1.01 [0.92-1.11],0.878027973106267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD2,Mothers against decapentaplegic homolog 2,3890,418,0.96 [0.84-1.10],0.575146639415334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD3,Mothers against decapentaplegic homolog 3,3890,418,0.98 [0.82-1.17],0.7873324080508058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD5,Mothers against decapentaplegic homolog 5,4485,502,0.53 [0.36-0.78],0.0013406791220783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMARCA2,Probable global transcription activator SNF2L2,4377,495,1.07 [0.96-1.19],0.2159658006240474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMC3,Structural maintenance of chromosomes protein 3,3762,409,0.98 [0.81-1.18],0.8023948853115621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,3888,421,0.96 [0.82-1.11],0.5627657298989241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC1,SPARC-related modular calcium-binding protein 1,4543,508,1.41 [1.12-1.77],0.0029623228682097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC2,SPARC-related modular calcium-binding protein 2,4527,505,1.63 [1.36-1.94],5.431770979635104e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPD1,Sphingomyelin phosphodiesterase,4517,502,1.12 [0.96-1.30],0.1453217572513761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPD3,Sphingomyelin phosphodiesterase 3,3792,418,1.02 [0.85-1.21],0.8356523344309507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,4517,503,0.91 [0.81-1.02],0.1161852346300335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,3890,418,0.81 [0.70-0.94],0.0062496243431017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMS,Spermine synthase,3781,416,1.06 [0.92-1.22],0.4127340719628308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMTN,Smoothelin,3885,422,1.01 [0.92-1.12],0.7789707907261368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP23,Synaptosomal-associated protein 23,4508,505,0.96 [0.88-1.06],0.42425238887695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP25,Synaptosomal-associated protein 25,3781,416,1.05 [0.86-1.26],0.645251199250872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP29,Synaptosomal-associated protein 29,4513,505,0.98 [0.90-1.06],0.5823684647438029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAPIN,SNARE-associated protein Snapin,3905,425,0.78 [0.67-0.92],0.0030793264425592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCA,Alpha-synuclein,3838,411,0.94 [0.87-1.02],0.12218175474461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCG,Gamma-synuclein,4473,505,1.36 [1.22-1.53],1.0841190429501909e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",3805,414,1.66 [1.30-2.12],5.545709197778318e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',3892,422,1.07 [0.90-1.27],0.4582439203010074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNU13,NHP2-like protein 1,3783,414,1.06 [0.91-1.23],0.4526791541657597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX15,Sorting nexin-15,3838,411,0.91 [0.76-1.08],0.2662132232913076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX18,Sorting nexin-18,3888,421,1.23 [1.01-1.48],0.0370645366693536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX2,Sorting nexin-2,3890,418,1.07 [0.96-1.19],0.2270720346784933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX5,Sorting nexin-5,3805,414,1.25 [0.92-1.69],0.151990890700891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX9,Sorting nexin-9,4508,505,1.03 [0.92-1.15],0.6466851287713227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD1,Superoxide dismutase [Cu-Zn],4423,495,0.98 [0.83-1.15],0.7972133366752687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",4525,508,0.85 [0.71-1.02],0.0743988985636035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD3,Extracellular superoxide dismutase,3921,425,1.01 [0.88-1.15],0.938174640858879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORBS1,Sorbin and SH3 domain-containing protein 1,3905,425,1.07 [0.87-1.31],0.5365781971236588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORCS2,VPS10 domain-containing receptor SorCS2,4377,493,1.60 [1.31-1.94],2.243674009727004e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORD,Sorbitol dehydrogenase,4521,506,0.82 [0.74-0.90],9.120782891895145e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORT1,Sortilin,4506,503,1.03 [0.84-1.26],0.785932130052361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOST,Sclerostin,4506,503,1.13 [0.93-1.37],0.231223694260155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,3819,418,1.01 [0.84-1.21],0.920996269559933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOX2,Transcription factor SOX-2,3898,423,0.79 [0.53-1.18],0.2566509145743048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOX9,Transcription factor SOX-9,3819,418,1.50 [1.05-2.13],0.0258356131469035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,3905,425,1.07 [0.80-1.43],0.6598095582149093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPAG1,Sperm-associated antigen 1,3905,425,1.09 [0.93-1.28],0.2947239001198065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPARC,SPARC,4513,505,1.02 [0.91-1.13],0.7768720838652439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPARCL1,SPARC-like protein 1,4502,505,1.13 [0.85-1.50],0.3842168153825455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPART,Spartin,3838,411,0.96 [0.85-1.09],0.5242985277877257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPESP1,Sperm equatorial segment protein 1,3900,420,1.15 [0.87-1.53],0.3242940310349288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK1,Serine protease inhibitor Kazal-type 1,4525,508,2.04 [1.81-2.30],9.717220471588138e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK2,Serine protease inhibitor Kazal-type 2,3838,411,1.36 [1.09-1.68],0.005687563820036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK4,Serine protease inhibitor Kazal-type 4,4504,507,1.74 [1.58-1.91],3.0111637411017293e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK5,Serine protease inhibitor Kazal-type 5,4525,508,1.26 [1.01-1.57],0.0378551886977278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK6,Serine protease inhibitor Kazal-type 6,4543,508,1.05 [0.91-1.21],0.5426837273984402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK8,Serine protease inhibitor Kazal-type 8,3783,414,1.04 [0.80-1.36],0.7530071843257129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT1,Kunitz-type protease inhibitor 1,4511,505,1.54 [1.18-2.00],0.0013929249895345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT2,Kunitz-type protease inhibitor 2,4527,505,1.66 [1.38-2.00],6.086104952687872e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT3,Kunitz-type protease inhibitor 3,3888,421,0.97 [0.91-1.03],0.3271190915401525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPOCK1,Testican-1,4473,505,0.43 [0.33-0.57],4.348622199195594e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON1,Spondin-1,4513,504,2.08 [1.70-2.53],4.40324471016184e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON2,Spondin-2,4490,501,1.71 [1.40-2.09],2.0075805551377968e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPP1,Osteopontin,4557,512,1.02 [0.87-1.20],0.7690275374013996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",3792,418,0.90 [0.71-1.13],0.3613665939405454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRING1,SREBP regulating gene protein,3762,409,1.05 [0.89-1.23],0.5652896817800355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRR1B,Cornifin-B,3845,412,1.02 [0.91-1.14],0.7075841527502363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRR3,Small proline-rich protein 3,3892,422,1.08 [0.95-1.23],0.2231645251492137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRY2,Protein sprouty homolog 2,4402,494,1.00 [0.92-1.09],0.937515803624943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",3781,416,1.06 [0.80-1.41],0.66278218435599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPTLC1,Serine palmitoyltransferase 1,3892,422,1.00 [0.79-1.28],0.986631161807372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRC,Proto-oncogene tyrosine-protein kinase Src,4504,503,1.00 [0.94-1.07],0.97479798923899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRP14,Signal recognition particle 14 kDa protein,4485,502,0.99 [0.87-1.13],0.8643448956483729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRPK2,SRSF protein kinase 2,4504,507,1.00 [0.91-1.10],0.9490881410169824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRPX,Sushi repeat-containing protein SRPX,3900,420,1.28 [1.01-1.63],0.0452206949936564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSB,Lupus La protein,4377,495,1.03 [0.91-1.16],0.6135650058524471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",3792,418,0.99 [0.77-1.29],0.9690195503468808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,4506,503,0.92 [0.86-0.97],0.003761250442811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4526,507,1.02 [0.85-1.22],0.858113217992449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSH3,Protein phosphatase Slingshot homolog 3,3762,409,0.82 [0.58-1.17],0.2748436862492406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,3888,421,1.05 [0.88-1.25],0.5992681308422078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST13,Hsc70-interacting protein,3838,411,0.87 [0.74-1.04],0.1186755859156226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4485,502,1.51 [1.31-1.75],1.0434984308205544e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",4564,512,1.20 [0.93-1.56],0.1610958644315408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",3792,418,0.78 [0.60-1.01],0.0564295462455877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAB2,Stabilin-2,3920,425,0.96 [0.69-1.34],0.8317086334939762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAM,Signal transducing adapter molecule 1,3890,418,0.79 [0.59-1.04],0.0964907470969266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAMBP,STAM-binding protein,4464,504,0.97 [0.86-1.11],0.6872564707870632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAT2,Signal transducer and activator of transcription 2,3792,418,1.00 [0.88-1.13],0.9744434653683954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAT5B,Signal transducer and activator of transcription 5B,4485,502,0.98 [0.92-1.03],0.4049650155790911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,3762,409,1.05 [0.91-1.20],0.5163678672497708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC1,Stanniocalcin-1,4541,507,1.30 [1.11-1.53],0.0011527488830973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC2,Stanniocalcin-2,4518,507,1.40 [1.03-1.91],0.0331366456487374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STEAP4,Metalloreductase STEAP4,3781,416,0.96 [0.84-1.11],0.6170051938743166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STIP1,Stress-induced-phosphoprotein 1,4516,506,0.99 [0.87-1.11],0.8367026008176345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK11,Serine/threonine-protein kinase STK11,4430,500,1.00 [0.90-1.12],0.977475459912093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK24,Serine/threonine-protein kinase 24,4377,495,1.04 [0.91-1.19],0.5542447155751017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK4,Serine/threonine-protein kinase 4,4508,505,0.96 [0.88-1.05],0.3959072171663402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STOML2,"Stomatin-like protein 2, mitochondrial",3762,409,0.97 [0.87-1.08],0.5634192301402368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX16,Syntaxin-16,4377,493,0.98 [0.85-1.13],0.7622475927113255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX1B,Syntaxin-1B,3819,418,1.03 [0.82-1.30],0.7831094401452416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX3,Syntaxin-3,3892,422,0.88 [0.68-1.16],0.3639727829669205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX4,Syntaxin-4,4485,502,1.07 [0.94-1.21],0.3266100696374829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX5,Syntaxin-5,3792,418,1.09 [0.89-1.33],0.4212888673683852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX6,Syntaxin-6,4377,493,1.04 [0.92-1.18],0.5581009145154185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX7,Syntaxin-7,3792,418,1.10 [0.91-1.35],0.3301026254639292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX8,Syntaxin-8,4504,507,1.06 [0.90-1.25],0.4622181656667902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STXBP1,Syntaxin-binding protein 1,3905,425,0.95 [0.84-1.07],0.3749985627714564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STXBP3,Syntaxin-binding protein 3,4377,493,1.00 [0.82-1.20],0.9661816954071606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUGP1,SURP and G-patch domain-containing protein 1,3888,421,0.98 [0.78-1.24],0.8827895034291385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUGT1,Protein SGT1 homolog,4377,493,1.00 [0.90-1.11],0.9917239748748066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SULT1A1,Sulfotransferase 1A1,4541,507,0.99 [0.93-1.05],0.7634457999203491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SULT2A1,Bile salt sulfotransferase,4504,507,0.96 [0.86-1.08],0.5382703872064001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUMF1,Formylglycine-generating enzyme,3792,418,1.04 [0.91-1.19],0.603874879145054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,4541,507,1.03 [0.89-1.20],0.6704916574750945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUOX,"Sulfite oxidase, mitochondrial",3905,425,0.91 [0.79-1.05],0.1854044874003156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD1,Sushi domain-containing protein 1,4430,500,0.94 [0.80-1.10],0.4481983900208703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD2,Sushi domain-containing protein 2,4525,508,1.68 [1.31-2.16],3.680247388058656e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD4,Sushi domain-containing protein 4,3890,418,1.04 [0.84-1.28],0.7276098608879391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD5,Sushi domain-containing protein 5,3821,409,1.26 [0.97-1.62],0.0833646771682985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SV2A,Synaptic vesicle glycoprotein 2A,3819,418,1.14 [0.99-1.32],0.0597582943477516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SWAP70,Switch-associated protein 70,3888,421,0.98 [0.75-1.28],0.8843927206268779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYAP1,Synapse-associated protein 1,3838,411,0.89 [0.75-1.05],0.154219373959066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,3781,416,1.02 [0.87-1.20],0.8188437661877389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYT1,Synaptotagmin-1,3892,422,0.94 [0.73-1.22],0.666515836776975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYTL4,Synaptotagmin-like protein 4,3900,420,0.99 [0.87-1.12],0.8552273458797454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,3845,412,1.00 [0.91-1.09],0.9273074249367304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACC3,Transforming acidic coiled-coil-containing protein 3,4485,502,0.99 [0.93-1.06],0.769127405699847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACSTD2,Tumor-associated calcium signal transducer 2,3988,444,2.18 [1.66-2.86],1.585829870750883e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TADA3,Transcriptional adapter 3,3890,418,0.93 [0.74-1.18],0.5678471844407321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAFA5,Chemokine-like protein TAFA-5,4485,502,1.63 [1.36-1.94],7.574599313027599e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAGLN3,Transgelin-3,3762,409,1.00 [0.86-1.17],0.9691947976264798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TALDO1,Transaldolase,3913,425,0.96 [0.78-1.19],0.699246468978387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TANK,TRAF family member-associated NF-kappa-B activator,4402,494,0.94 [0.84-1.06],0.2920114103746775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAP1,Antigen peptide transporter 1,3845,412,1.00 [0.86-1.16],0.9994240088433448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARBP2,RISC-loading complex subunit TARBP2,4377,495,1.01 [0.91-1.12],0.8145929694273136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",3819,418,1.02 [0.89-1.16],0.8018493119620094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",3890,418,0.86 [0.66-1.11],0.2377003698355758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAX1BP1,Tax1-binding protein 1,3892,422,0.97 [0.83-1.12],0.653551664051766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D17,TBC1 domain family member 17,4377,495,1.08 [0.91-1.27],0.3766538249654073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D23,TBC1 domain family member 23,4485,502,0.99 [0.91-1.08],0.8105249465646849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D5,TBC1 domain family member 5,4504,507,0.96 [0.87-1.06],0.4304404542429731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCA,Tubulin-specific chaperone A,3838,411,0.99 [0.88-1.11],0.8316120846704855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCB,Tubulin-folding cofactor B,4473,505,1.00 [0.92-1.08],0.9387024453550245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCC,Tubulin-specific chaperone C,4473,505,1.01 [0.91-1.11],0.8827647647419931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,4377,493,1.02 [0.92-1.12],0.7372311675398013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBR1,T-box brain protein 1,3819,418,0.98 [0.82-1.19],0.8716326754455634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1A,T-cell leukemia/lymphoma protein 1A,4470,504,0.87 [0.81-0.94],0.0002851249114445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1B,T-cell leukemia/lymphoma protein 1B,4430,500,1.03 [0.93-1.13],0.6072461017158474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN1,Transcobalamin-1,3825,414,0.77 [0.59-1.02],0.0690401772771648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN2,Transcobalamin-2,4557,512,2.14 [1.73-2.65],3.190759203393278e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCOF1,Treacle protein,3900,420,1.21 [0.91-1.60],0.189411651108121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCP11,T-complex protein 11 homolog,3845,412,1.02 [0.87-1.19],0.8339890624453868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCTN3,Tectonic-3,3900,420,0.86 [0.64-1.16],0.3201904457287535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDGF1,Teratocarcinoma-derived growth factor 1,4377,495,1.02 [0.97-1.07],0.5013342603545595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDO2,"Tryptophan 2,3-dioxygenase",3819,418,0.80 [0.61-1.04],0.0917968804561305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,3890,418,0.99 [0.87-1.13],0.8494834907649363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDRKH,Tudor and KH domain-containing protein,4377,495,0.99 [0.90-1.09],0.82245333624379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEF,Thyrotroph embryonic factor,3783,414,0.92 [0.73-1.15],0.4551392480694671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEK,Angiopoietin-1 receptor,4513,505,1.61 [1.16-2.24],0.0046783259296418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TERF1,Telomeric repeat-binding factor 1,3792,418,0.85 [0.61-1.19],0.3364092153287478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TET2,Methylcytosine dioxygenase TET2,3835,411,0.96 [0.87-1.06],0.400851441525925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEX101,Testis-expressed protein 101,3819,418,1.04 [0.88-1.23],0.6387405236491666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEX33,Testis-expressed protein 33,3845,412,0.94 [0.73-1.22],0.6581656609721503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TF,Serotransferrin,3917,422,1.48 [0.98-2.25],0.0654440705083725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFAP2A,Transcription factor AP-2-alpha,3781,416,1.04 [0.89-1.21],0.6453878111608136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF1,Trefoil factor 1,4504,507,1.42 [1.31-1.53],7.321905036027103e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF2,Trefoil factor 2,4520,504,1.68 [1.51-1.87],2.2718504142674587e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF3,Trefoil factor 3,4489,506,1.74 [1.55-1.96],1.4605909140166238e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFPI,Tissue factor pathway inhibitor,4507,503,0.90 [0.71-1.14],0.3847214102393538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFPI2,Tissue factor pathway inhibitor 2,4504,504,1.17 [0.98-1.39],0.0870389972769257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFRC,Transferrin receptor protein 1,4524,506,1.26 [1.04-1.52],0.0186427544313927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TG,Thyroglobulin,3890,418,1.03 [0.95-1.12],0.4064301597479609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFA,Protransforming growth factor alpha,4504,507,1.42 [1.23-1.65],2.661938029477163e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFB1,Transforming growth factor beta-1 proprotein,4548,506,1.13 [0.93-1.37],0.2180633125263718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFB2,Transforming growth factor beta-2 proprotein,3890,418,1.05 [0.88-1.24],0.6036308546134377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,4488,501,0.56 [0.43-0.74],4.023886952169745e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR1,TGF-beta receptor type-1,3792,418,1.11 [0.71-1.73],0.6563649982218889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR2,TGF-beta receptor type-2,4513,505,1.94 [1.65-2.28],1.3906936892893381e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR3,Transforming growth factor beta receptor type 3,4564,512,1.37 [1.08-1.75],0.0098526006846874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,4496,503,0.96 [0.86-1.06],0.3865190686327796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGOLN2,Trans-Golgi network integral membrane protein 2,3921,425,1.91 [1.40-2.62],5.084047224307209e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,3756,409,0.88 [0.78-0.99],0.0405252711025192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBD,Thrombomodulin,4508,505,1.76 [1.40-2.21],1.499313995357634e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBS2,Thrombospondin-2,4525,508,1.24 [1.06-1.45],0.0064523892441903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBS4,Thrombospondin-4,4517,503,0.92 [0.79-1.08],0.3346338695176081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THOP1,Thimet oligopeptidase,4492,502,0.69 [0.55-0.88],0.002225770654072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THPO,Thrombopoietin,4430,500,1.12 [0.93-1.36],0.2347159934628397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THRAP3,Thyroid hormone receptor-associated protein 3,3783,414,0.92 [0.83-1.02],0.1017324931558253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THSD1,Thrombospondin type-1 domain-containing protein 1,3764,413,1.07 [0.82-1.38],0.6216446711511632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THTPA,Thiamine-triphosphatase,3883,418,1.02 [0.91-1.14],0.7395038600495485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THY1,Thy-1 membrane glycoprotein,4541,507,1.44 [1.13-1.84],0.0036473067227897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIA1,Nucleolysin TIA-1 isoform p40,4378,492,1.01 [0.94-1.08],0.8290111534098032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIE1,Tyrosine-protein kinase receptor Tie-1,4564,512,1.20 [0.99-1.47],0.0647896439940314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",4368,494,0.99 [0.83-1.18],0.8922116429561789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,3845,412,1.26 [1.08-1.48],0.0040557272641882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,4526,507,0.77 [0.65-0.91],0.0019461548201999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,3900,420,1.03 [0.81-1.29],0.8266199133728748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,3892,422,0.98 [0.88-1.09],0.7055303701604743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP1,Metalloproteinase inhibitor 1,4454,501,1.61 [1.27-2.04],7.244635894349461e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP2,Metalloproteinase inhibitor 2,3900,420,1.34 [1.00-1.78],0.0489437996866243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP3,Metalloproteinase inhibitor 3,4527,505,1.00 [0.95-1.06],0.94734860008418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP4,Metalloproteinase inhibitor 4,4525,508,1.16 [0.96-1.39],0.1200664204817313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TINAGL1,Tubulointerstitial nephritis antigen-like,4500,503,1.90 [1.36-2.64],0.000155521091677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TJAP1,Tight junction-associated protein 1,4513,505,0.97 [0.89-1.07],0.5795074557713815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TJP3,Tight junction protein ZO-3,3781,416,1.08 [0.88-1.34],0.4591145983453528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TK1,"Thymidine kinase, cytosolic",3845,412,0.92 [0.74-1.15],0.4798038679685336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR1,Toll-like receptor 1,3792,418,1.50 [1.07-2.09],0.0182038671725825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR2,Toll-like receptor 2,3845,412,1.29 [0.86-1.94],0.2189637790612576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR3,Toll-like receptor 3,4556,506,1.12 [0.99-1.26],0.0828643722244467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR4,Toll-like receptor 4,3792,418,0.85 [0.61-1.20],0.3592441884357907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,3819,418,1.02 [0.85-1.22],0.8420492638026006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED1,Transmembrane emp24 domain-containing protein 1,3845,412,1.03 [0.86-1.23],0.7555924267000557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED10,Transmembrane emp24 domain-containing protein 10,3783,414,1.05 [0.85-1.29],0.6774685644111259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED4,Transmembrane emp24 domain-containing protein 4,3783,414,0.84 [0.69-1.02],0.0820138866389534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED8,Protein TMED8,3888,421,0.99 [0.90-1.08],0.7758024234511578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM106A,Transmembrane protein 106A,3890,418,0.99 [0.86-1.13],0.8635807937191301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM132A,Transmembrane protein 132A,3805,414,1.09 [0.94-1.26],0.247014161738642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM25,Transmembrane protein 25,3905,425,1.21 [0.99-1.47],0.0649807279605455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMOD4,Tropomodulin-4,3762,409,1.02 [0.81-1.30],0.8539412589902713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS11B,Transmembrane protease serine 11B,3781,416,0.98 [0.86-1.11],0.7199734080781415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS11D,Transmembrane protease serine 11D,3884,422,1.22 [0.98-1.51],0.0759530907324697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS15,Enteropeptidase,4485,502,1.34 [1.23-1.46],2.4812038241106928e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS5,Transmembrane protease serine 5,4454,503,1.19 [0.97-1.46],0.1043293959529927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMSB10,Thymosin beta-10,4525,508,1.14 [1.02-1.26],0.0169341462538605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNC,Tenascin,4526,507,1.16 [0.99-1.35],0.0613364210020665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNF,Tumor necrosis factor,4426,499,1.35 [1.14-1.59],0.0003729787794915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,3888,421,1.02 [0.85-1.21],0.8632695748475936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,4402,494,0.98 [0.79-1.22],0.8775763118011486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,3838,411,1.00 [0.86-1.16],0.9885841860985116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,4473,505,2.04 [1.73-2.41],4.6848384688610717e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,4473,505,1.41 [1.28-1.55],1.112812324498066e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,4524,507,1.10 [0.93-1.29],0.2723904697550258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,4556,506,2.12 [1.82-2.47],2.8140185330705585e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,4504,504,1.60 [1.28-2.01],4.561593383818789e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,4513,505,2.03 [1.69-2.43],2.5977764089832882e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,4513,504,1.63 [1.35-1.98],5.018879950809479e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,4402,494,1.36 [1.15-1.62],0.0004669468377244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,4513,504,2.37 [1.97-2.87],2.438314147062773e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,3838,411,1.35 [1.08-1.69],0.007749871825788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,4543,508,1.78 [1.49-2.13],3.463281593083864e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,4525,508,2.69 [2.20-3.28],1.8955071936035408e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,4525,508,1.50 [1.33-1.69],4.414203906741656e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,4541,507,1.81 [1.40-2.34],5.188993628330136e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,4548,506,2.01 [1.70-2.38],4.447972855162343e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,4473,505,1.32 [1.16-1.50],2.6895897114396773e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,4541,507,1.37 [1.17-1.61],7.722051709905206e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,4473,505,1.67 [1.45-1.93],2.813539723580302e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,4556,506,0.72 [0.54-0.97],0.0308918578346912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,4504,507,0.81 [0.71-0.92],0.0015314987907078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,4556,506,0.64 [0.49-0.84],0.001122897493273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,4527,505,2.49 [1.92-3.23],7.228575805794594e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,4560,512,1.08 [0.83-1.41],0.5705112718748555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,4473,505,1.01 [0.88-1.16],0.8585410726791971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,3920,425,1.30 [1.03-1.65],0.0253784086150671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNIP1,TNFAIP3-interacting protein 1,3892,422,0.97 [0.87-1.08],0.5845525810549532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNN,Tenascin-N,3920,425,0.98 [0.80-1.21],0.8819945345962975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNNI3,"Troponin I, cardiac muscle",4430,500,0.96 [0.87-1.05],0.3334806455176599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNPO1,Transportin-1,3845,412,1.22 [0.93-1.60],0.1510669236867179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNR,Tenascin-R,4473,505,1.22 [1.01-1.46],0.0354614852432333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNXB,Tenascin-X,4525,508,0.63 [0.48-0.83],0.001198883348907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,3900,420,1.06 [0.94-1.19],0.3621472187624198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP1,DNA topoisomerase 1,3888,421,1.04 [0.96-1.12],0.3712917440717447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP1MT,"DNA topoisomerase I, mitochondrial",3762,409,0.87 [0.70-1.07],0.1813135658934764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP2B,DNA topoisomerase 2-beta,3792,418,0.98 [0.87-1.11],0.7651467973898414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOR1AIP1,Torsin-1A-interacting protein 1,3805,414,1.12 [0.96-1.32],0.1542310112745652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53,Cellular tumor antigen p53,4377,493,1.12 [0.93-1.34],0.2187911583719098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53BP1,TP53-binding protein 1,3792,418,1.04 [0.93-1.17],0.4726629015155656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53I3,Quinone oxidoreductase PIG3,3743,400,0.91 [0.76-1.09],0.3034481300074062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,4430,500,1.09 [0.85-1.40],0.4929571088538325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP73,Tumor protein p73,3819,418,0.92 [0.70-1.22],0.561995210244244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPBGL,Trophoblast glycoprotein-like,3819,418,0.94 [0.74-1.20],0.6412905370489179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPD52L2,Tumor protein D54,3838,411,0.97 [0.89-1.06],0.5448365037560909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPK1,Thiamin pyrophosphokinase 1,3900,420,0.50 [0.36-0.69],3.302167430342716e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPM3,Tropomyosin alpha-3 chain,3783,414,1.05 [0.86-1.29],0.6243251467657339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPMT,Thiopurine S-methyltransferase,4377,493,0.91 [0.81-1.02],0.0895658726995905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPP1,Tripeptidyl-peptidase 1,4476,502,1.25 [1.07-1.45],0.0044130282861527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPPP2,Tubulin polymerization-promoting protein family member 2,3845,412,1.03 [0.91-1.16],0.6446233025788837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPPP3,Tubulin polymerization-promoting protein family member 3,4377,495,0.79 [0.62-1.00],0.0538335982850062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPR,Nucleoprotein TPR,3783,414,0.93 [0.77-1.13],0.4653024266897416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPRKB,EKC/KEOPS complex subunit TPRKB,3762,409,0.99 [0.85-1.15],0.9083196160849448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSAB1,Tryptase alpha/beta-1,4548,506,1.19 [1.02-1.40],0.0303313969872709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSD1,Tryptase delta,3905,425,1.23 [0.96-1.57],0.0994905062953515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSG1,Tryptase gamma,3792,418,0.95 [0.67-1.35],0.772865036262772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPT1,Translationally-controlled tumor protein,4402,494,1.05 [0.92-1.19],0.4682131887341043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF2,TNF receptor-associated factor 2,4504,507,0.95 [0.85-1.06],0.3615664185279218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",3792,418,0.95 [0.74-1.21],0.662927481619893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,3783,414,0.94 [0.77-1.15],0.5722692853918396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,3845,412,0.96 [0.86-1.08],0.5077134686347947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREH,Trehalase,3920,425,1.05 [0.93-1.19],0.440517696552184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREM2,Triggering receptor expressed on myeloid cells 2,4504,504,1.04 [0.91-1.19],0.5167131610594888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREML1,Trem-like transcript 1 protein,3921,425,1.00 [0.84-1.19],0.987918073064178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREML2,Trem-like transcript 2 protein,4525,508,1.08 [0.87-1.35],0.4823568704328982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,4543,508,1.08 [0.95-1.23],0.212312534817707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,4504,507,0.98 [0.89-1.09],0.7371274928243623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM24,Transcription intermediary factor 1-alpha,3837,412,0.99 [0.86-1.15],0.8904021038403895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,3888,421,0.99 [0.91-1.08],0.8702607299927959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM26,Tripartite motif-containing protein 26,3762,409,0.91 [0.77-1.08],0.2850661729396898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM40,E3 ubiquitin ligase TRIM40,3819,418,0.97 [0.86-1.11],0.6887607134083844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM5,Tripartite motif-containing protein 5,4504,507,0.98 [0.89-1.07],0.6198435901517746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,3890,418,0.98 [0.88-1.09],0.7064339455426754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,3783,414,0.95 [0.78-1.15],0.5653871564563251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSC1,Hamartin,3792,418,0.91 [0.79-1.06],0.2312047869322188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSC22D1,TSC22 domain family protein 1,3905,425,1.08 [0.94-1.24],0.2995668589214244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSHB,Thyrotropin subunit beta,4508,505,0.84 [0.76-0.92],0.0004589957559846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSLP,Thymic stromal lymphopoietin,4430,500,1.09 [0.97-1.23],0.1381011477710667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSNAX,Translin-associated protein X,3783,414,1.02 [0.80-1.30],0.8945212487246749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN1,Tetraspanin-1,4430,500,1.04 [0.93-1.15],0.5219494262615036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN15,Tetraspanin-15,3783,414,1.01 [0.84-1.21],0.9065445213967132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN7,Tetraspanin-7,3781,416,0.96 [0.86-1.08],0.5143877767053919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN8,Tetraspanin-8,3888,421,0.98 [0.90-1.07],0.7073493973558951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPYL1,Testis-specific Y-encoded-like protein 1,3792,418,1.01 [0.80-1.28],0.931939921608528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TST,Thiosulfate sulfurtransferase,4375,495,1.04 [0.93-1.15],0.5071721646743345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTF2,Transcription termination factor 2,3819,418,1.07 [0.89-1.29],0.4639453111780424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTN,Titin,3783,414,1.14 [1.00-1.29],0.0545356665276477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTR,Transthyretin,3880,420,1.04 [0.74-1.47],0.8130322366127161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TUBB3,Tubulin beta-3 chain,3781,416,1.22 [0.86-1.74],0.2669781441997421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TWF2,Twinfilin-2,3920,425,1.02 [0.92-1.14],0.712505168296153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXK,Tyrosine-protein kinase TXK,3845,412,0.98 [0.87-1.12],0.8117269828077482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXLNA,Alpha-taxilin,4473,505,1.00 [0.91-1.09],0.991553714799884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXN,Thioredoxin,3853,418,1.00 [0.81-1.25],0.9771304809761344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC15,Thioredoxin domain-containing protein 15,4513,505,0.95 [0.72-1.24],0.6901808725032794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC5,Thioredoxin domain-containing protein 5,4541,507,1.17 [1.04-1.31],0.0072862512528653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC9,Thioredoxin domain-containing protein 9,3892,422,0.98 [0.83-1.17],0.8591104151128569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNL1,Thioredoxin-like protein 1,3776,415,1.01 [0.92-1.12],0.7664715208527532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",4525,508,0.92 [0.78-1.09],0.3545143171037261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYMP,Thymidine phosphorylase,4476,501,0.97 [0.86-1.10],0.6540454574915908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,4508,505,1.23 [0.94-1.62],0.1278044886389499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",3792,418,1.27 [1.09-1.47],0.0017453440295137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBAC1,Ubiquitin-associated domain-containing protein 1,4485,502,1.05 [0.84-1.32],0.6499544103232562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,3890,418,1.10 [0.79-1.52],0.5801439939973461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,3900,420,1.01 [0.86-1.18],0.8929725878802043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,3792,418,1.05 [0.89-1.24],0.5497790765162618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBQLN3,Ubiquilin-3,3783,414,0.93 [0.79-1.10],0.3929171148500346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBXN1,UBX domain-containing protein 1,3838,411,0.96 [0.84-1.10],0.5868089013453284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,3888,421,1.00 [0.94-1.07],0.9659520527866932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UGDH,UDP-glucose 6-dehydrogenase,3783,414,1.06 [0.97-1.16],0.1833318077356758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,3783,414,1.13 [0.85-1.50],0.3856793974194222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ULBP2,UL16-binding protein 2,4473,505,1.65 [1.38-1.97],3.7715395196182056e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UMOD,Uromodulin,4547,507,0.72 [0.63-0.82],7.613425060427186e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNC5D,Netrin receptor UNC5D,3792,418,1.04 [0.73-1.48],0.8425055796027809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNC79,Protein unc-79 homolog,3762,409,1.12 [0.95-1.33],0.1723984755652723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNG,Uracil-DNA glycosylase,3890,418,0.98 [0.74-1.30],0.9099306037977132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPB1,Beta-ureidopropionase,3900,420,0.89 [0.81-0.97],0.0119766962371997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPK3A,Uroplakin-3a,3781,416,0.95 [0.78-1.14],0.5598990403089228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPK3BL1,Uroplakin-3b-like protein 1,3838,410,0.95 [0.78-1.16],0.6064676877134614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UROD,Uroporphyrinogen decarboxylase,3838,411,0.93 [0.81-1.08],0.3469750440812575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UROS,Uroporphyrinogen-III synthase,3819,418,1.08 [0.93-1.24],0.3073072418838908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USO1,General vesicular transport factor p115,4485,502,1.02 [0.93-1.11],0.6802058014445472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,3890,418,1.01 [0.89-1.16],0.8382362207569115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,3892,422,1.46 [1.19-1.81],0.0003526354589815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,3783,414,1.10 [0.99-1.21],0.076929553578893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,4430,500,1.03 [0.95-1.12],0.4714524337161011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UXS1,UDP-glucuronic acid decarboxylase 1,4377,493,1.08 [0.94-1.24],0.2726699127538167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAMP5,Vesicle-associated membrane protein 5,4430,500,1.02 [0.89-1.18],0.7570247943655994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAMP8,Vesicle-associated membrane protein 8,3792,418,0.98 [0.88-1.09],0.7231868412464117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,4504,507,1.01 [0.92-1.11],0.8207581325341546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASN,Vasorin,4439,494,2.04 [1.57-2.65],7.582297098158659e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASP,Vasodilator-stimulated phosphoprotein,3921,425,0.97 [0.85-1.10],0.5955136566073066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,4485,502,1.11 [0.75-1.64],0.6065610668527688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAV3,Guanine nucleotide exchange factor VAV3,3781,416,1.01 [0.92-1.11],0.8269947081048248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAM1,Vascular cell adhesion protein 1,4523,505,2.03 [1.59-2.60],1.5064164320897864e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAN,Versican core protein,4541,507,1.23 [0.96-1.58],0.1087037700071261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCPKMT,Protein-lysine methyltransferase METTL21D,3762,409,1.00 [0.89-1.12],0.9566177059902758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFA,Vascular endothelial growth factor A,4542,505,1.15 [1.01-1.31],0.0313660366242475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFB,Vascular endothelial growth factor B,3792,418,0.98 [0.72-1.35],0.9179326413422936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFC,Vascular endothelial growth factor C,4513,505,1.01 [0.88-1.16],0.8681285188569422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFD,Vascular endothelial growth factor D,4548,505,1.82 [1.50-2.21],1.2241480422609604e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VGF,Neurosecretory protein VGF,3905,425,1.02 [0.77-1.36],0.8898740223273488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIM,Vimentin,4430,500,0.99 [0.92-1.05],0.6813315813526515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,3805,414,1.18 [0.80-1.73],0.399229950706931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIT,Vitrin,3900,420,0.94 [0.74-1.19],0.5998146221375855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VMO1,Vitelline membrane outer layer protein 1 homolog,4485,502,1.20 [1.06-1.36],0.0036897234092135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VNN1,Pantetheinase,3921,425,0.93 [0.82-1.04],0.2129008467987148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VNN2,Vascular non-inflammatory molecule 2,4485,502,1.09 [0.92-1.29],0.3276239304304179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,3845,412,0.99 [0.85-1.14],0.845896018196028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS37A,Vacuolar protein sorting-associated protein 37A,4485,502,1.01 [0.91-1.12],0.831266614960692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS4B,Vacuolar protein sorting-associated protein 4B,3890,418,1.00 [0.90-1.10],0.952586383523804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,4485,502,0.98 [0.89-1.08],0.6888117069610739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,3890,418,1.02 [0.79-1.31],0.8836947156036231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,3783,414,1.28 [0.99-1.66],0.0605265171012547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,3890,418,1.46 [1.31-1.64],3.442018448075152e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,4518,507,2.01 [1.72-2.35],3.448868211009339e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,4501,505,1.14 [1.01-1.28],0.036257057672111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSNL1,Visinin-like protein 1,3892,422,0.64 [0.51-0.81],0.0001479510112768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM1,V-set and transmembrane domain-containing protein 1,4377,495,1.11 [0.95-1.30],0.2067026680478766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,3845,412,0.87 [0.67-1.11],0.2657071292172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,4430,500,1.22 [1.09-1.38],0.0009108954653549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,4541,507,1.00 [0.89-1.12],0.9766433272035292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,4377,493,1.37 [1.10-1.71],0.0051397578143965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,3838,411,0.96 [0.82-1.14],0.6737630963997161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWA1,von Willebrand factor A domain-containing protein 1,4535,508,1.02 [0.84-1.23],0.8710881169921733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWA5A,von Willebrand factor A domain-containing protein 5A,3762,409,1.04 [0.93-1.16],0.5003796456483908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2,Brorin,4457,504,1.50 [1.25-1.79],1.5166239783904406e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,3905,425,1.14 [0.96-1.34],0.13055995298236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWF,von Willebrand factor,4564,512,1.04 [0.94-1.16],0.4238543855957094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",4525,508,0.98 [0.80-1.20],0.8094503118097025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WAS,Wiskott-Aldrich syndrome protein,4402,494,1.01 [0.89-1.14],0.8961395781446755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,4430,500,0.98 [0.90-1.07],0.6661010407582295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,4377,495,0.97 [0.88-1.07],0.5192547257898625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASHC3,WASH complex subunit 3,3892,422,0.99 [0.87-1.12],0.8289213947926375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASL,Neural Wiskott-Aldrich syndrome protein,3792,418,1.00 [0.85-1.17],0.9522612365728924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WDR46,WD repeat-containing protein 46,3890,418,0.82 [0.62-1.08],0.1500258951588985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC1,WAP four-disulfide core domain protein 1,3815,410,1.08 [0.92-1.26],0.3602241729209189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC12,WAP four-disulfide core domain protein 12,4537,508,1.15 [1.02-1.29],0.0177563951764407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC2,WAP four-disulfide core domain protein 2,4284,468,1.92 [1.65-2.22],9.984337813938409e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",4457,503,0.81 [0.67-0.97],0.0216262524697932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",4513,504,1.21 [0.97-1.51],0.0855782252958625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WIF1,Wnt inhibitory factor 1,4543,508,0.60 [0.48-0.76],1.0158257068351511e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WNT9A,Protein Wnt-9a,4402,494,1.98 [1.64-2.38],7.075971291249404e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,4473,505,0.88 [0.76-1.03],0.1036114724213291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XCL1,Lymphotactin,4543,508,1.27 [1.13-1.43],9.606998391732506e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XG,Glycoprotein Xg,4540,511,1.85 [1.52-2.25],1.0048447987570779e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XIAP,E3 ubiquitin-protein ligase XIAP,3792,418,1.03 [0.87-1.21],0.7384168233882327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XPNPEP2,Xaa-Pro aminopeptidase 2,4513,505,0.89 [0.82-0.95],0.0011363802946259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XRCC4,DNA repair protein XRCC4,4377,495,0.99 [0.80-1.23],0.933128926763487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YAP1,Transcriptional coactivator YAP1,3892,422,2.14 [1.61-2.84],1.2809013122506346e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",3888,421,1.00 [0.94-1.07],0.9087787844669976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YES1,Tyrosine-protein kinase Yes,4485,502,1.01 [0.94-1.08],0.8053972347114696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YJU2,Splicing factor YJU2,3890,418,1.02 [0.76-1.37],0.9061126500796138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YOD1,Ubiquitin thioesterase OTU1,3783,414,0.89 [0.77-1.03],0.1129045445684419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YTHDF3,YTH domain-containing family protein 3,4402,494,1.00 [0.91-1.10],0.9583130197277416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YWHAQ,14-3-3 protein theta,3838,411,0.96 [0.85-1.10],0.5839855007726334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YY1,Transcriptional repressor protein YY1,3792,418,0.81 [0.57-1.15],0.2401441002111916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBP1,Z-DNA-binding protein 1,3792,418,0.96 [0.75-1.23],0.7419680480331017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,4377,493,0.95 [0.85-1.06],0.3471276872879831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,4430,500,1.05 [0.88-1.26],0.576940556497719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,3783,414,0.92 [0.78-1.08],0.3239878027792473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZFYVE19,Abscission/NoCut checkpoint regulator,3888,421,1.00 [0.90-1.11],0.9604636260590949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZHX2,Zinc fingers and homeoboxes protein 2,3892,422,1.03 [0.80-1.34],0.7996114324480414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF174,Zinc finger protein 174,3792,418,0.87 [0.66-1.16],0.3569456958290262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF75D,Zinc finger protein 75D,3845,412,0.92 [0.79-1.09],0.3357061997670417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF830,Zinc finger protein 830,3890,418,1.04 [0.92-1.17],0.502765980473182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNRD2,Protein ZNRD2,3888,421,1.07 [0.95-1.22],0.2669503559432956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,3890,418,0.97 [0.82-1.16],0.7690492382085189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZP3,Zona pellucida sperm-binding protein 3,3805,414,1.03 [0.99-1.07],0.1456707048705448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZP4,Zona pellucida sperm-binding protein 4,3762,409,1.11 [0.86-1.43],0.4344662173139988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZPR1,Zinc finger protein ZPR1,3781,416,0.97 [0.88-1.07],0.5597089715363452
